+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 54843

Chapter 54843 contains a list of PDF Full Texts available from EurekaMag.





Shematorova, E.K.; Shpakovskiĭ, D.G.; Shpakovskiĭ, G.V., 2010:
PSM2 and POLR2J gene families as molecular markers of the higher primate evolution

Eder, M.; Eisenhut, M.; Babich, J.; Haberkorn, U., 2013:
PSMA as a target for radiolabelled small molecules

Wang, W.; Tavora, F.; Sharma, R.; Eisenberger, M.; Netto, G.J., 2008:
PSMA expression in Schwannoma: a potential clinical mimicker of metastatic prostate carcinoma

Jin, J.; Sui, B.; Gou, J.; Liu, J.; Tang, X.; Xu, H.; Zhang, Y.; Jin, X., 2015:
PSMA ligand conjugated PCL-PEG polymeric micelles targeted to prostate cancer cells

Su, Y.; Yu, L.; Liu, N.; Guo, Z.; Wang, G.; Zheng, J.; Wei, M.; Wang, H.; Yang, A-Gang.; Qin, W.; Wen, W., 2014:
PSMA specific single chain antibody-mediated targeted knockdown of Notch1 inhibits human prostate cancer cell proliferation and tumor growth

Rybalov, M.; Ananias, H.J.K.; Hoving, H.D.; van der Poel, H.G.; Rosati, S.; de Jong, I.J., 2014:
PSMA, EpCAM, VEGF and GRPR as imaging targets in locally recurrent prostate cancer after radiotherapy

Gao, Y.; Li, Y.; Li, Y.; Yuan, L.; Zhou, Y.; Li, J.; Zhao, L.; Zhang, C.; Li, X.; Liu, Y., 2015:
PSMA-mediated endosome escape-accelerating polymeric micelles for targeted therapy of prostate cancer and the real time tracing of their intracellular trafficking

Zuccolotto, G.; Fracasso, G.; Merlo, A.; Montagner, I.Monia.; Rondina, M.; Bobisse, S.; Figini, M.; Cingarlini, S.; Colombatti, M.; Zanovello, P.; Rosato, A., 2016:
PSMA-specific CAR-engineered T cells eradicate disseminated prostate cancer in preclinical models

Akhtar, N.H.; Osborne, J.R.; Fareedy, S.B.; Tagawa, S.T., 2013:
PSMA-targeted dendrimers: a patent evaluation (WO2012078534)

Huang, B.; Otis, J.; Joice, M.; Kotlyar, A.; Thomas, T.P., 2014:
PSMA-targeted stably linked "dendrimer-glutamate urea-methotrexate" as a prostate cancer therapeutic

Chen, Z.; Penet, M-France.; Nimmagadda, S.; Li, C.; Banerjee, S.R.; Winnard, P.T.; Artemov, D.; Glunde, K.; Pomper, M.G.; Bhujwalla, Z.M., 2013:
PSMA-targeted theranostic nanoplex for prostate cancer therapy

Tse, B.Wan-Chi.; Cowin, G.J.; Soekmadji, C.; Jovanovic, L.; Vasireddy, R.S.; Ling, M-Tat.; Khatri, A.; Liu, T.; Thierry, B.; Russell, P.J., 2015:
PSMA-targeting iron oxide magnetic nanoparticles enhance MRI of preclinical prostate cancer

Jemaa, A.Ben.; Bouraoui, Y.; Sallami, S.; Banasr, A.; Nouira, Y.; Oueslati, R., 2014:
PSMA/PSA ratio evaluated by immunohistochemistry may improve diagnosis of prostate cancer

Yang, L.; Tang, Z.; Zhang, H.; Kou, W.; Lu, Z.; Li, X.; Li, Q.; Miao, Z., 2014:
PSMA7 directly interacts with NOD1 and regulates its function

Tan, J-Yu.; Huang, X.; Luo, Y-Ling., 2012:
PSMA7 inhibits the tumorigenicity of A549 human lung adenocarcinoma cells

Du, H.; Huang, X.; Wang, S.; Wu, Y.; Xu, W.; Li, M., 2009:
PSMA7, a potential biomarker of diseases

Kriegova, E.; Arakelyan, A.; Fillerova, R.; Zatloukal, J.; Mrazek, F.; Navratilova, Z.; Kolek, V.; du Bois, R.M.; Petrek, M., 2008:
PSMB2 and RPL32 are suitable denominators to normalize gene expression profiles in bronchoalveolar cells

Camarena, A.; Aquino-Galvez, A.; Falfán-Valencia, Rés.; Sánchez, G.; Montaño, M.; Ramos, C.; Juárez, A.; García-de-Alba, C.; Granados, J.; Selman, Més., 2010:
PSMB8 (LMP7) but not PSMB9 (LMP2) gene polymorphisms are associated to pigeon breeder's hypersensitivity pneumonitis

Agarwal, A.K.; Xing, C.; DeMartino, G.N.; Mizrachi, D.; Hernandez, M.Dolores.; Sousa, A.Berta.; Martínez de Villarreal, L.; dos Santos, Hísa.G.; Garg, A., 2011:
PSMB8 encoding the β5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome

Park, J.Eun.; Ao, L.; Miller, Z.; Kim, K.; Wu, Y.; Jang, E.Ryoung.; Lee, E.Young.; Kim, K.Bo.; Lee, W., 2014:
PSMB9 codon 60 polymorphisms have no impact on the activity of the immunoproteasome catalytic subunit B1i expressed in multiple types of solid cancer

Gómez-Garre, P.; Jesús, S.; Carrillo, Fátima.; Cáceres-Redondo, M.Teresa.; Bernal-Bernal, I.; Carballo, M.; Gao, L.; Mir, P., 2013:
PSMC1 Gene in Parkinson's Disease

Langlands, F.E.; Dodwell, D.; Hanby, A.M.; Horgan, K.; Millican-Slater, R.A.; Speirs, V.; Verghese, E.T.; Smith, L.; Hughes, T.A., 2015:
PSMD9 expression predicts radiotherapy response in breast cancer

Gragnoli, C., 2009:
PSMD9 gene in the NIDDM2 locus is linked to type 2 diabetes in Italians

Gragnoli, C., 2010:
PSMD9 is linked to MODY3

Rasigade, J-Philippe.; Trouillet-Assant, S.; Ferry, T.; Diep, B.An.; Sapin, Aïs.; Lhoste, Y.; Ranfaing, Jérémy.; Badiou, Cédric.; Benito, Y.; Bes, Mèle.; Couzon, F.; Tigaud, S.; Lina, Gérard.; Etienne, Jérôme.; Vandenesch, Fçois.; Laurent, Fédéric., 2014:
PSMs of hypervirulent Staphylococcus aureus act as intracellular toxins that kill infected osteoblasts

Cope, C., 2011:
PSNA endeavors to advance the nursing profession reflected in IOM recommendations

Zhang, J.; Zhao, X.; Sun, P.; Ma, Z., 2015:
PSNO: predicting cysteine S-nitrosylation sites by incorporating various sequence-derived features into the general form of Chou's PseAAC

Cheng, W-Chang., 2014:
PSO algorithm particle filters for improving the performance of lane detection and tracking systems in difficult roads

Bao, Y.; Xiong, T.; Hu, Z., 2013:
PSO-MISMO modeling strategy for multistep-ahead time series prediction

Giaquinto, A.; Fornarelli, G., 2010:
PSO-based cloning template design for CNN associative memories

Leong, W-Fung.; Yen, G.G., 2008:
PSO-based multiobjective optimization with dynamic population size and adaptive local archives

Liu, X.; Fu, H., 2015:
PSO-based support vector machine with cuckoo search technique for clinical disease diagnoses

Liao, Y.Lan.; Wang, J.Feng.; Wu, J.Lei.; Wang, J.Jiao.; Zheng, X.Ying., 2013:
PSO/ACO algorithm-based risk assessment of human neural tube defects in Heshun County, China

Anonymous, 2007:
PSO: an evolving, critical role in health care quality

Linder, D.; Altomare, G.; Amato, S.; Amerio, P.; Balato, N.; Campanati, A.; Conti, A.; Gisondi, P.; Prignano, F.; Saraceno, R.; Piaserico, S., 2016:
PSOCUBE, a multidimensional assessment of psoriasis patients as a both clinically/practically sustainable and evidence-based algorithm

Papp, K.A.; Strober, B.; Augustin, M.; Calabro, S.; Londhe, A.; Chevrier, M.; Augustin, M.; Chevrier, M.; Fiorentino, D.; Gelfand, J.; Gordon, K.; Gottlieb, A.B.; Ho, V.; Kalb, R.; Kerdel, F.A.; Kimball, A.B.; Krueger, G.G.; Langley, R.; Lebwohl, M.; Leonardi, C.L.; Menter, A.; Naldi, L.; Papp, K.; Pariser, D.; Strober, B., 2013:
PSOLAR: design, utility, and preliminary results of a prospective, international, disease-based registry of patients with psoriasis who are receiving, or are candidates for, conventional systemic treatments or biologic agents

Sun, H.; Xu, B.; Meng, Q.; Yang, Q.; Chang, X., 2014:
PSORS1C1/CDSN is associated with ankylosing spondylitis

Jordan, C.T.; Cao, L.; Roberson, E.D.O.; Pierson, K.C.; Yang, C-Fan.; Joyce, C.E.; Ryan, C.; Duan, S.; Helms, C.A.; Liu, Y.; Chen, Y.; McBride, A.A.; Hwu, W-Liang.; Wu, J-Yuarn.; Chen, Y-Tsong.; Menter, A.; Goldbach-Mansky, R.; Lowes, M.A.; Bowcock, A.M., 2012:
PSORS2 is due to mutations in CARD14

Yu, N.Y.; Wagner, J.R.; Laird, M.R.; Melli, G.; Rey, Sébastien.; Lo, R.; Dao, P.; Sahinalp, S.Cenk.; Ester, M.; Foster, L.J.; Brinkman, F.S.L., 2010:
PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes

Yu, N.Y.; Laird, M.R.; Spencer, C.; Brinkman, F.S.L., 2011:
PSORTdb--an expanded, auto-updated, user-friendly protein subcellular localization database for Bacteria and Archaea

Anonymous, 2014:
PSOs tout benefits of membership

Schaub, D.; Juckel, G., 2012:
PSP Scale: German version of the Personal and Social Performance Scale: valid instrument for the assessment of psychosocial functioning in the treatment of schizophrenia

Lajaunias, F., 2015:
PSP and NT-proCNP assessed for predisposition to infection

Kurata, T.; Kametaka, S.; Ohta, Y.; Morimoto, N.; Deguchi, S.; Deguchi, K.; Ikeda, Y.; Takao, Y.; Ohta, T.; Manabe, Y.; Sato, S.; Abe, K., 2012:
PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage

Roje-Busatto, R.; Ujević, I., 2014:
PSP toxins profile in ascidian Microcosmus vulgaris (Heller, 1877) after human poisoning in Croatia (Adriatic Sea)

Caballero, I.; Vazquez, J.M.; Mayor, G.M.; Almiñana, C.; Calvete, J.J.; Sanz, L.; Roca, J.; Martinez, E.A., 2008:
PSP-I/PSP-II spermadhesin exert a decapacitation effect on highly extended boar spermatozoa

Li, L.; Bimmler, D.; Graf, R.; Zhou, S.; Sun, Z.; Chen, J.; Siech, M.; Bachem, M.G., 2011:
PSP/reg inhibits cultured pancreatic stellate cell and regulates MMP/ TIMP ratio

Williams, B., 2008:
PSP: an experiment in solving Tennessee's prescription drug problem

Su, F.; Ou, H-Yu.; Tao, F.; Tang, H.; Xu, P., 2014:
PSP: rapid identification of orthologous coding genes under positive selection across multiple closely related prokaryotic genomes

Rummel, S.; Penatzer, C.E.; Shriver, C.D.; Ellsworth, R.E., 2014:
PSPHL and breast cancer in African American women: causative gene or population stratification?

Lee, M.S.; Bondugula, R.; Desai, V.; Zavaljevski, N.; Yeh, I-Chul.; Wallqvist, A.; Reifman, J., 2009:
PSPP: a protein structure prediction pipeline for computing clusters

Chatterjee, P.; Basu, S.; Kundu, M.; Nasipuri, M.; Plewczynski, D., 2012:
PSP_MCSVM: brainstorming consensus prediction of protein secondary structures using two-stage multiclass support vector machines

Laszlo, S.; Armstrong, B.C., 2015:
PSPs and ERPs: applying the dynamics of post-synaptic potentials to individual units in simulation of temporally extended Event-Related Potential reading data

Sanazaro, P.J., 1979:
PSRO, Politics and Quality Assurance

Msmw, 1977:
PSRO-Update 1977

Flick, A.L., 1980:
PSRO: Views of an Anti-PSRO Physician

Sharma, M.R.; Dönhöfer, A.; Barat, C.; Marquez, V.; Datta, P.P.; Fucini, P.; Wilson, D.N.; Agrawal, R.K., 2010:
PSRP1 is not a ribosomal protein, but a ribosome-binding factor that is recycled by the ribosome-recycling factor (RRF) and elongation factor G (EF-G)

Lee, S.Jong.; Oh, K.Nam.; Lee, J.Min.; Kim, J.Hyun.; Cheong, I.Woo., 2010:
PSS resin-fortified polythiophene nanoparticles for highly transparent conducting films

Mrozek, D.; Wieczorek, D.; Malysiak-Mrozek, B.; Kozielski, S., 2011:
PSS-SQL: protein secondary structure - structured query language

Fragoso, C.M.; Schumann Burkard, G.; Oberle, M.; Renggli, C.Kunz.; Hilzinger, K.; Roditi, I., 2010:
PSSA-2, a membrane-spanning phosphoprotein of Trypanosoma brucei, is required for efficient maturation of infection

Oh, J-Yeol.; Kim, J-Hwan.; Lee, H-Soo.; Kim, J-Young., 2010:
PSSK modulation scheme for high-data rate implantable medical devices

Li, L.; Cui, X.; Yu, S.; Zhang, Y.; Luo, Z.; Yang, H.; Zhou, Y.; Zheng, X., 2015:
PSSP-RFE: accurate prediction of protein structural class by recursive feature extraction from PSI-BLAST profile, physical-chemical property and functional annotations

Kumar, P.; Chaitanya, P.S.; Nagarajaram, H.A., 2011:
PSSRdb: a relational database of polymorphic simple sequence repeats extracted from prokaryotic genomes

Hartman, D.E., 2007:
PSST! Wanna buy a good new memory test-cheap?: The Test of Memory and Learning-2

Shin, J.; Camblor, M.A.; Woo, H.Chul.; Miller, S.R.; Wright, P.A.; Hong, S.Bong., 2009:
PST-1: a synthetic small-pore zeolite that selectively adsorbs H2

Joseph, M.M.; Aravind, S.R.; Varghese, S.; Mini, S.; Sreelekha, T.T., 2013:
PST-Gold nanoparticle as an effective anticancer agent with immunomodulatory properties

Brusig, E.; Davies, W., 2008:
PSTAC survey in 2006 was instrumental in obtaining permanent (category I) CPT codes for MTM services performed by pharmacists

Tseng, S.H., 2009:
PSTD Simulation of optical phase conjugation of light propagating long optical paths

Chitu, V.; Nacu, V.; Charles, J.F.; Henne, W.M.; McMahon, H.T.; Nandi, S.; Ketchum, H.; Harris, R.; Nakamura, M.C.; Stanley, E.Richard., 2013:
PSTPIP2 deficiency in mice causes osteopenia and increased differentiation of multipotent myeloid precursors into osteoclasts

Strehl, E., 2009:
PSUR - Instrument for pharmacovigilance and patient safety. What pharmacists should know about periodic safety update reports

Zheng, Z-Qian.; Fu, Y-Ying.; Li, B-Heng.; Zhang, M-Ling.; Yang, X-Li.; Xin, C-Wei.; Shi, J-Na.; Ying, Y.; Huang, P., 2014:
PSY-1, a Taxus chinensis var. mairei extract, inhibits cancer cell metastasis by interfering with MMPs

Anonymous, 2014:
PSYCHE and the skin; emotional factors in dermatoses

Paradiso, R.; Bianchi, A.M.; Lau, K.; Scilingo, E.P., 2011:
PSYCHE: personalised monitoring systems for care in mental health

Hanley, F.W., 1964:
PSYCHEDELICS (Hallucinogens)

Bennett, A.E., 1960:
PSYCHIATRIC UNITS IN GENERAL HOSPITALS-Problems in Development and Efficient Operation

Anonymous, 1946:
PSYCHIATRIC disorders and reactions: definitions and manner of recording

Anonymous, 1947:
PSYCHIATRIC nursing; a career that is worth while

Anonymous, 1946:
PSYCHIATRIC problems of repatriated prisoners

Anonymous, 1949:
PSYCHIATRIC service in municipal and county courts

Anonymous, 1947:
PSYCHIATRIC social worker in the mental hospital

Anonymous, 2015:
PSYCHIATRIC testimony before courts-martial

Anonymous, 1946:
PSYCHIATRY nomenclature; psychiatric disorders and reactions: definitions and manner of recording

Anonymous, 2011:
PSYCHO-DRAMA and the death problem

Khubalkar, R.; Gupta, O.P., 1984:
PSYCHO-DYNAMICS OF KORO: (A Case Report)

Soranzo, A.; Grassi, M., 2014:
PSYCHOACOUSTICS: a comprehensive MATLAB toolbox for auditory testing

Mack, C.W., 1916:
PSYCHOGENIC FACTORS IN ORGANIC DISEASE: Illustrated by two cases

Anonymous, 2014:
PSYCHOLOGICAL TEST construction and research in the Bureau of Naval Personnel; Navy radio technician training program

Anonymous, 2012:
PSYCHOLOGICAL impact of aircraft accidents

Anonymous, 1946:
PSYCHOLOGICAL research on pilot training in the AAF

Anonymous, 2014:
PSYCHOLOGICAL test construction and research in the Bureau of Naval Personnel; measurement of achievement in Navy training

Anonymous, 1946:
PSYCHONEUROSIS in industry

Weiss, M.G. , 1981:
PSYCHOPATHOLOGY IN THE EARLY AURVEDIC TEXTS: (With Special reference to unmada)

Anonymous, 1946:
PSYCHOSOMATIC medicine is not new

Anonymous, 1949:
PSYCHOSOMATIC sleep in dentistry; a preliminary report

Anonymous, 2014:
PSYCHOTHERAPY and the general practitioner

Anonymous, 2014:
PSYCHOTHERAPY by television; closed-circuit television gives promise of being an effective medium for the administration of therapy to the mentally ill

McAtee, W.L., 1915:
PSYLLIDAe WINTERING ON CONIFERS ABOUT WASHINGTON, D. C

Pasciak, A.S.; Jones, A.Kyle., 2012:
PShield: an exact three-dimensional numerical solution for determining optimal shielding designs for PET/CT facilities

Pandit, S.B.; Brylinski, M.; Zhou, H.; Gao, M.; Arakaki, A.K.; Skolnick, J., 2010:
PSiFR: an integrated resource for prediction of protein structure and function

Kaznadzey, A.; Alexandrova, N.; Novichkov, V.; Kaznadzey, D., 2013:
PSimScan: algorithm and utility for fast protein similarity search

Leedman, B., 2008:
PSivida corporation

Jayapandian, J.; Swarrup, J.Sakthi.; Sheela, O.K.; Ravi, U., 2012:
PSoC-based embedded design and quartz tuning fork for low-temperature measurement system design

Maione, E.; Tortoli, P.; Lypacewicz, G.; Nowicki, A.; Reid, J.M., 2008:
PSpice modelling of ultrasound transducers: comparison of software models to experiment

Wild, G.; Hinckley, S., 2010:
PSpice simulation of an electro-acoustic communications channel

van Deventer, J.; Lofqvist, T.; Delsing, J., 2008:
PSpice simulation of ultrasonic systems

Castaldi, G.; Savoia, S.; Galdi, V.; Alù, A.; Engheta, N., 2013:
PT metamaterials via complex-coordinate transformation optics

Dmytriv, M.; Rowland, K.; Gavagan, T.; Holub, D., 2010:
PT or cervical collar for cervical radiculopathy?

Bender, C.M.; DeKieviet, M.; Klevansky, S.P., 2013:
PT quantum mechanics

Bittner, S.; Dietz, B.; Günther, U.; Harney, H.L.; Miski-Oglu, M.; Richter, A.; Schäfer, F., 2012:
PT symmetry and spontaneous symmetry breaking in a microwave billiard

Mannheim, P.D., 2013:
PT symmetry as a necessary and sufficient condition for unitary time evolution

Li, H-Jun.; Dou, J-Peng.; Huang, G., 2014:
PT symmetry via electromagnetically induced transparency

Hang, C.; Huang, G.; Konotop, V.V., 2013:
PT symmetry with a system of three-level atoms

Dutta, S.; Snyder, M.J.; Rosile, D.; Binz, K.L.; Roll, E.H.; Suryadi, J.; Bierbach, U.; Guthold, M., 2014:
PT-ACRAMTU, a platinum-acridine anticancer agent, lengthens and aggregates, but does not stiffen or soften DNA

Chantreau, M.; Grec, Sébastien.; Gutierrez, L.; Dalmais, M.; Pineau, C.; Demailly, Hé.; Paysant-Leroux, C.; Tavernier, R.; Trouvé, J-Paul.; Chatterjee, M.; Guillot, X.; Brunaud, Véronique.; Chabbert, B.; van Wuytswinkel, O.; Bendahmane, A.; Thomasset, B.; Hawkins, S., 2014:
PT-Flax (phenotyping and TILLinG of flax): development of a flax (Linum usitatissimum L.) mutant population and TILLinG platform for forward and reverse genetics

Bennett, C.L.; McNeer, R.R., 2012:
PT-SAFE: a software tool for development and annunciation of medical audible alarms

Ramezani, H.; Christodoulides, D.N.; Kovanis, V.; Vitebskiy, I.; Kottos, T., 2012:
PT-symmetric Talbot effects

Bludov, Y.V.; Hang, C.; Huang, G.; Konotop, V.V., 2014:
PT-symmetric coupler with a coupling defect: soliton interaction with exceptional point

Longhi, S.; Feng, L., 2014:
PT-symmetric microring laser-absorber

Li, K.; Kevrekidis, P.G., 2011:
PT-symmetric oligomers: analytical solutions, linear stability, and nonlinear dynamics

Jing, H.; Özdemir, S.K.; Lü, X-You.; Zhang, J.; Yang, L.; Nori, F., 2014:
PT-symmetric phonon laser

Prosen, Tž., 2012:
PT-symmetric quantum Liouvillean dynamics

Milton, K.A.; Abalo, E.K.; Parashar, P.; Pourtolami, N.; Wagner, J., 2013:
PT-symmetric quantum electrodynamics and unitarity

West, C.T.; Kottos, T.; Prosen, T., 2010:
PT-symmetric wave Chaos

Chong, Y.D.; Ge, L.; Stone, A.Douglas., 2011:
PT-symmetry breaking and laser-absorber modes in optical scattering systems

Yang, X.; Zhen, L.; Pan, M.; Han, J.; Li, D.; Liao, C., 2015:
PT/NBL ratio assessment at mid-trimester in prenatal screening for Down syndrome in a Chinese population

Kawar, N.; Maclaughlan, S.; Horan, T.C.; Uzun, A.; Lange, T.S.; Kim, K.K.; Hopson, R.; Singh, A.P.; Sidhu, P.S.; Glass, K.A.; Shaw, S.; Padbury, J.F.; Vorsa, N.; Arnold, L.A.; Moore, R.G.; Brard, L.; Singh, R.K., 2014:
PT19c, Another Nonhypercalcemic Vitamin D2 Derivative, Demonstrates Antitumor Efficacy in Epithelial Ovarian and Endometrial Cancer Models

Ezura, M.; Takahashi, A.; Fukuchi, M.; Yoshimoto, T., 1998:
PTA for Internal Carotid Artery Stenosis

Peregrin, J.H.; Koznar, B.; Kovác, J.; Lastovicková, J.; Novotný, Jí.; Vedlich, D.; Skibová, J., 2010:
PTA of infrapopliteal arteries: long-term clinical follow-up and analysis of factors influencing clinical outcome

Kieninger, B.; Gioeva, Z.; Krüger, S.; Westermark, G.T.; Friedrich, R.P.; Fändrich, M.; Röcken, C., 2011:
PTAA and B10: new approaches to amyloid detection in tissue-evaluation of amyloid detection in tissue with a conjugated polyelectrolyte and a fibril-specific antibody fragment

Espinosa-Hernández, W.; Velez-Uriza, D.; Valdés, Jús.; Vélez-Del Valle, C.; Salas-Benito, J.; Martínez-Contreras, R.; García-Espítia, M.; Salas-Benito, M.; Vega-Almeida, T.; De Nova-Ocampo, Mónica., 2016:
PTB binds to the 3' untranslated region of the human astrovirus type 8: a possible role in viral replication

Shibasaki, T.; Tokunaga, A.; Sakamoto, R.; Sagara, H.; Noguchi, S.; Sasaoka, T.; Yoshida, N., 2014:
PTB deficiency causes the loss of adherens junctions in the dorsal telencephalon and leads to lethal hydrocephalus

Dombrowski, H.; Neumaier, S., 2015:
PTB intercomparisons of passive H*(10) area dosemeters for environmental monitoring

Dong, L.; Zhang, X.; Fu, X.; Zhang, X.; Gao, X.; Zhu, M.; Wang, X.; Yang, Z.; Jensen, O.Nørregaard.; Saarikettu, J.; Yao, Z.; Silvennoinen, O.; Yang, J., 2011:
PTB-associated splicing factor (PSF) functions as a repressor of STAT6-mediated Ig epsilon gene transcription by recruitment of HDAC1

Tsukahara, T.; Haniu, H.; Matsuda, Y., 2013:
PTB-associated splicing factor (PSF) is a PPARγ-binding protein and growth regulator of colon cancer cells

Suckale, J.; Wendling, O.; Masjkur, J.; Jäger, M.; Münster, C.; Anastassiadis, K.; Stewart, A.Francis.; Solimena, M., 2011:
PTBP1 is required for embryonic development before gastrulation

Knoch, K-Peter.; Nath-Sain, S.; Petzold, A.; Schneider, H.; Beck, M.; Wegbrod, C.; Sönmez, A.; Münster, C.; Friedrich, A.; Roivainen, M.; Solimena, M., 2014:
PTBP1 is required for glucose-stimulated cap-independent translation of insulin granule proteins and Coxsackieviruses in beta cells

Sharma, K.; Kaur, G.Kirandeep., 2014:
PTC bitter taste genetic polymorphism, food choices, physical growth in body height and body fat related traits among adolescent girls from Kangra Valley, Himachal Pradesh (India)

Jin, Y.; Taylor Eves, P.; Tang, F.; Weisman, L.S., 2009:
PTC1 is required for vacuole inheritance and promotes the association of the myosin-V vacuole-specific receptor complex

Goodier, J.L.; Mayer, J., 2009:
PTC124 for cystic fibrosis

Tan, L.; Narayan, S.B.; Chen, J.; Meyers, G.Ditewig.; Bennett, M.J., 2011:
PTC124 improves readthrough and increases enzymatic activity of the CPT1A R160X nonsense mutation

Wilton, S., 2007:
PTC124, nonsense mutations and Duchenne muscular dystrophy

Goldmann, T.; Overlack, N.; Wolfrum, U.; Nagel-Wolfrum, K., 2011:
PTC124-mediated translational readthrough of a nonsense mutation causing Usher syndrome type 1C

Thompson, C.A., 2011:
PTCB considers changes to certification, recertification

Traynor, K., 2014:
PTCB plans major update to certification requirements

Such, B.; Goryl, G.; Godlewski, S.; Kolodziej, J.J.; Szymonski, M., 2008:
PTCDA molecules on a KBr/InSb system: a low temperature STM study

Kolodziej, J.J.; Goryl, M.; Konior, J.; Krok, F.; Szymonski, M., 2007:
PTCDA molecules on an InSb(001) surface studied with atomic force microscopy

Karacuban, H.; Koch, S.; Fendrich, M.; Wagner, T.; Möller, R., 2011:
PTCDA on Cu(111) partially covered with NaCl

Li, T-J.; Yuan, J-W.; Gu, X-M.; Sun, L-S.; Zhao, H-S., 2008:
PTCH germline mutations in Chinese nevoid basal cell carcinoma syndrome patients

Heitzer, E.; Bambach, I.; Dandachi, N.; Horn, M.; Wolf, P., 2011:
PTCH promoter methylation at low level in sporadic basal cell carcinoma analysed by three different approaches

Valin, A.; Barnay-Verdier, Séphanie.; Robert, T.; Ripoche, H.; Brellier, F.; Chevallier-Lagente, O.; Avril, M-Françoise.; Magnaldo, T., 2009:
PTCH1 +/- dermal fibroblasts isolated from healthy skin of Gorlin syndrome patients exhibit features of carcinoma associated fibroblasts

Alonso-Dominguez, J.M.; Grinfeld, J.; Alikian, M.; Marin, D.; Reid, A.; Daghistani, M.; Hedgley, C.; O'Brien, S.; Clark, R.E.; Apperley, J.; Foroni, L.; Gerrard, G., 2015:
PTCH1 expression at diagnosis predicts imatinib failure in chronic myeloid leukaemia patients in chronic phase

Endo, M.; Fujii, K.; Miyashita, T.; Uchikawa, H.; Tanabe, R.; Sugita, K.; Arai, H.; Kohno, Y., 2009:
PTCH1 gene analysis in 25 Japanese patients with Gorlin syndrome

Begnini, A.; Tessari, G.; Turco, A.; Malerba, G.; Naldi, L.; Gotti, E.; Boschiero, L.; Forni, A.; Rugiu, C.; Piaserico, S.; Fortina, A.B.; Brunello, A.; Cascone, C.; Girolomoni, G.; Gomez Lira, M., 2011:
PTCH1 gene haplotype association with basal cell carcinoma after transplantation

Gomes, C.Cavaliéri.; Gomez, R.Santiago., 2011:
PTCH1 gene inactivation is not a Keratocystic odontogenic tumour exclusive alteration

Guo, Y-Yan.; Zhang, J-Yun.; Li, X-Fen.; Luo, H-Yan.; Chen, F.; Li, T-Jun., 2014:
PTCH1 gene mutations in Keratocystic odontogenic tumors: a study of 43 Chinese patients and a systematic review

Diniz, M.Gonçalves.; Borges, E.Rievrs.; Guimarães, Aé.Luiz.Sena.; Moreira, P.Rocha.; Brito, Jão.Artur.Ricieri.; Gomez, M.Vinícius.; De Marco, L.; Gomez, R.Santiago., 2008:
PTCH1 isoforms in odontogenic keratocysts

Saito, T.; Mitomi, H.; Imamhasan, A.; Hayashi, T.; Kurisaki-Arakawa, A.; Mitani, K.; Takahashi, M.; Kajiyama, Y.; Yao, T., 2015:
PTCH1 mutation is a frequent event in oesophageal basaloid squamous cell carcinoma

Pan, S.; Li, T-Jun., 2011:
PTCH1 mutations in odontogenic keratocysts: are they related to epithelial cell proliferation?

You, S.; Zhou, J.; Chen, S.; Zhou, P.; Lv, J.; Han, X.; Sun, Y., 2010:
PTCH1, a receptor of Hedgehog signaling pathway, is correlated with metastatic potential of colorectal cancer

Xu, L-Li.; Li, T-Jun., 2008:
PTCH2 gene alterations in keratocystic odontogenic tumors associated with nevoid basal cell carcinoma syndrome

Khan, N.; Cheson, B.D., 2014:
PTCL therapies: a review of treatment and outline of novel therapies

Kinami, S.; Fujimura, T.; Ojima, E.; Fushida, S.; Ojima, T.; Funaki, H.; Fujita, H.; Takamura, H.; Ninomiya, I.; Nishimura, G.; Kayahara, M.; Ohta, T.; Yoh, Z., 2008:
PTD classification: proposal for a new classification of gastric cancer location based on physiological lymphatic flow

Ye, N.; Lin, Y.; Pan, J.; Liu, S.; Rao, P., 2012:
PTD mediated protein transduction technology and its application in medical field

Palm-Apergi, C.; Eguchi, A.; Dowdy, S.F., 2011:
PTD-DRBD siRNA delivery

Zhi, Q-Wen.; Wang, S-Hao.; Zhang, F-Ying.; Li, S-Gui.; Sun, M-Ji., 2007:
PTD-hEGF fusion protein--gene expression and function analysis

Liu, X.; Xu, X.; Lin, X.; Tian, Y.; Ji, B.; Xia, S.; Xu, S.; Yin, Q.; Zhang, M.; Jiao, Z.; Wang, S.; Xu, H.; Shao, Q., 2013:
PTD-hFOXP3 protein acts as an immune regulator to convert human CD4(+)CD25(-) T cells to regulatory T-like cells

Liu, X.; Zhao, Q.; Peng, X.; Xia, S.; Shen, W.; Zong, Y.; Cheng, J.; Wu, W.; Zhang, M.; Du, F.; Xu, W.; Qian, H.; Shao, Q., 2014:
PTD-mediated intracellular delivery of mutant NFAT minimum DNA binding domain inhibited the proliferation of T cells

Yang, Q.; Larsen, S.K.; Mi, Z.; Robbins, P.D.; Basse, P.H., 2009:
PTD-mediated loading of tumor-seeking lymphocytes with prodrug-activating enzymes

Kwon, Y.Min.; Li, Y.Tao.; Liang, J.F.; Park, Y.Jeong.; Chang, L-Chien.; Yang, V.C., 2008:
PTD-modified ATTEMPTS system for enhanced asparaginase therapy: a proof-of-concept investigation

Presente, A.; Dowdy, S.F., 2013:
PTD/CPP peptide-mediated delivery of siRNAs

Jin, J-lu.; Gong, J.; Yin, T-jun.; Lu, Y-jun.; Xia, J-jing.; Xie, Y-yuan.; Di, Y.; He, L.; Guo, J-li.; Sun, J.; Noteborn, M.H.M.; Qu, S., 2011:
PTD4-apoptin protein and dacarbazine show a synergistic antitumor effect on B16-F1 melanoma in vitro and in vivo

Sun, J.; Yan, Y.; Wang, X-Ting.; Liu, X-Wen.; Peng, D-Jun.; Wang, M.; Tian, J.; Zong, Y-Qiang.; Zhang, Y-Hui.; Noteborn, M.H.M.; Qu, S., 2009:
PTD4-apoptin protein therapy inhibits tumor growth in vivo

Sun, Z.; Huang, C.; He, J.; Lamb, K.L.; Kang, X.; Gu, T.; Shen, W.Hong.; Yin, Y., 2015:
PTEN C-terminal deletion causes genomic instability and tumor development

Ikenoue, T.; Inoki, K.; Zhao, B.; Guan, K-Liang., 2008:
PTEN acetylation modulates its interaction with PDZ domain

Ren, Y.; Zhou, X.; Qi, Y.; Li, G.; Mei, M.; Yao, Z., 2012:
PTEN activation sensitizes breast cancer to PI3-kinase inhibitor through the β-catenin signaling pathway

Hao, J.; Zhu, L.; Zhao, S.; Liu, S.; Liu, Q.; Duan, H., 2011:
PTEN ameliorates high glucose-induced lipid deposits through regulating SREBP-1/FASN/ACC pathway in renal proximal tubular cells

Lertkhachonsuk, R.; Tantbirojn, P.; Paiwattananupant, K., 2012:
PTEN and MDM2 expression in the prediction of postmolar gestational trophoblastic neoplasia

Keng, V.W.; Rahrmann, E.P.; Watson, A.L.; Tschida, B.R.; Moertel, C.L.; Jessen, W.J.; Rizvi, T.A.; Collins, M.H.; Ratner, N.; Largaespada, D.A., 2012:
PTEN and NF1 inactivation in Schwann cells produces a severe phenotype in the peripheral nervous system that promotes the development and malignant progression of peripheral nerve sheath tumors

Liu, C-zheng.; Liu, W.; Zheng, Y.; Su, J-mei.; Li, J-jing.; Yu, L.; He, X-dong.; Chen, S-sen., 2012:
PTEN and PDCD4 are bona fide targets of microRNA-21 in human cholangiocarcinoma

Singh, A.R.; Peirce, S.K.; Joshi, S.; Durden, D.L., 2014:
PTEN and PI-3 kinase inhibitors control LPS signaling and the lymphoproliferative response in the CD19+ B cell compartment

Endoh, H.; Yatabe, Y.; Kosaka, T.; Kuwano, H.; Mitsudomi, T., 2007:
PTEN and PIK3CA expression is associated with prolonged survival after gefitinib treatment in EGFR-mutated lung cancer patients

Gupta, A.; Dey, C.Sankar., 2009:
PTEN and SHIP2 regulates PI3K/Akt pathway through focal adhesion kinase

Kuijk, E.W.; van Mil, A.; Brinkhof, B.; Penning, L.C.; Colenbrander, B.; Roelen, B.A.J., 2010:
PTEN and TRP53 independently suppress Nanog expression in spermatogonial stem cells

Fragoso, R.; Barata, Jão.T., 2015:
PTEN and leukemia stem cells

Conde-Perez, A.; Larue, L., 2013:
PTEN and melanomagenesis

Eitel, J.A.; Bijangi-Vishehsaraei, K.; Saadatzadeh, M.Reza.; Bhavsar, J.R.; Murphy, M.P.; Pollok, K.E.; Mayo, L.D., 2009:
PTEN and p53 are required for hypoxia induced expression of maspin in glioblastoma cells

Rahal, O.M.; Simmen, R.C.M., 2010:
PTEN and p53 cross-regulation induced by soy isoflavone genistein promotes mammary epithelial cell cycle arrest and lobuloalveolar differentiation

Cheng, Z.Y.; Guo, X.L.; Yang, X.Y.; Niu, Z.Y.; Li, S.H.; Wang, S.Y.; Chen, H.; Pan, L., 2009:
PTEN and rapamycin inhibiting the growth of K562 cells through regulating mTOR signaling pathway

Chalhoub, N.; Baker, S.J., 2008:
PTEN and the PI3-kinase pathway in cancer

Hong, X.; Song, R.; Song, H.; Zheng, T.; Wang, J.; Liang, Y.; Qi, S.; Lu, Z.; Song, X.; Jiang, H.; Liu, L.; Zhang, Z., 2014:
PTEN antagonises Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis

Snietura, M.; Jaworska, M.; Mlynarczyk-Liszka, J.; Goraj-Zajac, A.; Piglowski, W.; Lange, D.; Wozniak, G.; Nowara, E.; Suwinski, R., 2012:
PTEN as a prognostic and predictive marker in postoperative radiotherapy for squamous cell cancer of the head and neck

Shi, Y.; Paluch, B.E.; Wang, X.; Jiang, X., 2013:
PTEN at a glance

Vinciguerra, M.; Foti, M., 2008:
PTEN at the crossroad of metabolic diseases and cancer in the liver

Sha, S-Hua.; Chen, F-Quan.; Schacht, J., 2010:
PTEN attenuates PIP3/Akt signaling in the cochlea of the aging CBA/J mouse

Thomas, S.L.; Alam, R.; Lemke, N.; Schultz, L.R.; Gutiérrez, J.A.; Rempel, S.A., 2010:
PTEN augments SPARC suppression of proliferation and inhibits SPARC-induced migration by suppressing SHC-RAF-ERK and AKT signaling

Wan, X.; Li, J.; Xie, X.; Lu, W., 2007:
PTEN augments doxorubicin-induced apoptosis in PTEN-null Ishikawa cells

Alimonti, A., 2010:
PTEN breast cancer susceptibility: a matter of dose

Feron, M.; Guevel, L.; Rouger, K.; Dubreil, L.; Arnaud, M-Claire.; Ledevin, M.; Megeney, L.A.; Cherel, Y.; Sakanyan, V., 2009:
PTEN contributes to profound PI3K/Akt signaling pathway deregulation in dystrophin-deficient dog muscle

Bardet, P-Luc.; Guirao, B.; Paoletti, C.; Serman, F.; Léopold, V.; Bosveld, F.; Goya, Yûki.; Mirouse, V.; Graner, Fçois.; Bellaïche, Y., 2013:
PTEN controls junction lengthening and stability during cell rearrangement in epithelial tissue

Zeng, N.; Yang, K-Ting.; Bayan, J-Ann.; He, L.; Aggarwal, R.; Stiles, J.W.; Hou, X.; Medina, V.; Abad, D.; Palian, B.M.; Al-Abdullah, I.; Kandeel, F.; Johnson, D.L.; Stiles, B.L., 2014:
PTEN controls β-cell regeneration in aged mice by regulating cell cycle inhibitor p16ink4a

Arendt, K.L.; Benoist, M.; Lario, A.; Draffin, J.E.; Muñoz, Mía.; Esteban, Jé.A., 2015:
PTEN counteracts PIP3 upregulation in spines during NMDA-receptor-dependent long-term depression

Morani, F.; Phadngam, S.; Follo, C.; Titone, R.; Thongrakard, V.; Galetto, A.; Alabiso, O.; Isidoro, C., 2014:
PTEN deficiency and mutant p53 confer glucose-addiction to thyroid cancer cells: impact of glucose depletion on cell proliferation, cell survival, autophagy and cell migration

Zhang, X.; Park, J.Soo.; Park, K.Hyun.; Kim, K.Hyang.; Jung, M.; Chung, H.Cheol.; Rha, S.Young.; Kim, H.Song., 2015:
PTEN deficiency as a predictive biomarker of resistance to HER2-targeted therapy in advanced gastric cancer

Yang, G.; Sun, Q.; Teng, Y.; Li, F.; Weng, T.; Yang, X., 2008:
PTEN deficiency causes dyschondroplasia in mice by enhanced hypoxia-inducible factor 1alpha signaling and endoplasmic reticulum stress

Squarize, C.H.; Castilho, R.M.; Abrahao, A.C.; Molinolo, A.; Lingen, M.W.; Gutkind, J.Silvio., 2013:
PTEN deficiency contributes to the development and progression of head and neck cancer

Schade, B.; Rao, T.; Dourdin, N.; Lesurf, R.; Hallett, M.; Cardiff, R.D.; Muller, W.J., 2009:
PTEN deficiency in a luminal ErbB-2 mouse model results in dramatic acceleration of mammary tumorigenesis and metastasis

Dedes, K.J.; Wetterskog, D.; Mendes-Pereira, A.M.; Natrajan, R.; Lambros, M.B.; Geyer, F.C.; Vatcheva, R.; Savage, K.; Mackay, A.; Lord, C.J.; Ashworth, A.; Reis-Filho, J.S., 2011:
PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors

Furumoto, Y.; Charles, N.; Olivera, A.; Leung, W.Hang.; Dillahunt, S.; Sargent, J.L.; Tinsley, K.; Odom, S.; Scott, E.; Wilson, T.M.; Ghoreschi, K.; Kneilling, M.; Chen, M.; Lee, D.M.; Bolland, S.; Rivera, J., 2012:
PTEN deficiency in mast cells causes a mastocytosis-like proliferative disease that heightens allergic responses and vascular permeability

Liu, Y.Lucy.; Castleberry, R.P.; Emanuel, P.D., 2008:
PTEN deficiency is a common defect in juvenile myelomonocytic leukemia

Blando, J.; Portis, M.; Benavides, F.; Alexander, A.; Mills, G.; Dave, B.; Conti, C.J.; Kim, J.; Walker, C.Lyn., 2009:
PTEN deficiency is fully penetrant for prostate adenocarcinoma in C57BL/6 mice via mTOR-dependent growth

Patel, M.; Gomez, N.C.; McFadden, A.W.; Moats-Staats, B.M.; Wu, S.; Rojas, A.; Sapp, T.; Simon, J.M.; Smith, S.V.; Kaiser-Rogers, K.; Davis, I.J., 2015:
PTEN deficiency mediates a reciprocal response to IGFI and mTOR inhibition

Li, W.; Huang, R.; Chen, Z.; Yan, L-J.; Simpkins, J.W.; Yang, S-H., 2015:
PTEN degradation after ischemic stroke: a double-edged sword

Radziszewska, A.; Choi, D.; Nguyen, K-Tung.T.; Schroer, S.A.; Tajmir, P.; Wang, L.; Suzuki, A.; Mak, T.W.; Evan, G.I.; Woo, M., 2008:
PTEN deletion and concomitant c-Myc activation do not lead to tumor formation in pancreatic beta cells

Li, Y.; Su, J.; DingZhang, X.; Zhang, J.; Yoshimoto, M.; Liu, S.; Bijian, K.; Gupta, A.; Squire, J.A.; Alaoui Jamali, M.A.; Bismar, T.A., 2011:
PTEN deletion and heme oxygenase-1 overexpression cooperate in prostate cancer progression and are associated with adverse clinical outcome

Wang, L.; Luk, C.T.; Cai, E.P.; Schroer, S.A.; Allister, E.M.; Shi, S.Y.; Wheeler, M.B.; Gaisano, H.Y.; Woo, M., 2015:
PTEN deletion in pancreatic α-cells protects against high-fat diet-induced hyperglucagonemia and insulin resistance

Fraser, M.; Zhao, H.; Luoto, K.R.; Lundin, C.; Coackley, C.; Chan, N.; Joshua, A.M.; Bismar, T.A.; Evans, A.; Helleday, T.; Bristow, R.G., 2012:
PTEN deletion in prostate cancer cells does not associate with loss of RAD51 function: implications for radiotherapy and chemotherapy

Mina, S.; Bohn, B.A.; Simon, R.; Krohn, A.; Reeh, M.; Arnold, D.; Bokemeyer, C.; Sauter, G.; Izbicki, J.R.; Marx, A.; Stahl, P.R., 2012:
PTEN deletion is rare but often homogeneous in gastric cancer

Shi, G.D.; OuYang, Y.P.; Shi, J.G.; Liu, Y.; Yuan, W.; Jia, L.S., 2011:
PTEN deletion prevents ischemic brain injury by activating the mTOR signaling pathway

Cordes, I.; Kluth, M.; Zygis, D.; Rink, M.; Chun, F.; Eichelberg, C.; Dahlem, R.; Fisch, M.; Höppner, W.; Wagner, W.; Doh, O.; Terracciano, L.; Simon, R.; Wilczak, W.; Sauter, G.; Minner, S., 2014:
PTEN deletions are related to disease progression and unfavourable prognosis in early bladder cancer

Ning, K.; Drepper, C.; Valori, C.F.; Ahsan, M.; Wyles, M.; Higginbottom, A.; Herrmann, T.; Shaw, P.; Azzouz, M.; Sendtner, M., 2010:
PTEN depletion rescues axonal growth defect and improves survival in SMN-deficient motor neurons

Tsoyi, K.; Jang, H.Jin.; Nizamutdinova, I.Tsoy.; Park, K.; Kim, Y.Min.; Kim, H.Jung.; Seo, H.Geuk.; Lee, J.Heun.; Chang, K.Churl., 2011:
PTEN differentially regulates expressions of ICAM-1 and VCAM-1 through PI3K/Akt/GSK-3β/GATA-6 signaling pathways in TNF-α-activated human endothelial cells

Gregorian, C.; Nakashima, J.; Dry, S.M.; Nghiemphu, P.Leia.; Smith, K.Barzan.; Ao, Y.; Dang, J.; Lawson, G.; Mellinghoff, I.K.; Mischel, P.S.; Phelps, M.; Parada, L.F.; Liu, X.; Sofroniew, M.V.; Eilber, F.C.; Wu, H., 2009:
PTEN dosage is essential for neurofibroma development and malignant transformation

Ruan, Z-Ping.; Xu, R.; Lv, Y.; Tian, T.; Wang, W-Juan.; Guo, H.; Nan, K-Jun., 2012:
PTEN enhances the sensitivity of human hepatocellular carcinoma cells to sorafenib

Loupakis, F.; Pollina, L.; Stasi, I.; Ruzzo, A.; Scartozzi, M.; Santini, D.; Masi, G.; Graziano, F.; Cremolini, C.; Rulli, E.; Canestrari, E.; Funel, N.; Schiavon, G.; Petrini, I.; Magnani, M.; Tonini, G.; Campani, D.; Floriani, I.; Cascinu, S.; Falcone, A., 2009:
PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancer

Ciuffreda, L.; Falcone, I.; Incani, U.Cesta.; Del Curatolo, A.; Conciatori, F.; Matteoni, S.; Vari, S.; Vaccaro, V.; Cognetti, F.; Milella, M., 2015:
PTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting

Li, X-Han.; Zheng, H-Chuan.; Takahashi, H.; Masuda, S.; Yang, X-Hong.; Takano, Y., 2009:
PTEN expression and mutation in colorectal carcinomas

Bai, Z-Gang.; Ye, Y-Jiang.; Shen, D-Hua.; Lu, Y-Yong.; Zhang, Z-Tao.; Wang, S., 2013:
PTEN expression and suppression of proliferation are associated with Cdx2 overexpression in gastric cancer cells

Bouali, S.; Chrétien, A-Sophie.; Ramacci, C.; Rouyer, M.; Becuwe, P.; Merlin, J-Louis., 2009:
PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells

Lacey, J.V.; Mutter, G.L.; Ronnett, B.M.; Ioffe, O.B.; Duggan, Máire.A.; Rush, B.B.; Glass, A.G.; Richesson, D.A.; Chatterjee, N.; Langholz, B.; Sherman, M.E., 2008:
PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma

Panagiotou, I.; Tsiambas, E.; Lazaris, A.C.; Kavantzas, N.; Konstantinou, M.; Kalkandi, P.; Ragkos, V.; Metaxas, G.E.; Roukas, D.K.; Vilaras, G.; Patsouris, E., 2013:
PTEN expression in non small cell lung carcinoma based on digitized image analysis

Loures, L.Fernandes.; Cândido, E.Batista.; Vidigal, P.Vieira.Teixeira.; Seabra, M.Ataydes.Leite.; Marco, L.Armando.Cunha.de.; Silva-Filho, A.Lopes.da., 2016:
PTEN expression in patients with carcinoma of the cervix and its association with p53, Ki-67 and CD31

Opitz, I.; Soltermann, A.; Abaecherli, M.; Hinterberger, M.; Probst-Hensch, N.; Stahel, R.; Moch, H.; Weder, W., 2008:
PTEN expression is a strong predictor of survival in mesothelioma patients

Atreya, C.E.; Sangale, Z.; Xu, N.; Matli, M.R.; Tikishvili, E.; Welbourn, W.; Stone, S.; Shokat, K.M.; Warren, R.S., 2014:
PTEN expression is consistent in colorectal cancer primaries and metastases and associates with patient survival

Hao, L.Sen.; Zhang, X.Lan.; An, J.Yan.; Karlin, J.; Tian, X.Peng.; Dun, Z.Na.; Xie, S.Rui.; Chen, S., 2009:
PTEN expression is down-regulated in liver tissues of rats with hepatic fibrosis induced by biliary stenosis

Mriouah, J.; Boura, Cédric.; Gargouri, M.; Plénat, Fçois.; Faivre, Béatrice., 2014:
PTEN expression is involved in the invasive properties of HNSCC: a key protein to consider in locoregional recurrence

Waniczek, D.; Śnietura, Mław.; Młynarczyk-Liszka, J.; Pigłowski, W.; Kopeć, A.; Lange, D.; Rudzki, M.; Arendt, J., 2014:
PTEN expression profiles in colorectal adenocarcinoma and its precancerous lesions

Hopkins, B.D.; Hodakoski, C.; Barrows, D.; Mense, S.M.; Parsons, R.E., 2014:
PTEN function: the long and the short of it

Zhao, Z.; Qin, Y.; Ma, J.; Zhao, H.; Li, J.; Wang, L.; Ren, C.; Che, L.; Chen, Z-Jiang., 2011:
PTEN gene analysis in premature ovarian failure patients

Karseladze, A.I.; Kulevich, E.E.; Karseladze, D.A.; Poddubnaia, I.V., 2011:
PTEN gene in triple-negative breast cancer

Zou, S.; El-Hage, N.; Podhaizer, E.M.; Knapp, P.E.; Hauser, K.F., 2011:
PTEN gene silencing prevents HIV-1 gp120(IIIB)-induced degeneration of striatal neurons

Romano, C.; Schepis, C., 2012:
PTEN gene: a model for genetic diseases in dermatology

Bismar, T.A.; Yoshimoto, M.; Vollmer, R.T.; Duan, Q.; Firszt, M.; Corcos, J.; Squire, J.A., 2011:
PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer

Sircar, K.; Yoshimoto, M.; Monzon, F.A.; Koumakpayi, I.H.; Katz, R.L.; Khanna, A.; Alvarez, K.; Chen, G.; Darnel, A.D.; Aprikian, A.G.; Saad, F.; Bismar, T.A.; Squire, J.A., 2009:
PTEN genomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer

Choucair, K.; Ejdelman, J.; Brimo, F.; Aprikian, A.; Chevalier, S.; Lapointe, J., 2013:
PTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity

Mester, J.L.; Moore, R.A.; Eng, C., 2014:
PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing?

Kurek, K.C.; Howard, E.; Tennant, L.B.; Upton, J.; Alomari, A.I.; Burrows, P.E.; Chalache, K.; Harris, D.J.; Trenor, C.C.; Eng, C.; Fishman, S.J.; Mulliken, J.B.; Perez-Atayde, A.R.; Kozakewich, H.P.W., 2012:
PTEN hamartoma of soft tissue: a distinctive lesion in PTEN syndromes

Hopman, S.M.J.; Van Rijn, R.R.; Eng, C.; Bras, J.; Alders, M.; van der Horst, C.M.; Hennekam, R.C.M.; Merks, J.H.M., 2012:
PTEN hamartoma tumor syndrome and Gorham-Stout phenomenon

Hobert, J.A.; Eng, C., 2009:
PTEN hamartoma tumor syndrome: an overview

Piccione, M.; Fragapane, T.; Antona, V.; Giachino, D.; Cupido, F.; Corsello, G., 2014:
PTEN hamartoma tumor syndromes in childhood: description of two cases and a proposal for follow-up protocol

Smpokou, P.; Fox, V.L.; Tan, W-Hann., 2015:
PTEN hamartoma tumour syndrome: early tumour development in children

Lopiccolo, J.; Ballas, M.S.; Dennis, P.A., 2007:
PTEN hamartomatous tumor syndromes (PHTS): rare syndromes with great relevance to common cancers and targeted drug development

Leow, M.K., 2013:
PTEN haploinsufficiency, obesity, and insulin sensitivity

Yasui, M.; Matsuoka, S.; Ueda, M., 2015:
PTEN hopping on the cell membrane is regulated via a positively-charged C2 domain

Pan, Q.F.; Li, W.T.; Dong, H.C.; Chen, Y.Z.; Yin, L.; Liu, W.; Wang, W.W.; Liu, D.; Li, S.G.; Gu, W.Y.; Chen, J.Z.; Yang, L.; Zhang, W.J.; Li, F., 2015:
PTEN hypermethylation profiles of Chinese Kazakh patients with esophageal squamous cell carcinoma

Hosgood, H.Dean.; Menashe, I.; He, X.; Chanock, S.; Lan, Q., 2010:
PTEN identified as important risk factor of chronic obstructive pulmonary disease

Li, Y.; Wang, X-Yu.; Wang, L-Jing.; Xu, T.; Lu, X-Ye.; Cai, D-Qing.; Geng, J-Guo.; Yang, X-Song., 2011:
PTEN impedes EMT during chick embryo gastrulation

Zhang, M., 2009:
PTEN in action: coordinating with p53 to regulate maspin gene expression

Haas-Kogan, D.; Stokoe, D., 2008:
PTEN in brain tumors

Peyrou, M.; Bourgoin, L.; Foti, M., 2011:
PTEN in liver diseases and cancer

Peyrou, M.; Bourgoin, L.; Foti, M., 2010:
PTEN in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and cancer

Qi, X.; Xu, J.; Gu, P.; Yang, X.; Gao, X., 2015:
PTEN in smooth muscle cells is essential for colonic immune homeostasis

Chen, X-Y.; Lu, F.; Wang, Y-M.; Yang, Y.; Wei, G-Q.; Wu, D.; Wang, L-F.; Wu, Y-M., 2015:
PTEN inactivation by germline/somatic c.950_953delTACT mutation in patients with Lhermitte-Duclos disease manifesting progressive phenotypes

Errafiy, R.; Aguado, C.; Ghislat, G.; Esteve, J.M.; Gil, A.; Loutfi, M.; Knecht, E., 2014:
PTEN increases autophagy and inhibits the ubiquitin-proteasome pathway in glioma cells independently of its lipid phosphatase activity

Wyatt, L.A.; Filbin, M.T.; Keirstead, H.S., 2015:
PTEN inhibition enhances neurite outgrowth in human embryonic stem cell-derived neuronal progenitor cells

Hu, Z.; Wang, H.; Lee, I.Hee.; Modi, S.; Wang, X.; Du, J.; Mitch, W.E., 2010:
PTEN inhibition improves muscle regeneration in mice fed a high-fat diet

Christie, K.J.; Webber, C.A.; Martinez, J.A.; Singh, B.; Zochodne, D.W., 2010:
PTEN inhibition to facilitate intrinsic regenerative outgrowth of adult peripheral axons

Walker, C.L.; Xu, X-Ming., 2014:
PTEN inhibitor bisperoxovanadium protects oligodendrocytes and myelin and prevents neuronal atrophy in adult rats following cervical hemicontusive spinal cord injury

Zu, L.; Shen, Z.; Wesley, J.; Cai, Z.P., 2011:
PTEN inhibitors cause a negative inotropic and chronotropic effect in mice

Fan, C.; He, L.; Kapoor, A.; Rybak, A.P.; De Melo, J.; Cutz, J-Claude.; Tang, D., 2010:
PTEN inhibits BMI1 function independently of its phosphatase activity

Guo, L.; Chen, L.; Bi, S.; Chai, L.; Wang, Z.; Cao, C.; Tao, L.; Li, S., 2012:
PTEN inhibits proliferation and functions of hypertrophic scar fibroblasts

Zhang, L-Li.; Liu, J.; Lei, S.; Zhang, J.; Zhou, W.; Yu, H-Gang., 2014:
PTEN inhibits the invasion and metastasis of gastric cancer via downregulation of FAK expression

Tian, T.; Nan, K-Jun.; Guo, H.; Wang, W-Juan.; Ruan, Z-Ping.; Wang, S-Hong.; Liang, X.; Lu, C-Xin., 2010:
PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway

Chen, Z.Hong.; Zhu, M.; Yang, J.; Liang, H.; He, J.; He, S.; Wang, P.; Kang, X.; McNutt, M.A.; Yin, Y.; Shen, W.H., 2015:
PTEN interacts with histone H1 and controls chromatin condensation

Lin, M-Chieh.; Liu, Y-Chuan.; Tam, M.F.; Lu, Y-Ju.; Hsieh, Y-Ting.; Lin, L-Yuan., 2012:
PTEN interacts with metal-responsive transcription factor 1 and stimulates its transcriptional activity

Ying, H.; Elpek, K.G.; Vinjamoori, A.; Zimmerman, S.M.; Chu, G.C.; Yan, H.; Fletcher-Sananikone, E.; Zhang, H.; Liu, Y.; Wang, W.; Ren, X.; Zheng, H.; Kimmelman, A.C.; Paik, J-hye.; Lim, C.; Perry, S.R.; Jiang, S.; Malinn, B.; Protopopov, A.; Colla, S.; Xiao, Y.; Hezel, A.F.; Bardeesy, N.; Turley, S.J.; Wang, Y.Alan.; Chin, L.; Thayer, S.P.; DePinho, R.A., 2012:
PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine network

Pramanik, M.Kamruzzaman.; Iijima, M.; Iwadate, Y.; Yumura, S., 2009:
PTEN is a mechanosensing signal transducer for myosin II localization in Dictyostelium cells

Cui, M.; Augert, A.; Rongione, M.; Conkrite, K.; Parazzoli, S.; Nikitin, A.Yu.; Ingolia, N.; MacPherson, D., 2015:
PTEN is a potent suppressor of small cell lung cancer

Peng, C.; Chen, Y.; Yang, Z.; Zhang, H.; Osterby, L.; Rosmarin, A.G.; Li, S., 2010:
PTEN is a tumor suppressor in CML stem cells and BCR-ABL-induced leukemias in mice

Haws, M.E.; Jaramillo, T.C.; Espinosa, F.; Widman, A.J.; Stuber, G.D.; Sparta, D.R.; Tye, K.M.; Russo, S.J.; Parada, L.F.; Stavarache, M.; Kaplitt, M.; Bonci, A.; Powell, C.M., 2014:
PTEN knockdown alters dendritic spine/protrusion morphology, not density

Haga, K.; Tomioka, A.; Liao, C-Peng.; Kimura, T.; Matsumoto, H.; Ohno, I.; Hermann, K.; Logg, C.R.; Jiao, J.; Tanaka, M.; Hirao, Y.; Wu, H.; Kruse, C.A.; Roy-Burman, P.; Kasahara, N., 2009:
PTEN knockout prostate cancer as a model for experimental immunotherapy

Carracedo, A.; Alimonti, A.; Pandolfi, P.Paolo., 2011:
PTEN level in tumor suppression: how much is too little?

Hill, R.; Calvopina, J.Hargan.; Kim, C.; Wang, Y.; Dawson, D.W.; Donahue, T.R.; Dry, S.; Wu, H., 2010:
PTEN loss accelerates KrasG12D-induced pancreatic cancer development

Tanwar, P.S.; Kaneko-Tarui, T.; Lee, H-Joon.; Zhang, L.; Teixeira, J.M., 2013:
PTEN loss and HOXA10 expression are associated with ovarian endometrioid adenocarcinoma differentiation and progression

Davies, E.J.; Marsh Durban, V.; Meniel, V.; Williams, G.T.; Clarke, A.R., 2014:
PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine

McEllin, B.; Camacho, C.V.; Mukherjee, B.; Hahm, B.; Tomimatsu, N.; Bachoo, R.M.; Burma, S., 2010:
PTEN loss compromises homologous recombination repair in astrocytes: implications for glioblastoma therapy with temozolomide or poly(ADP-ribose) polymerase inhibitors

Paraiso, K.H.T.; Xiang, Y.; Rebecca, V.W.; Abel, E.V.; Chen, Y.Ann.; Munko, A.Cecilia.; Wood, E.; Fedorenko, I.V.; Sondak, V.K.; Anderson, A.R.A.; Ribas, A.; Palma, M.Dalla.; Nathanson, K.L.; Koomen, J.M.; Messina, J.L.; Smalley, K.S.M., 2011:
PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression

Sos, M.L.; Koker, M.; Weir, B.A.; Heynck, S.; Rabinovsky, R.; Zander, T.; Seeger, J.M.; Weiss, J.; Fischer, F.; Frommolt, P.; Michel, K.; Peifer, M.; Mermel, C.; Girard, L.; Peyton, M.; Gazdar, A.F.; Minna, J.D.; Garraway, L.A.; Kashkar, H.; Pao, W.; Meyerson, M.; Thomas, R.K., 2009:
PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR

Pfeifer, M.; Grau, M.; Lenze, D.; Wenzel, Sören-Sebastian.; Wolf, A.; Wollert-Wulf, B.; Dietze, K.; Nogai, H.; Storek, B.; Madle, H.; Dörken, B.; Janz, M.; Dirnhofer, S.; Lenz, P.; Hummel, M.; Tzankov, A.; Lenz, G., 2013:
PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma

Lan, R.; Geng, H.; Polichnowski, A.J.; Singha, P.K.; Saikumar, P.; McEwen, D.G.; Griffin, K.A.; Koesters, R.; Weinberg, J.M.; Bidani, A.K.; Kriz, W.; Venkatachalam, M.A., 2012:
PTEN loss defines a TGF-β-induced tubule phenotype of failed differentiation and JNK signaling during renal fibrosis

Yang, L.; Clarke, M.J.; Carlson, B.L.; Mladek, A.C.; Schroeder, M.A.; Decker, P.; Wu, W.; Kitange, G.J.; Grogan, P.T.; Goble, J.M.; Uhm, J.; Galanis, E.; Giannini, C.; Lane, H.A.; James, C.David.; Sarkaria, J.N., 2008:
PTEN loss does not predict for response to RAD001 (Everolimus) in a glioblastoma orthotopic xenograft test panel

Mithal, P.; Allott, E.; Gerber, L.; Reid, J.; Welbourn, W.; Tikishvili, E.; Park, J.; Younus, A.; Sangale, Z.; Lanchbury, J.S.; Stone, S.; Freedland, S.J., 2015:
PTEN loss in biopsy tissue predicts poor clinical outcomes in prostate cancer

Sanchez-Gurmaches, J.; Hung, C-Min.; Sparks, C.A.; Tang, Y.; Li, H.; Guertin, D.A., 2013:
PTEN loss in the Myf5 lineage redistributes body fat and reveals subsets of white adipocytes that arise from Myf5 precursors

Song, M.; Chen, D.; Lu, B.; Wang, C.; Zhang, J.; Huang, L.; Wang, X.; Timmons, C.L.; Hu, J.; Liu, B.; Wu, X.; Wang, L.; Wang, J.; Liu, H., 2014:
PTEN loss increases PD-L1 protein expression and affects the correlation between PD-L1 expression and clinical parameters in colorectal cancer

Bowen, K.A.; Doan, H.Q.; Zhou, B.P.; Wang, Q.; Zhou, Y.; Rychahou, P.G.; Evers, B.Mark., 2010:
PTEN loss induces epithelial--mesenchymal transition in human colon cancer cells

Metcalfe, C.; Alicke, B.; Crow, A.; Lamoureux, M.; Dijkgraaf, G.J.P.; Peale, F.; Gould, S.E.; de Sauvage, F.J., 2014:
PTEN loss mitigates the response of medulloblastoma to Hedgehog pathway inhibition

Peacock, J.W.; Palmer, J.; Fink, D.; Ip, S.; Pietras, E.M.; Mui, A.L-F.; Chung, S.W.; Gleave, M.E.; Cox, M.E.; Parsons, R.; Peter, M.E.; Ong, C.J., 2009:
PTEN loss promotes mitochondrially dependent type II Fas-induced apoptosis via PEA-15

Gont, A.; Hanson, J.E.L.; Lavictoire, S.J.; Parolin, D.A.; Daneshmand, M.; Restall, I.J.; Soucie, M.; Nicholas, G.; Woulfe, J.; Kassam, A.; Da Silva, V.F.; Lorimer, I.A.J., 2014:
PTEN loss represses glioblastoma tumor initiating cell differentiation via inactivation of Lgl1

Kim, R-Ju.; Bae, E.; Hong, Y.Kwon.; Hong, J.Yup.; Kim, N.Keun.; Ahn, H.Jung.; Oh, J.Jin.; Park, D.Soo., 2015:
PTEN loss-mediated Akt activation increases the properties of cancer stem-like cell populations in prostate cancer

Inglés, M.; Gambini, J.; Miguel, M.Graça.; Bonet-Costa, V.; Abdelaziz, K.M.; El Alami, M.; Viña, J.; Borrás, C., 2014:
PTEN mediates the antioxidant effect of resveratrol at nutritionally relevant concentrations

Yang, J.; Zuo, X.; Bai, W.; Niu, P.; Tian, L.; Gao, A., 2014:
PTEN methylation involved in benzene-induced hematotoxicity

Mendes, R.D.; Sarmento, L.M.; Canté-Barrett, K.; Zuurbier, L.; Buijs-Gladdines, J.G.C.A.M.; Póvoa, V.; Smits, W.K.; Abecasis, M.; Yunes, J.Andres.; Sonneveld, E.; Horstmann, M.A.; Pieters, R.; Barata, Jão.T.; Meijerink, J.P.P., 2014:
PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination events

Kim, Y-Jae.; Park, S-Jeong.; Choi, E.Young.; Kim, S.; Kwak, H.Jin.; Yoo, B.Chul.; Yoo, H.; Lee, S-Hoon.; Kim, D.; Park, J.Bae.; Kim, J.Heon., 2012:
PTEN modulates miR-21 processing via RNA-regulatory protein RNH1

Boosani, C.S.; Agrawal, D.K., 2013:
PTEN modulators: a patent review

Yang, J.; Ren, Y.; Wang, L.; Li, B.; Chen, Y.; Zhao, W.; Xu, W.; Li, T.; Dai, F., 2010:
PTEN mutation spectrum in breast cancers and breast hyperplasia

Hühns, M.; Salem, T.; Schneider, Börn.; Krohn, M.; Linnebacher, M.; Prall, F., 2015:
PTEN mutation, loss of heterozygosity, promoter methylation and expression in colorectal carcinoma: two hits on the gene?

Liu, W.; Zhou, Y.; Reske, S.N.; Shen, C., 2009:
PTEN mutation: many birds with one stone in tumorigenesis

Goschzik, T.; Gessi, M.; Denkhaus, D.; Pietsch, T., 2014:
PTEN mutations and activation of the PI3K/Akt/mTOR signaling pathway in papillary tumors of the pineal region

Jin, G.; Kim, M.Jung.; Jeon, H-Sung.; Choi, J.Eun.; Kim, D.Sun.; Lee, E.Bae.; Cha, S.Ick.; Yoon, G.Sook.; Kim, C.Ho.; Jung, T.Hoon.; Park, J.Yong., 2011:
PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers

Pal, A.; Barber, T.M.; Van de Bunt, M.; Rudge, S.A.; Zhang, Q.; Lachlan, K.L.; Cooper, N.S.; Linden, H.; Levy, J.C.; Wakelam, M.J.O.; Walker, L.; Karpe, F.; Gloyn, A.L., 2012:
PTEN mutations as a cause of constitutive insulin sensitivity and obesity

Nakdimon, I.; Walser, M.; Fröhli, E.; Hajnal, A., 2012:
PTEN negatively regulates MAPK signaling during Caenorhabditis elegans vulval development

Kuo, H-Mei.; Lin, C-Yao.; Lam, H-Chung.; Lin, P-Ru.; Chan, H-Hung.; Tseng, J-Cheng.; Sun, C-Kwan.; Hsu, T-Fa.; Wu, C-Ching.; Yang, C-Yuh.; Hsu, C-Mei.; Tai, M-Hong., 2012:
PTEN overexpression attenuates angiogenic processes of endothelial cells by blockade of endothelin-1/endothelin B receptor signaling

Wu, H.; Wang, K.; Liu, W.; Hao, Q., 2014:
PTEN overexpression improves cisplatin-resistance of human ovarian cancer cells through upregulating KRT10 expression

Jagan, I.C.; Deevi, R.K.; Fatehullah, A.; Topley, R.; Eves, J.; Stevenson, M.; Loughrey, M.; Arthur, K.; Campbell, F.Charles., 2014:
PTEN phosphatase-independent maintenance of glandular morphology in a predictive colorectal cancer model system

Wu, Y.; Zhou, H.; Wu, K.; Lee, S.; Li, R.; Liu, X., 2014:
PTEN phosphorylation and nuclear export mediate free fatty acid-induced oxidative stress

Ge, H.; Cao, Y.Y.; Chen, L.Q.; Wang, Y.M.; Chen, Z.F.; Wen, D.G.; Zhang, X.F.; Guo, W.; Wang, N.; Li, Y.; Zhang, J.H., 2009:
PTEN polymorphisms and the risk of esophageal carcinoma and gastric cardiac carcinoma in a high incidence region of China

Silva, A.; Yunes, J.Andrés.; Cardoso, B.A.; Martins, L.R.; Jotta, Pícia.Y.; Abecasis, M.; Nowill, A.E.; Leslie, N.R.; Cardoso, A.A.; Barata, J.T., 2008:
PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability

Ho, C-Ming.; Lin, M-Chieh.; Huang, S-Hung.; Huang, C-Jung.; Lai, H-Cheng.; Chien, T-Yen.; Chang, S-Fen., 2009:
PTEN promoter methylation and LOH of 10q22-23 locus in PTEN expression of ovarian clear cell adenocarcinomas

Jelovac, D.; Park, B.Ho., 2010:
PTEN promoter silencing and Cowden syndrome: the role of epigenetic regulation of KILLIN

Agarwal, V.; Campbell, A.; Beaumont, K.L.; Cawkwell, L.; Lind, M.J., 2013:
PTEN protein expression in malignant pleural mesothelioma

Milovanovic, Z.; Dzodic, R.; Susnjar, S.; Plesinac-Karapandzic, V.; Juranic, Z.; Tatic, S., 2011:
PTEN protein expression in postmenopausal steroid receptor positive early breast cancer patients treated with adjuvant tamoxifen

Lotan, T.L.; Gurel, B.; Sutcliffe, S.; Esopi, D.; Liu, W.; Xu, J.; Hicks, J.L.; Park, B.H.; Humphreys, E.; Partin, A.W.; Han, M.; Netto, G.J.; Isaacs, W.B.; De Marzo, A.M., 2012:
PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients

Goodwin, C.Rory.; Lal, B.; Ho, S.; Woodard, C.L.; Zhou, X.; Taeger, A.; Xia, S.; Laterra, J., 2012:
PTEN reconstitution alters glioma responses to c-Met pathway inhibition

Lusche, D.F.; Wessels, D.; Richardson, N.A.; Russell, K.B.; Hanson, B.M.; Soll, B.A.; Lin, B.H.; Soll, D.R., 2016:
PTEN redundancy: overexpressing lpten, a homolog of Dictyostelium discoideum ptenA, the ortholog of human PTEN, rescues all behavioral defects of the mutant ptenA-

Huang, F-Fang.; Zhang, L.; Wu, D-Shu.; Yuan, X-Yu.; Yu, Y-Hui.; Zhao, X-Lan.; Chen, F-Ping.; Zeng, H., 2015:
PTEN regulates BCRP/ABCG2 and the side population through the PI3K/Akt pathway in chronic myeloid leukemia

Conley-LaComb, M.Katie.; Huang, W.; Wang, S.; Shi, D.; Jung, Y.Suk.; Najy, A.; Fridman, R.; Bonfil, R.Daniel.; Cher, M.L.; Chen, Y.Q.; Kim, H-Reh.Choi., 2012:
PTEN regulates PDGF ligand switch for β-PDGFR signaling in prostate cancer

Choi, Y.Jeong.; Jung, J.; Chung, H.Kyun.; Im, E.; Rhee, S.Hoon., 2013:
PTEN regulates TLR5-induced intestinal inflammation by controlling Mal/TIRAP recruitment

Tian, T.; Nan, K-Jun.; Wang, S-Hong.; Liang, X.; Lu, C-Xin.; Guo, H.; Wang, W-Juan.; Ruan, Z-Ping., 2010:
PTEN regulates angiogenesis and VEGF expression through phosphatase-dependent and -independent mechanisms in HepG2 cells

Ma, J.; Sawai, H.; Ochi, N.; Matsuo, Y.; Xu, D.; Yasuda, A.; Takahashi, H.; Wakasugi, T.; Takeyama, H., 2010:
PTEN regulates angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells

Saini, M.Kaur.; Sanyal, S.Nath., 2012:
PTEN regulates apoptotic cell death through PI3-K/Akt/GSK3β signaling pathway in DMH induced early colon carcinogenesis in rat

Weng, Z.; Li, D.; Zhang, L.; Chen, J.; Ruan, C.; Chen, G.; Gartner, T.Kent.; Liu, J., 2010:
PTEN regulates collagen-induced platelet activation

Iwasa, K.; Hayashi, S.; Fujishiro, T.; Kanzaki, N.; Hashimoto, S.; Sakata, S.; Chinzei, N.; Nishiyama, T.; Kuroda, R.; Kurosaka, M., 2014:
PTEN regulates matrix synthesis in adult human chondrocytes under oxidative stress

Morani, F.; Phadngam, S.; Follo, C.; Titone, R.; Aimaretti, G.; Galetto, A.; Alabiso, O.; Isidoro, C., 2015:
PTEN regulates plasma membrane expression of glucose transporter 1 and glucose uptake in thyroid cancer cells

Nair, J.S.; Sheikh, T.; Ho, A.L.; Schwartz, G.K., 2013:
PTEN regulates sensitivity of melanoma cells to RO4929097, the γ-secretase inhibitor

Chetram, M.A.; Hinton, C.V., 2013:
PTEN regulation of ERK1/2 signaling in cancer

Xiong, Q.; Oviedo, H.V.; Trotman, L.C.; Zador, A.M., 2012:
PTEN regulation of local and long-range connections in mouse auditory cortex

Sun, C.; Zhao, J.; Jin, Y.; Hou, C.; Zong, W.; Lu, T.; Li, H.; Gao, J., 2014:
PTEN regulation of the proliferation and differentiation of auditory progenitors through the PTEN/PI3K/Akt-signaling pathway in mice

Chen, H.; Mei, L.; Zhou, L.; Shen, X.; Guo, C.; Zheng, Y.; Zhu, H.; Zhu, Y.; Huang, L., 2011:
PTEN restoration and PIK3CB knockdown synergistically suppress glioblastoma growth in vitro and in xenografts

Jang, K.; Kim, M.; Seo, H-Sook.; Shin, I., 2010:
PTEN sensitizes MDA-MB-468 cells to inhibition of MEK/Erk signaling for the blockade of cell proliferation

Koul, D., 2008:
PTEN signaling pathways in glioblastoma

Tarnawski, A.S.; Pai, R.; Tanigawa, T.; Matysiak-Budnik, T.; Ahluwalia, A., 2010:
PTEN silencing reverses aging-related impairment of angiogenesis in microvascular endothelial cells

Cheng, R-Bin.; Ma, R-Juan.; Wang, Z-Kai.; Yang, S-Jun.; Lin, X-Zhi.; Rong, H.; Ma, Y., 2011:
PTEN status is related to cell proliferation and self-renewal independent of CD133 phenotype in the glioma-initiating cells

Muh, C.R.; Joshi, S.; Singh, A.R.; Kesari, S.; Durden, D.L.; Makale, M.T., 2014:
PTEN status mediates 2ME2 anti-tumor efficacy in preclinical glioblastoma models: role of HIF1α suppression

Shen, Z.; Huhn, S., 2014:
PTEN sumo-wrestles human RAD52 to mystery land

Petrella, B.L.; Brinckerhoff, C.E., 2010:
PTEN suppression of YY1 induces HIF-2 activity in von-Hippel-Lindau-null renal-cell carcinoma

Jia, L.; Ji, S.; Maillet, J-Christian.; Zhang, X., 2011:
PTEN suppression promotes neurite development exclusively in differentiating PC12 cells via PI3-kinase and MAP kinase signaling

Liu, Y.; Malaviarachchi, P.; Beggs, M.; Emanuel, P.D., 2011:
PTEN transcript variants caused by illegitimate splicing in "aged" blood samples and EBV-transformed cell lines

Liu, B.; Wu, J-zheng.; Guan, S-min.; Li, Y.; Xu, X-fang., 2015:
PTEN tumor suppressor gene combined with doxycycline inhibites telomerase activity in human mucoepidermoid carcinoma cell line

Liu, Y-Yan.; Yao, S-Na.; Zhao, Y.; Yao, Z-Hua.; Ma, J.; Xia, Q-Xin.; Fu, K.; Yang, S-Jun., 2010:
PTEN tumor suppressor plays less prognostic role than P53 tumor suppressor in diffuse large B-cell lymphoma

Birnbaum, Y.; Nanhwan, M.K.; Ling, S.; Perez-Polo, J.R.; Ye, Y.; Bajaj, M., 2015:
PTEN upregulation may explain the development of insulin resistance and type 2 diabetes with high dose statins

Zhiyong, C.; Wentong, L.; Xiaoyang, Y.; Ling, P., 2012:
PTEN's regulation of VEGF and VEGFR1 expression and its clinical significance in myeloid leukemia

Duman, B.B.; Sahin, B.; Acikalin, A.; Ergin, M.; Zorludemir, S., 2013:
PTEN, Akt, MAPK, p53 and p95 expression to predict trastuzumab resistance in HER2 positive breast cancer

Esteva, F.J.; Guo, H.; Zhang, S.; Santa-Maria, C.; Stone, S.; Lanchbury, J.S.; Sahin, A.A.; Hortobagyi, G.N.; Yu, D., 2011:
PTEN, PIK3CA, p-AKT, and p-p70S6K status: association with trastuzumab response and survival in patients with HER2-positive metastatic breast cancer

Buckingham, L.; Penfield Faber, L.; Kim, A.; Liptay, M.; Barger, C.; Basu, S.; Fidler, M.; Walters, K.; Bonomi, P.; Coon, J., 2010:
PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients

Gupta, A.; Dey, C.Sankar., 2013:
PTEN, a widely known negative regulator of insulin/PI3K signaling, positively regulates neuronal insulin resistance

Liu, J.; Feng, Z., 2012:
PTEN, energy metabolism and tumor suppression

Hager, M.; Haufe, H.; Lusuardi, L.; Schmeller, N.; Kolbitsch, C., 2011:
PTEN, pAKT, and pmTOR expression and subcellular distribution in primary renal cell carcinomas and their metastases

Hill, R.; Wu, H., 2009:
PTEN, stem cells, and cancer stem cells

Huang, L.C.; Ye, J.C.; Hsieh, C.H.; Chen, L.M.; Lin, T.Y.; Hung, Y.C.; Chang, W.C., 2011:
PTEN, tau-AP-3, thymidylate synthase immunohistochemistry scoring expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignancy potential and uterine leiomyosarcomas

Zheng, T.; Meng, X.; Wang, J.; Chen, X.; Yin, D.; Liang, Y.; Song, X.; Pan, S.; Jiang, H.; Liu, L., 2011:
PTEN- and p53-mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude mice

Smith, U., 2012:
PTEN--linking metabolism, cell growth, and cancer

Maillet, J-Christian.; Zhang, Y.; Li, X.; Zhang, X., 2008:
PTEN-5-HT2C coupling: a new target for treating drug addiction

Mosessian, S.; Wu, H., 2010:
PTEN-Associated Complexes: An Overview

Wee, S.; Wiederschain, D.; Maira, S-Michel.; Loo, A.; Miller, C.; deBeaumont, R.; Stegmeier, F.; Yao, Y-Mae.; Lengauer, C., 2008:
PTEN-deficient cancers depend on PIK3CB

Chin, Y.Rebecca.; Yuan, X.; Balk, S.P.; Toker, A., 2015:
PTEN-deficient tumors depend on AKT2 for maintenance and survival

Billia, F.; Hauck, L.; Konecny, F.; Rao, V.; Shen, J.; Mak, T.Wah., 2011 :
PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart function

Plum, L.Marie.; Brieger, A.; Engelhardt, G.; Hebel, S.; Nessel, A.; Arlt, M.; Kaltenberg, J.; Schwaneberg, U.; Huber, M.; Rink, L.; Haase, H., 2015:
PTEN-inhibition by zinc ions augments interleukin-2-mediated Akt phosphorylation

Pavlakis, K.; Messini, I.; Vrekoussis, T.; Panoskaltsis, T.; Chrissanthakis, D.; Yiannou, P.; Stathopoulos, E.N., 2010:
PTEN-loss and nuclear atypia of EIN in endometrial biopsies can predict the existence of a concurrent endometrial carcinoma

Alyasiri, N.Sherif.; Mehdi, S.Jafar.; Alam, M.Shabbir.; Ali, A.; Mandal, A.K.; Gupta, S.; Singh, I.; Rizvi, M.Moshahid.Alam., 2012:
PTEN-mediated AKT activation contributes to the reduced apoptosis among Indian oral squamous cell carcinoma patients

Kamo, N.; Ke, B.; Busuttil, R.W.; Kupiec-Weglinski, J.W., 2013:
PTEN-mediated Akt/β-catenin/Foxo1 signaling regulates innate immune responses in mouse liver ischemia/reperfusion injury

Deb, T.B.; Barndt, R.J.; Zuo, A.H.; Sengupta, S.; Coticchia, C.M.; Johnson, M.D., 2014:
PTEN-mediated ERK1/2 inhibition and paradoxical cellular proliferation following Pnck overexpression

van Duijn, P.W.; Ziel-van der Made, A.C.J.; van der Korput, J.A.G.; Trapman, J., 2010:
PTEN-mediated G1 cell-cycle arrest in LNCaP prostate cancer cells is associated with altered expression of cell-cycle regulators

Uzoh, C.C.; Perks, C.M.; Bahl, A.; Holly, J.M.P.; Sugiono, M.; Persad, R.A., 2009:
PTEN-mediated pathways and their association with treatment-resistant prostate cancer

Gan, Y-Hua.; Zhang, S., 2011:
PTEN/AKT pathway involved in histone deacetylases inhibitor induced cell growth inhibition and apoptosis of oral squamous cell carcinoma cells

Goo, C.Kiat.; Lim, H.Ying.; Ho, Q.Shi.; Too, H-Phon.; Clement, M-Veronique.; Wong, K.Ping., 2013:
PTEN/Akt signaling controls mitochondrial respiratory capacity through 4E-BP1

Kar, S.; Samii, A.; Bertalanffy, H., 2016:
PTEN/PI3K/Akt/VEGF signaling and the cross talk to KRIT1, CCM2, and PDCD10 proteins in cerebral cavernous malformations

Zhang, Y.; Zhang, J.; Xu, K.; Xiao, Z.; Sun, J.; Xu, J.; Wang, J.; Tang, Q., 2014:
PTEN/PI3K/mTOR/B7-H1 signaling pathway regulates cell progression and immuno-resistance in pancreatic cancer

Park, K.K.; Liu, K.; Hu, Y.; Kanter, J.L.; He, Z., 2010:
PTEN/mTOR and axon regeneration

Jung, I.Lae.; Kang, H.Jin.; Kim, K.Chan.; Kim, I.Gyu., 2010:
PTEN/pAkt/p53 signaling pathway correlates with the radioresponse of non-small cell lung cancer

Garcia-Junco-Clemente, P.; Golshani, P., 2014:
PTEN: A master regulator of neuronal structure, function, and plasticity

Thérier, J.; Solari, F.; Billaud, M., 2007:
PTEN: a guard of nuclear safety

Blair, P.J.; Harvey, J., 2012:
PTEN: a new player controlling structural and functional synaptic plasticity

Liang, W-Tong.; Cheng, Z-Yong.; Jia, Z-Qiang.; Wang, B-Yan., 2013:
PTEN: a new target in inhibiting of tumor invasion and metastasis

Leslie, N.R., 2013:
PTEN: an intercellular peacekeeper?

Naik, U.P., 2010:
PTEN: not just a tumor suppressor

Liang, H.; He, S.; Yang, J.; Jia, X.; Wang, P.; Chen, X.; Zhang, Z.; Zou, X.; McNutt, M.A.; Shen, W.Hong.; Yin, Y., 2015:
PTENα, a PTEN isoform translated through alternative initiation, regulates mitochondrial function and energy metabolism

Anonymous, 1946:
PTERINS and macrocytic anemia factors

Lepäntalo, M.; Laurila, K.; Roth, W-D.; Rossi, P.; Lavonen, J.; Mäkinen, K.; Manninen, H.; Romsi, P.; Perälä, J.; Bergqvist, D., 2009:
PTFE bypass or thrupass for superficial femoral artery occlusion? A randomised controlled trial

Lundgren, F.; Bergquist, D.; Norgren, L.; Schroeder, T.; Carstensen, J.; Hälsa, T.; Almstrom, C.; Almgren, B.; Drott, C.; Jansson, I.; Hallstensson, S.; Jivegard, L.; Ortenwall, P.; Tuvesson, T.; Plate, G.; Potemkowski, A.; Lundqvist, B.; Emtersjo, G.; Jonsson, B.; Jonung, T.; Lindblad, B.; Almstrom, C.; Wingren, U.; Svensson, M.; Fornander, B.; Bjorck, M.; Brunes, L.; Johansson, G.; Karlstrom, L.; Tornell, P-Erland.; Ljungman, C.; Aldman, A.; Forsberg, O.; Bjorkman, H.; Arfvidsson, B.; Bohlin,, 2010:
PTFE bypass to below-knee arteries: distal vein collar or not? A prospective randomised multicentre study

Donati, G.; Cianciolo, G.; Mauro, R.; Rucci, P.; Scrivo, A.; Marchetti, A.; Giampalma, E.; Golfieri, R.; Panicali, L.; Iorio, M.; Stella, A.; La Manna, G.; Stefoni, S., 2015:
PTFE grafts versus tunneled cuffed catheters for hemodialysis: which is the second choice when arteriovenous fistula is not feasible?

Yu, C-Hao.; Kusumawardhana, I.; Lai, J-Yih.; Liu, Y-Ling., 2009:
PTFE/polyamide thin-film composite membranes using PTFE films modified with ethylene diamine polymer and interfacial polymerization: preparation and pervaporation application

Bonmassar, G.; Fujimoto, K.; Golby, A.J., 2013:
PTFOS: flexible and absorbable intracranial electrodes for magnetic resonance imaging

Turnbull, J.; DePaoli-Roach, A.A.; Zhao, X.; Cortez, M.A.; Pencea, N.; Tiberia, E.; Piliguian, M.; Roach, P.J.; Wang, P.; Ackerley, C.A.; Minassian, B.A., 2011:
PTG depletion removes Lafora bodies and rescues the fatal epilepsy of Lafora disease

Turnbull, J.; Epp, J.R.; Goldsmith, D.; Zhao, X.; Pencea, N.; Wang, P.; Frankland, P.W.; Ackerley, C.A.; Minassian, B.A., 2014:
PTG protein depletion rescues malin-deficient Lafora disease in mouse

Isidoro-García, M.; Sanz, C.; García-Solaesa, V.; Pascual, M.; Pescador, D.B.; Lorente, F.; Dávila, I., 2012:
PTGDR gene in asthma: a functional, genetic, and epigenetic study

Leung, T.Fan.; Li, C.Yi.; Kong, A.P.S.; Chan, I.H.S.; Ng, M.C.Y.; Chan, M.H.M.; So, W.Yee.; Wong, G.W.K.; Lam, C.W.K.; Chan, J.C.N., 2009:
PTGDR is not a major candidate gene for asthma and atopy in Chinese children

Lee, Y.Ho.; Choi, S.Jae.; Ji, J.Dae.; Song, G.Gyu., 2014:
PTGDR polymorphisms and susceptibility to asthma: a meta-analysis

Chandras, C.; Harris, T.E.; Bernal, A.López.; Abayasekara, D.R.E.; Michael, A.E., 2007:
PTGER1 and PTGER2 receptors mediate regulation of progesterone synthesis and type 1 11beta-hydroxysteroid dehydrogenase activity by prostaglandin E2 in human granulosa lutein cells

Thibodeau, J-François.; Nasrallah, R.; Carter, A.; He, Y.; Touyz, R.; Hébert, R.L.; Kennedy, C.R.J., 2014:
PTGER1 deletion attenuates renal injury in diabetic mouse models

Baba, Y.; Nosho, K.; Shima, K.; Goessling, W.; Chan, A.T.; Ng, K.; Chan, J.A.; Giovannucci, E.L.; Fuchs, C.S.; Ogino, S., 2010:
PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype

Glas, Jürgen.; Seiderer, J.; Czamara, D.; Pasciuto, G.; Diegelmann, J.; Wetzke, M.; Olszak, T.; Wolf, C.; Müller-Myhsok, B.; Balschun, T.; Achkar, J-Paul.; Kamboh, M.Ilyas.; Franke, A.; Duerr, R.H.; Brand, S., 2013:
PTGER4 expression-modulating polymorphisms in the 5p13.1 region predispose to Crohn's disease and affect NF-κB and XBP1 binding sites

Prager, M.; Büttner, J.; Büning, C., 2015:
PTGER4 modulating variants in Crohn's disease

May, P.; Kreuchwig, A.; Steinke, T.; Koch, I., 2010:
PTGL: a database for secondary structure-based protein topologies

Yagmur, E.; Weiskirchen, R.; Schedel, A.; Bugert, P., 2014:
PTGS1 compound heterozygosity impairs gene expression and platelet aggregation and is associated with severe bleeding complications

Ben Nasr, H.; Chahed, K.; Bouaouina, N.; Chouchane, L., 2007:
PTGS2 (COX-2) -765 G > C functional promoter polymorphism and its association with risk and lymph node metastasis in nasopharyngeal carcinoma

Daraei, A.; Salehi, R.; Mohamadhashem, F., 2012:
PTGS2 (COX2) -765G>C gene polymorphism and risk of sporadic colorectal cancer in Iranian population

Kunzmann, A.T.; Murray, L.J.; Cardwell, C.R.; McShane, C.M.; McMenamin, U.C.; Cantwell, M.M., 2014:
PTGS2 (Cyclooxygenase-2) expression and survival among colorectal cancer patients: a systematic review

Dossus, L.; Kaaks, R.; Canzian, F.; Albanes, D.; Berndt, S.I.; Boeing, H.; Buring, J.; Chanock, S.J.; Clavel-Chapelon, F.; Feigelson, H.Spencer.; Gaziano, J.M.; Giovannucci, E.; Gonzalez, C.; Haiman, C.A.; Hallmans, Göran.; Hankinson, S.E.; Hayes, R.B.; Henderson, B.E.; Hoover, R.N.; Hunter, D.J.; Khaw, K-Tee.; Kolonel, L.N.; Kraft, P.; Ma, J.; Le Marchand, L.; Lund, E.; Peeters, P.H.M.; Stampfer, M.; Stram, D.O.; Thomas, G.; Thun, M.J.; Tjonneland, A.; Trichopoulos, D.; Tumino, R.; Riboli, E.;, 2010:
PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3)

Xuan, C-L.; Yan, W.; Xuan, L.; Xu, R-H., 2014:
PTGS2 gene polymorphism -765G>C is associated with coronary artery disease: a meta-analysis

Narayanan, D.; Anitha, A.; Jayakumar, R.; Chennazhi, K.P., 2014:
PTH 1-34 loaded thiolated chitosan nanoparticles for osteoporosis: oral bioavailability and anabolic effect on primary osteoblast cells

Vescini, F.; Grimaldi, F., 2012:
PTH 1-84: bone rebuilding as a target for the therapy of severe osteoporosis

Vieira, J.Gilberto.H., 2012:
PTH Assays: Understanding What We Have and Forecasting What We Will Have

Almagro, M.Isabel.; Roman-Blas, J.A.; Bellido, M.; Castañeda, S.; Cortez, R.; Herrero-Beaumont, G., 2014:
PTH [1-34] enhances bone response around titanium implants in a rabbit model of osteoporosis

Orth, P.; Cucchiarini, M.; Wagenpfeil, S.; Menger, M.D.; Madry, H., 2015:
PTH [1-34]-induced alterations of the subchondral bone provoke early osteoarthritis

Verhaar, H.J.J.; Lems, W.F., 2010:
PTH analogues and osteoporotic fractures

Verhaar, H.J.J.; Lems, W.F., 2008:
PTH analogues: comparable or different?

Thomas, B.E.; Sharma, S.; Mierke, D.F.; Rosenblatt, M., 2008:
PTH and PTH antagonist induce different conformational changes in the PTHR1 receptor

Fukumoto, S., 2008:
PTH and mechanical stress

Ohishi, M.; Schipani, E., 2012:
PTH and stem cells

Li, J-Yi.; Adams, J.; Calvi, L.M.; Lane, T.F.; DiPaolo, R.; Weitzmann, M.Neale.; Pacifici, R., 2013:
PTH expands short-term murine hemopoietic stem cells through T cells

Dayer, R.; Brennan, T.C.; Rizzoli, R.; Ammann, P., 2011:
PTH improves titanium implant fixation more than pamidronate or renutrition in osteopenic rats chronically fed a low protein diet

Calvo, N.; de Boland, A.Russo.; Gentili, C., 2010:
PTH inactivates the AKT survival pathway in the colonic cell line Caco-2

Lavi-Moshayoff, V.; Wasserman, G.; Meir, T.; Silver, J.; Naveh-Many, T., 2010:
PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop

Bellido, M.; Lugo, L.; Castañeda, S.; Roman-Blas, J.A.; Rufián-Henares, J.A.; Navarro-Alarcón, M.; Largo, R.; Herrero-Beaumont, G., 2010:
PTH increases jaw mineral density in a rabbit model of osteoporosis

Zhao, L.; Zhang, M-jia.; Zhao, H-yan.; Sun, L-hao.; Li, J-li.; Tao, B.; Wang, W-qing.; Ning, G.; Liu, J-min., 2011:
PTH inhibition rate is useful in the detection of early-stage primary hyperparathyroidism

Marangella, M., 2010:
PTH measurement: where do we stand?

Au, A.Y.M.; McDonald, K.; Gill, A.; Sywak, M.; Diamond, T.; Conigrave, A.D.; Clifton-Bligh, R.J., 2008:
PTH mutation with primary hyperparathyroidism and undetectable intact PTH

Sheyn, D.; Cohn Yakubovich, D.; Kallai, I.; Su, S.; Da, X.; Pelled, G.; Tawackoli, W.; Cook-Weins, G.; Schwarz, E.M.; Gazit, D.; Gazit, Z., 2014:
PTH promotes allograft integration in a calvarial bone defect

Qiu, T.; Xian, L.; Crane, J.; Wen, C.; Hilton, M.; Lu, W.; Newman, P.; Cao, X., 2016:
PTH receptor signaling in osteoblasts regulates endochondral vascularization in maintenance of postnatal growth plate

Rhee, Y.; Allen, M.R.; Condon, K.; Lezcano, V.; Ronda, A.C.; Galli, C.; Olivos, N.; Passeri, G.; O'Brien, C.A.; Bivi, N.; Plotkin, L.I.; Bellido, T., 2011:
PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling

Kim, B-Gyu.; Park, Y-Je.; Libermann, T.A.; Cho, J-Yoel., 2011:
PTH regulates myleoid ELF-1-like factor (MEF)-induced MAB-21-like-1 (MAB21L1) expression through the JNK1 pathway

Moriya, S.; Hayata, T.; Notomi, T.; Aryal, S.; Nakamaoto, T.; Izu, Y.; Kawasaki, M.; Yamada, T.; Shirakawa, J.; Kaneko, K.; Ezura, Y.; Noda, M., 2016:
PTH regulates β2-adrenergic receptor expression in osteoblast-like MC3T3-E1 cells

Riss, P.; Asari, R.; Scheuba, C.; Bieglmayer, C.; Niederle, B., 2009:
PTH secretion of "manipulated" parathyroid adenomas

Harrington, E.Kern.; Coon, D.J.; Kern, M.F.; Svoboda, K.K.H., 2010:
PTH stimulated growth and decreased Col-X deposition are phosphotidylinositol-3,4,5 triphosphate kinase and mitogen activating protein kinase dependent in avian sterna

Weinman, E.J.; Steplock, D.; Cha, B.; Kovbasnjuk, O.; Frost, N.A.; Cunningham, R.; Shenolikar, S.; Blanpied, T.A.; Donowitz, M., 2009:
PTH transiently increases the percent mobile fraction of Npt2a in OK cells as determined by FRAP

Huber, B.; Zaruba, M.; Brunner, S.; Deindl, E.; David, R.; Fischer, R.; Assmann, G.; Mueller-Hoecker, J.; Franz, W., 2007:
PTH treatment after myocardial infarction in mice attenuates late ischemic cardiomyopathy: impact of bone marrow derived versus cardiac stem cells

Sikjaer, T.; Rejnmark, L.; Mosekilde, L., 2011:
PTH treatment in hypoparathyroidism

Theman, T.A.; Collins, M.T.; Dempster, D.W.; Zhou, H.; Reynolds, J.C.; Brahim, J.S.; Roschger, P.; Klaushofer, K.; Winer, K.K., 2008:
PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation

Lossdörfer, S.; Götz, W.; Jäger, A., 2012:
PTH(1-34)-induced changes in RANKL and OPG expression by human PDL cells modify osteoclast biology in a co-culture model with RAW 264.7 cells

Rubin, M.R.; Dempster, D.W.; Sliney, J.; Zhou, H.; Nickolas, T.L.; Stein, E.M.; Dworakowski, E.; Dellabadia, M.; Ives, R.; McMahon, D.J.; Zhang, C.; Silverberg, S.J.; Shane, E.; Cremers, S.; Bilezikian, J.P., 2012:
PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism

Cusano, N.E.; Rubin, M.R.; McMahon, D.J.; Irani, D.; Anderson, L.; Levy, E.; Bilezikian, J.P., 2015:
PTH(1-84) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy

Sikjaer, T.; Amstrup, A.Kristine.; Rolighed, L.; Kjaer, S.Geill.; Mosekilde, L.; Rejnmark, L., 2014:
PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment

Rodriguez, M.; Felsenfeld, A.J., 2008:
PTH, FGF-23 and early CKD

Garrett, G.; Sardiwal, S.; Lamb, E.J.; Goldsmith, D.J.A., 2013:
PTH--a particularly tricky hormone: why measure it at all in kidney patients?

Fabbri, S.; Ciuffi, S.; Nardone, V.; Gomes, A.Rita.; Mavilia, C.; Zonefrati, R.; Galli, G.; Luzi, E.; Tanini, A.; Brandi, M.Luisa., 2015:
PTH-C1: a rat continuous cell line expressing the parathyroid phenotype

Verhaar, H.J.J.; Lems, W.F., 2009:
PTH-analogs: comparable or different?

Dhillon, R.S.; Xie, C.; Tyler, W.; Calvi, L.M.; Awad, H.A.; Zuscik, M.J.; O'Keefe, R.J.; Schwarz, E.M., 2013:
PTH-enhanced structural allograft healing is associated with decreased angiopoietin-2-mediated arteriogenesis, mast cell accumulation, and fibrosis

Nicolae, I.; Schipor, S., 2010:
PTH-independent hypercalcaemia and non-melanoma skin cancer

Loupy, A.; Ramakrishnan, S.Krishna.; Wootla, B.; Chambrey, Régine.; de la Faille, R.; Bourgeois, S.; Bruneval, P.; Mandet, C.; Christensen, E.Ilso.; Faure, Hélène.; Cheval, L.; Laghmani, K.; Collet, C.; Eladari, D.; Dodd, R.H.; Ruat, M.; Houillier, P., 2012:
PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor

Blaine, J.; Okamura, K.; Giral, H.; Breusegem, S.; Caldas, Y.; Millard, A.; Barry, N.; Levi, M., 2009:
PTH-induced internalization of apical membrane NaPi2a: role of actin and myosin VI

Weinman, E.J.; Lederer, E.D., 2012:
PTH-mediated inhibition of the renal transport of phosphate

Khundmiri, S.J.; Ameen, M.; Delamere, N.A.; Lederer, E.D., 2008:
PTH-mediated regulation of Na+-K+-ATPase requires Src kinase-dependent ERK phosphorylation

Lee, P., 2014:
PTH-vitamin D-glycemia interactions reloaded

Suzuki, A.; Ozono, K.; Kubota, T.; Kondou, H.; Tachikawa, K.; Michigami, T., 2007:
PTH/cAMP/PKA signaling facilitates canonical Wnt signaling via inactivation of glycogen synthase kinase-3beta in osteoblastic Saos-2 cells

Candelario, J.; Tavakoli, H.; Chachisvilis, M., 2013:
PTH1 receptor is involved in mediating cellular response to long-chain polyunsaturated fatty acids

Chandra, A.; Lin, T.; Tribble, M.Beth.; Zhu, J.; Altman, A.R.; Tseng, W-Ju.; Zhang, Y.; Akintoye, S.O.; Cengel, K.; Liu, X.Sherry.; Qin, L., 2015:
PTH1-34 alleviates radiotherapy-induced local bone loss by improving osteoblast and osteocyte survival

Chandra, A.; Lin, T.; Zhu, J.; Tong, W.; Huo, Y.; Jia, H.; Zhang, Y.; Liu, X.Sherry.; Cengel, K.; Xia, B.; Qin, L., 2015:
PTH1-34 blocks radiation-induced osteoblast apoptosis by enhancing DNA repair through canonical Wnt pathway

Gruson, D.; Buglioni, A.; Burnett, J.C., 2015:
PTH: Potential role in management of heart failure

Guan, D.; Shao, J.; Zhao, Z.; Wang, P.; Qin, J.; Deng, Y.; Boheler, K.R.; Wang, J.; Yan, B., 2014:
PTHGRN: unraveling post-translational hierarchical gene regulatory networks using PPI, ChIP-seq and gene expression data

Huang, J.; Wang, L.; Jiang, M.; Lin, H.; Qi, L.; Diao, H., 2013:
PTHLH coupling upstream negative regulation of fatty acid biosynthesis and Wnt receptor signal to downstream peptidase activity-induced apoptosis network in human hepatocellular carcinoma by systems-theoretical analysis

Decker, E.; Stellzig-Eisenhauer, A.; Fiebig, B.S.; Rau, C.; Kress, W.; Saar, K.; Rüschendorf, F.; Hubner, N.; Grimm, T.; Weber, B.H.F., 2008:
PTHR1 loss-of-function mutations in familial, nonsyndromic primary failure of tooth eruption

Couvineau, A.; Wouters, V.; Bertrand, Gène.; Rouyer, C.; Gérard, Bénédicte.; Boon, L.M.; Grandchamp, B.; Vikkula, M.; Silve, C., 2008:
PTHR1 mutations associated with Ollier disease result in receptor loss of function

Hildreth, B.Eason.; Werbeck, J.L.; Thudi, N.K.; Deng, X.; Rosol, T.J.; Toribio, R.E., 2010:
PTHrP 1-141 and 1-86 increase in vitro bone formation

Cheung, V.; Bouralexis, S.; Gillespie, M.T., 2013:
PTHrP Overexpression Increases Sensitivity of Breast Cancer Cells to Apo2L/TRAIL

Onuma, E.; Okabe, H., 2008:
PTHrP and cancer cachexia

Nishihara, M.; Kanematsu, T.; Taguchi, T.; Razzaque, M.S., 2007:
PTHrP and tumorigenesis: is there a role in prognosis?

Li, J.; Karaplis, A.C.; Huang, D.C.; Siegel, P.M.; Camirand, A.; Yang, X.Fang.; Muller, W.J.; Kremer, R., 2012:
PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target

Zheng, L.; Zhu, K.; Jiao, H.; Zhao, Z.; Zhang, L.; Liu, M.; Deng, W.; Chen, D.; Yao, Z.; Xiao, G., 2014:
PTHrP expression in human MDA-MB-231 breast cancer cells is critical for tumor growth and survival and osteoblast inhibition

Nakao, A.; Kajiya, H.; Fukushima, H.; Fukushima, A.; Anan, H.; Ozeki, S.; Okabe, K., 2009:
PTHrP induces Notch signaling in periodontal ligament cells

Mak, I.W.Y.; Cowan, R.W.; Turcotte, R.E.; Singh, G.; Ghert, M., 2011:
PTHrP induces autocrine/paracrine proliferation of bone tumor cells through inhibition of apoptosis

Mi, D.; Zhang, M.; Yan, J-dong.; Zhang, J.; Wang, X.; Wang, Q.; Yang, S.; Zhu, T-hui., 2011:
PTHrP inhibits BMP-6 expression through the PKA signaling pathway in breast cancer cells

Lee, J-Min.; Im, G-Il., 2012:
PTHrP isoforms have differing effect on chondrogenic differentiation and hypertrophy of mesenchymal stem cells

Wang, D.; Taboas, J.M.; Tuan, R.S., 2011:
PTHrP overexpression partially inhibits a mechanical strain-induced arthritic phenotype in chondrocytes

Zhang, M.; Xie, R.; Hou, W.; Wang, B.; Shen, R.; Wang, X.; Wang, Q.; Zhu, T.; Jonason, J.H.; Chen, D., 2009:
PTHrP prevents chondrocyte premature hypertrophy by inducing cyclin-D1-dependent Runx2 and Runx3 phosphorylation, ubiquitylation and proteasomal degradation

Kim, Y-Ju.; Kim, H-Joung.; Im, G-Il., 2008:
PTHrP promotes chondrogenesis and suppresses hypertrophy from both bone marrow-derived and adipose tissue-derived MSCs

Mula, R.V.; Bhatia, V.; Falzon, M., 2010:
PTHrP promotes colon cancer cell migration and invasion in an integrin α6β4-dependent manner through activation of Rac1

Isowa, S.; Shimo, T.; Ibaragi, S.; Kurio, N.; Okui, T.; Matsubara, K.; Hassan, N.Mohammad.Monsur.; Kishimoto, K.; Sasaki, A., 2010:
PTHrP regulates angiogenesis and bone resorption via VEGF expression

Downs, T.M.; Burton, D.W.; Araiza, F.L.; Hastings, R.H.; Deftos, L.J., 2011:
PTHrP stimulates prostate cancer cell growth and upregulates aldo-keto reductase 1C3

Eller-Vainicher, C.; Ossola, M.Wally.; Beck-Peccoz, P.; Chiodini, I., 2012:
PTHrP-associated hypercalcemia of pregnancy resolved after delivery: a case report

Burns, L.H.; Wang, H-Yan., 2011:
PTI-609: a novel analgesic that binds filamin A to control opioid signaling

Liu, C.; Liang, D.; Gao, T.; Pang, X.; Song, J.; Yao, H.; Han, J.; Liu, Z.; Guan, X.; Jiang, K.; Li, H.; Chen, S., 2012:
PTIGS-IdIt, a system for species identification by DNA sequences of the psbA-trnH intergenic spacer region

Takeshita, T.; Yamamoto-Ibusuki, M.; Yamamoto, Y.; Omoto, Y.; Honda, Y.; Iyama, K-ichi.; Zhang, Z.; Iwase, H., 2014:
PTIP associated protein 1, PA1, is an independent prognostic factor for lymphnode negative breast cancer

Cho, Y-Wook.; Hong, T.; Hong, S.; Guo, H.; Yu, H.; Kim, D.; Guszczynski, T.; Dressler, G.R.; Copeland, T.D.; Kalkum, M.; Ge, K., 2007:
PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex

Daniel, J.A.; Santos, M.Almeida.; Wang, Z.; Zang, C.; Schwab, K.R.; Jankovic, M.; Filsuf, D.; Chen, H-Tang.; Gazumyan, A.; Yamane, A.; Cho, Y-Wook.; Sun, H-Wei.; Ge, K.; Peng, W.; Nussenzweig, M.C.; Casellas, R.; Dressler, G.R.; Zhao, K.; Nussenzweig, Aé., 2010:
PTIP promotes chromatin changes critical for immunoglobulin class switch recombination

Wu, J.; Prindle, M.J.; Dressler, G.R.; Yu, X., 2009:
PTIP regulates 53BP1 and SMC1 at the DNA damage sites

Craik, R.L., 2012:
PTJ Adopts a new process for review of RCTs

Gärtner, S.; Gunesch, A.; Knyazeva, T.; Wolf, P.; Högel, B.; Eiermann, W.; Ullrich, A.; Knyazev, P.; Ataseven, B., 2014:
PTK 7 is a transforming gene and prognostic marker for breast cancer and nodal metastasis involvement

Ting-An, W.; Hong-Xiang, Z., 2009:
PTK-pathways and TGF-beta signaling pathways in schistosomes

Lazarini, M.; Machado-Neto, Jão.Agostinho.; Archangelo, L.Fröhlich.; Mendes-Silva, B.Fernandes.; Bigarella, C.Louzão.; Traina, F.; Saad, S.Teresinha.Olalla. , 2014:
PTK2 and PTPN11 expression in myelodysplastic syndromes

Weisser, M.; Yeh, R-Fang.; Duchateau-Nguyen, G.; Palermo, G.; Nguyen, T.Quang.; Shi, X.; Stinson, S.Y.; Yu, N.; Dufour, A.; Robak, T.; Salogub, G.N.; Dmoszynska, A.; Solal-Celigny, P.; Warzocha, K.; Loscertales, J.; Catalano, J.; Larratt, L.; Rossiev, V.A.; Bence-Bruckler, I.; Geisler, C.H.; Montillo, M.; Fischer, K.; Fink, A-Maria.; Hallek, M.; Bloehdorn, J.; Busch, R.; Benner, A.; Döhner, H.; Valente, N.; Wenger, M.K.; Stilgenbauer, S.; Dornan, D., 2014:
PTK2 expression and immunochemotherapy outcome in chronic lymphocytic leukemia

Garatachea, N.; Fuku, N.; He, Z-Hong.; Tian, Y.; Arai, Y.; Abe, Y.; Murakami, H.; Miyachi, M.; Yvert, T.; Venturini, L.; Santiago, C.; Santos-Lozano, A.; Rodríguez, G.; Ricevuti, G.; Pareja-Galeano, H.; Sanchis-Gomar, F.; Emanuele, E.; Hirose, N.; Lucia, A., 2015:
PTK2 rs7460 and rs7843014 polymorphisms and exceptional longevity: a functional replication study

Luo, J.; McGinnis, L.K.; Carlton, C.; Beggs, H.E.; Kinsey, W.H., 2014:
PTK2b function during fertilization of the mouse oocyte

Zheng, Y.; Wang, Z.; Bie, W.; Brauer, P.M.; Perez White, B.E.; Li, J.; Nogueira, V.; Raychaudhuri, P.; Hay, N.; Tonetti, D.A.; Macias, V.; Kajdacsy-Balla, Aé.; Tyner, A.L., 2013:
PTK6 activation at the membrane regulates epithelial-mesenchymal transition in prostate cancer

Kang, S-Ae.; Lee, E-Saem.; Yoon, H-Young.; Randazzo, P.A.; Lee, S-Taek., 2010:
PTK6 inhibits down-regulation of EGF receptor through phosphorylation of ARAP1

Ono, H.; Basson, M.D.; Ito, H., 2014:
PTK6 promotes cancer migration and invasion in pancreatic cancer cells dependent on ERK signaling

Irie, H.Y.; Shrestha, Y.; Selfors, L.M.; Frye, F.; Iida, N.; Wang, Z.; Zou, L.; Yao, J.; Lu, Y.; Epstein, C.B.; Natesan, S.; Richardson, A.L.; Polyak, K.; Mills, G.B.; Hahn, W.C.; Brugge, J.S., 2010:
PTK6 regulates IGF-1-induced anchorage-independent survival

Peng, M.; Emmadi, R.; Wang, Z.; Wiley, E.L.; Gann, P.H.; Khan, S.; Banerji, N.; McDonald, W.; Asztalos, S.; Pham, T.N.D.; Tonetti, D.A.; Tyner, A.L., 2014:
PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors

Lin, Y.; Zhang, L-Hai.; Wang, X-Hong.; Xing, X-Fang.; Cheng, X-Jing.; Dong, B.; Hu, Y.; Du, H.; Li, Y-Ai.; Zhu, Y-Bing.; Ding, N.; Du, Y-Xia.; Li, J-You.; Ji, J-Fu., 2013:
PTK7 as a novel marker for favorable gastric cancer patient survival

Ataseven, B.; Gunesch, A.; Eiermann, W.; Kates, R.E.; Högel, B.; Knyazev, P.; Ullrich, A.; Harbeck, N., 2014:
PTK7 as a potential prognostic and predictive marker of response to adjuvant chemotherapy in breast cancer patients, and resistance to anthracycline drugs

Ataseven, B.; Angerer, R.; Kates, R.; Gunesch, A.; Knyazev, P.; Högel, B.; Becker, C.; Eiermann, W.; Harbeck, N., 2013:
PTK7 expression in triple-negative breast cancer

Yen, W.Wei.; Williams, M.; Periasamy, A.; Conaway, M.; Burdsal, C.; Keller, R.; Lu, X.; Sutherland, A., 2009:
PTK7 is essential for polarized cell motility and convergent extension during mouse gastrulation

Zhang, G-Ting.; Zhang, A-Qin., 2015:
PTK7 mRNA and protein expression level in serum of patients with acute lymphocytic leukemia and its clinical significance

Chan, D.N.; Azghadi, S.F.; Feng, J.; Lowry, W.E., 2013:
PTK7 marks the first human developmental EMT in vitro

Bin-Nun, N.; Lichtig, H.; Malyarova, A.; Levy, M.; Elias, S.; Frank, D., 2014:
PTK7 modulates Wnt signaling activity via LRP6

Shnitsar, I.; Borchers, A., 2008:
PTK7 recruits dsh to regulate neural crest migration

Liu, Q.; Zhang, C.; Yuan, J.; Fu, J.; Wu, M.; Su, J.; Wang, X.; Yuan, X.; Jiang, W., 2015:
PTK7 regulates Id1 expression in CD44-high glioma cells

Lee, J.; Andreeva, A.; Sipe, C.W.; Liu, L.; Cheng, A.; Lu, X., 2012:
PTK7 regulates myosin II activity to orient planar polarity in the mammalian auditory epithelium

Andreeva, A.; Lee, J.; Lohia, M.; Wu, X.; Macara, I.G.; Lu, X., 2014:
PTK7-Src signaling at epithelial cell contacts mediates spatial organization of actomyosin and planar cell polarity

Roorda, B.D.; Ter Elst, A.; Diks, S.H.; Meeuwsen-de Boer, T.G.J.; Kamps, W.A.; de Bont, E.S.J.M., 2010:
PTK787/ZK 222584 inhibits tumor growth promoting mesenchymal stem cells: kinase activity profiling as powerful tool in functional studies

Katsura, Y.; Wada, H.; Murakami, M.; Akita, H.; Hama, N.; Kawamoto, K.; Kobayashi, S.; Marubashi, S.; Eguchi, H.; Tanemura, M.; Umeshita, K.; Doki, Y.; Mori, M.; Nagano, H., 2014:
PTK787/ZK222584 combined with interferon alpha and 5-fluorouracil synergistically inhibits VEGF signaling pathway in hepatocellular carcinoma

Lhoumeau, A-Catherine.; Puppo, F.; Prébet, T.; Kodjabachian, L.; Borg, J-Paul., 2011:
PTK7: a cell polarity receptor with multiple facets

Stravodimou, A.; Cairoli, A.; Rausch, T.; Du Pasquier, R.; Michel, P., 2012:
PTLD Burkitt Lymphoma in a Patient with Remote Lymphomatoid Granulomatosis

Montserrat, E., 2012:
PTLD treatment: a step forward, a long way to go

Dharnidharka, V.R.; Gupta, S., 2010:
PTLD treatment: reducing the chemotherapy burden through addition of rituximab

Nanni, P.; Panse, C.; Gehrig, P.; Mueller, S.; Grossmann, J.; Schlapbach, R., 2014:
PTM MarkerFinder, a software tool to detect and validate spectra from peptides carrying post-translational modifications

Craveur, P.; Rebehmed, J.; de Brevern, A.G., 2014:
PTM-SD: a database of structurally resolved and annotated posttranslational modifications in proteins

Everett, L.; Vo, A.; Hannenhalli, S., 2009:
PTM-Switchboard--a database of posttranslational modifications of transcription factors, the mediating enzymes and target genes

Evaristo, G.P.C.; Verhaert, P.D.E.M.; Pinkse, M.W.H., 2013:
PTM-driven differential peptide display: survey of peptides containing inter/intra-molecular disulfide bridges in frog venoms

Naegle, K.M.; Gymrek, M.; Joughin, B.A.; Wagner, J.P.; Welsch, R.E.; Yaffe, M.B.; Lauffenburger, D.A.; White, F.M., 2011:
PTMScout, a Web resource for analysis of high throughput post-translational proteomics studies

Kertesz, V.; Connelly, H.M.; Erickson, B.K.; Hettich, R.L., 2010:
PTMSearchPlus: software tool for automated protein identification and post-translational modification characterization by integrating accurate intact protein mass and bottom-up mass spectrometric data searches

Kertész-Farkas, A.; Reiz, Báta.; Vera, R.; Myers, M.P.; Pongor, Sándor., 2014:
PTMTreeSearch: a novel two-stage tree-search algorithm with pruning rules for the identification of post-translational modification of proteins in MS/MS spectra

Chen, Y.; Chen, W.; Cobb, M.H.; Zhao, Y., 2009:
PTMap--a sequence alignment software for unrestricted, accurate, and full-spectrum identification of post-translational modification sites

Minguez, P.; Letunic, I.; Parca, L.; Garcia-Alonso, L.; Dopazo, J.; Huerta-Cepas, J.; Bork, P., 2015 :
PTMcode v2: a resource for functional associations of post-translational modifications within and between proteins

Minguez, P.; Letunic, I.; Parca, L.; Bork, P., 2013:
PTMcode: a database of known and predicted functional associations between post-translational modifications in proteins

Nahnsen, S.; Sachsenberg, T.; Kohlbacher, O., 2013:
PTMeta: increasing identification rates of modified peptides using modification prescanning and meta-analysis

Sethi, G.; Kwon, Y.; Burkhalter, R.J.; Pathak, H.B.; Madan, R.; McHugh, S.; Atay, S.; Murthy, S.; Tawfik, O.W.; Godwin, A.K., 2016:
PTN signaling: Components and mechanistic insights in human ovarian cancer

Boyd, G., 2007:
PTO pyramid

Li, Z.; Yang, X.; Xia, N.; Yang, L.; Yu, H.; Zhou, F.; X, C.; Zhou, Y., 2014:
PTOP and TRF1 help enhance the radio resistance in breast cancer cell

Gronchi, C.C.; Caldas, L.V.E., 2013:
PTOSL response of commercial Al2O3:C detectors to ultraviolet radiation

Youn, H-Sook.; Park, U-Hyun.; Kim, E-Joo.; Um, S-Jong., 2011:
PTOV1 antagonizes MED25 in RAR transcriptional activation

Yao, Y-Wei.; Shi, Y.; Jia, Z-Fu.; Jiang, Y-Hong.; Gu, Z.; Wang, J.; Aljofan, M.; Sun, Z-Gui., 2011:
PTOV1 is associated with UCH-L1 and in response to estrogen stimuli during the mouse oocyte development

Fernández, S.; Mosquera, J.L.; Alaña, L.; Sanchez-Pla, A.; Morote, J.; Ramón Y Cajal, S.; Reventós, J.; de Torres, Iés.; Paciucci, R., 2011:
PTOV1 is overexpressed in human high-grade malignant tumors

Park, J.Eun.; Park, B.Chul.; Song, M.; Park, S.Goo.; Lee, D.Hee.; Park, S-Young.; Kim, J.Hoon.; Cho, S., 2009:
PTP inhibitor IV protects JNK kinase activity by inhibiting dual-specificity phosphatase 14 (DUSP14)

Espejo, R.; Rengifo-Cam, W.; Schaller, M.D.; Evers, B.Mark.; Sastry, S.K., 2010:
PTP-PEST controls motility, adherens junction assembly, and Rho GTPase activity in colon cancer cells

Espejo, R.; Jeng, Y.; Paulucci-Holthauzen, A.; Rengifo-Cam, W.; Honkus, K.; Anastasiadis, P.Z.; Sastry, S.K., 2014:
PTP-PEST targets a novel tyrosine site in p120 catenin to control epithelial cell motility and Rho GTPase activity

Wyatt, L.; Khew-Goodall, Y., 2008:
PTP-Pez: a novel regulator of TGFbeta signaling

Stuible, M.; Doody, K.M.; Tremblay, M.L., 2008:
PTP1B and TC-PTP: regulators of transformation and tumorigenesis

Tiganis, T., 2013:
PTP1B and TCPTP--nonredundant phosphatases in insulin signaling and glucose homeostasis

Zhang, S.; Zhang, Z-Yin., 2007:
PTP1B as a drug target: recent developments in PTP1B inhibitor discovery

Wang, X-Min.; Shang, L.; Zhang, Y.; Hao, J-Jie.; Shi, F.; Luo, W.; Zhang, T-Tong.; Wang, B-Shi.; Yang, Y.; Liu, Z-Hua.; Zhan, Q-Min.; Wang, M-Rong., 2014:
PTP1B contributes to calreticulin-induced metastatic phenotypes in esophageal squamous cell carcinoma

Escrivá, F.; González-Rodriguez, A.; Fernández-Millán, E.; Rondinone, C.M.; Alvarez, C.; Valverde, A.M., 2010:
PTP1B deficiency enhances liver growth during suckling by increasing the expression of insulin-like growth factor-I

González-Rodriguez, A.; Nevado, C.; Escrivá, F.; Sesti, G.; Rondinone, C.M.; Benito, M.; Valverde, A.M., 2008:
PTP1B deficiency increases glucose uptake in neonatal hepatocytes: involvement of IRA/GLUT2 complexes

Zarelli, V.E.P.; Ruete, M.C.; Roggero, C.M.; Mayorga, L.S.; Tomes, C.N., 2009:
PTP1B dephosphorylates N-ethylmaleimide-sensitive factor and elicits SNARE complex disassembly during human sperm exocytosis

Wang, J.; Liu, B.; Chen, X.; Su, L.; Wu, P.; Wu, J.; Zhu, Z., 2012:
PTP1B expression contributes to gastric cancer progression

Tsuchiya, A.; Kanno, T.; Nagaya, H.; Shimizu, T.; Tanaka, A.; Nishizaki, T., 2015:
PTP1B inhibition causes Rac1 activation by enhancing receptor tyrosine kinase signaling

Shrestha, S.; Bhattarai, B.Raj.; Cho, H.; Choi, J-Kwon.; Cho, H., 2007:
PTP1B inhibitor Ertiprotafib is also a potent inhibitor of IkappaB kinase beta (IKK-beta)

Ma, Y-ming.; Tao, R-ya.; Liu, Q.; Li, J.; Tian, J-ying.; Zhang, X-lin.; Xiao, Z-yan.; Ye, F., 2012:
PTP1B inhibitor improves both insulin resistance and lipid abnormalities in vivo and in vitro

Tamrakar, A.Kumar.; Maurya, C.K.; Rai, A.K., 2015:
PTP1B inhibitors for type 2 diabetes treatment: a patent review (2011 - 2014)

Shi, D-Yong.; Xu, F.; Li, J.; Guo, S-Ju.; Su, H.; Han, L-Jun., 2009:
PTP1B inhibitory activities of bromophenol derivatives from algae

Lee, D-Sung.; Jang, J-Hyuk.; Ko, W.; Kim, K-Su.; Sohn, J.Hak.; Kang, M-Suk.; Ahn, J.Seog.; Kim, Y-Chul.; Oh, H., 2014:
PTP1B inhibitory and anti-inflammatory effects of secondary metabolites isolated from the marine-derived fungus Penicillium sp. JF-55

Seo, C.; Choi, Y-Hyeok.; Ahn, J.Seog.; Yim, J.Han.; Lee, H.Kum.; Oh, H., 2010:
PTP1B inhibitory effects of tridepside and related metabolites isolated from the Antarctic lichen Umbilicaria antarctica

Sohn, J.Hak.; Lee, Y-Ri.; Lee, D-Sung.; Kim, Y-Chul.; Oh, H., 2014:
PTP1B inhibitory secondary metabolites from marine-derived fungal strains Penicillium spp. and Eurotium sp

Lu, X.; Malumbres, R.; Shields, B.; Jiang, X.; Sarosiek, K.A.; Natkunam, Y.; Tiganis, T.; Lossos, I.S., 2008:
PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling

Lessard, L.; Labbé, D.P.; Deblois, Gève.; Bégin, L.R.; Hardy, S.; Mes-Masson, A-Marie.; Saad, F.; Trotman, L.C.; Giguère, V.; Tremblay, M.L., 2012:
PTP1B is an androgen receptor-regulated phosphatase that promotes the progression of prostate cancer

Matulka, K.; Lin, H-Hwai.; Hříbková, H.; Uwanogho, D.; Dvořák, P.; Sun, Y-Man., 2014:
PTP1B is an effector of activin signaling and regulates neural specification of embryonic stem cells

Nievergall, E.; Janes, P.W.; Stegmayer, C.; Vail, M.E.; Haj, F.G.; Teng, S.Wei.; Neel, B.G.; Bastiaens, P.I.; Lackmann, M., 2011:
PTP1B regulates Eph receptor function and trafficking

Johnson, K.J.; Peck, A.R.; Liu, C.; Tran, T.H.; Utama, F.E.; Sjolund, A.B.; Schaber, J.D.; Witkiewicz, A.K.; Rui, H., 2011:
PTP1B suppresses prolactin activation of Stat5 in breast cancer cells

Stuible, M.; Abella, J.V.; Feldhammer, M.; Nossov, M.; Sangwan, V.; Blagoev, B.; Park, M.; Tremblay, M.L., 2010:
PTP1B targets the endosomal sorting machinery: dephosphorylation of regulatory sites on the endosomal sorting complex required for transport component STAM2

Yip, S-Chin.; Saha, S.; Chernoff, J., 2011:
PTP1B: a double agent in metabolism and oncogenesis

Feldhammer, M.; Uetani, N.; Miranda-Saavedra, D.; Tremblay, M.L., 2014:
PTP1B: a simple enzyme for a complex world

Lanahan, A.A.; Lech, D.; Dubrac, A.; Zhang, J.; Zhuang, Z.W.; Eichmann, A.; Simons, M., 2014:
PTP1b is a physiologic regulator of vascular endothelial growth factor signaling in endothelial cells

Pryczynicz, A.; Guzińska-Ustymowicz, K.; Chang, X-Jia.; Kiśluk, J.; Kemona, A., 2011:
PTP4A3 (PRL-3) expression correlate with lymphatic metastases in gastric cancer

Guzinska-Ustymowicz, K.; Pryczynicz, A.; Kemona, A., 2009:
PTP4A3 expression increases strongly in lymph node metastases from colorectal carcinoma

Chesini, I.M.; Debyser, G.; Croes, H.; Ten Dam, G.B.; Devreese, B.; Stoker, A.W.; Hendriks, W.J.A.J., 2012:
PTPBR7 binding proteins in myelinating neurons of the mouse brain

Carlucci, A.; Porpora, M.; Garbi, C.; Galgani, M.; Santoriello, M.; Mascolo, M.; di Lorenzo, D.; Altieri, V.; Quarto, M.; Terracciano, L.; Gottesman, M.E.; Insabato, L.; Feliciello, A., 2011:
PTPD1 supports receptor stability and mitogenic signaling in bladder cancer cells

Hou, S-Wang.; Zhi, H-Ying.; Pohl, N.; Loesch, M.; Qi, X-Mei.; Li, R-Shan.; Basir, Z.; Chen, G., 2010:
PTPH1 dephosphorylates and cooperates with p38gamma MAPK to increase ras oncogenesis through PDZ-mediated interaction

Koch, P.; Petri, M.; Paradowska, A.; Stenzinger, A.; Sturm, K.; Steger, K.; Wimmer, M., 2009:
PTPIP51 mRNA and protein expression in tissue microarrays and promoter methylation of benign prostate hyperplasia and prostate carcinoma

Petri, M.K.; Koch, P.; Stenzinger, A.; Kuchelmeister, K.; Nestler, U.; Paradowska, A.; Steger, K.; Brobeil, A.; Viard, M.; Wimmer, M., 2012:
PTPIP51, a positive modulator of the MAPK/Erk pathway, is upregulated in glioblastoma and interacts with 14-3-3β and PTP1B in situ

Brobeil, A.; Graf, M.; Oeschger, S.; Steger, K.; Wimmer, M., 2010:
PTPIP51-a myeloid lineage specific protein interacts with PTP1B in neutrophil granulocytes

Bobrich, M.A.; Schwabe, S.A.; Brobeil, A.; Viard, M.; Kamm, M.; Mooren, F.C.; Krüger, K.; Tag, C.; Wimmer, M., 2013:
PTPIP51: a new interaction partner of the insulin receptor and PKA in adipose tissue

Glondu-Lassis, M.; Dromard, M.; Lacroix-Triki, M.; Nirdé, P.; Puech, C.; Knani, D.; Chalbos, D.; Freiss, G., 2010:
PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase

Abaan, O.D.; Toretsky, J.A., 2008:
PTPL1: a large phosphatase with a split personality

Zhu, S.; Wang, Z.; Zhang, Z.; Wang, J.; Li, Y.; Yao, L.; Mei, Q.; Zhang, W., 2014:
PTPLAD2 is a tumor suppressor in esophageal squamous cell carcinogenesis

El-Kouhen, K.; Tremblay, M.L., 2011:
PTPMT1: connecting cardiolipin biosynthesis to mitochondrial function

Anonymous, 2014:
PTPN1 is recurrently mutated in lymphoid cancers

Bauer, F.; Onland-Moret, N.Charlotte.; Charlotte, O-Moret.N.; Niehoff, A.G.; Elbers, C.C.; Grobbee, D.E.; Wijmenga, C.; van der Schouw, Y.T., 2010:
PTPN1 polymorphisms are associated with total and low-density lipoprotein cholesterol

Brasil, A.Salem.; Pereira, A.C.; Wanderley, L.Turolla.; Kim, C.Ae.; Malaquias, A.C.; Jorge, A.A.L.; Krieger, Jé.Eduardo.; Bertola, Débora.Romeo., 2010:
PTPN11 and KRAS gene analysis in patients with Noonan and Noonan-like syndromes

Faienza, M.Felicia.; Giordani, L.; Ferraris, M.; Bona, G.; Cavallo, L., 2010:
PTPN11 gene mutation and severe neonatal hypertrophic cardiomyopathy: what is the link?

Jain Ghai, S.; Keating, S.; Chitayat, D., 2011:
PTPN11 gene mutation associated with abnormal gonadal determination

Jefferies, J.L.; Belmont, J.W.; Pignatelli, R.; Towbin, J.A.; Craigen, W.J., 2010:
PTPN11 mutation associated with aortic dilation and hypertrophic cardiomyopathy in a pediatric patient with Noonan syndrome

Lin, I-Shou.; Wang, J-Neng.; Chao, S-Chiou.; Wu, J-Ming.; Lin, S-Jean., 2010:
PTPN11 mutations in LEOPARD syndrome: report of four cases in Taiwan

Ko, J.Min.; Kim, J-Min.; Kim, G-Hwan.; Yoo, H-Wook., 2008:
PTPN11, SOS1, KRAS, and RAF1 gene analysis, and genotype-phenotype correlation in Korean patients with Noonan syndrome

Villa-Moruzzi, E., 2013:
PTPN12 controls PTEN and the AKT signalling to FAK and HER2 in migrating ovarian cancer cells

Sardina, Jé.L.; López-Ruano, G.; Prieto-Bermejo, R.; Sánchez-Sánchez, B.; Pérez-Fernández, A.; Sánchez-Abarca, L.Ignacio.; Pérez-Simón, Jé.Antonio.; Quintales, L.; Sánchez-Yagüe, Jús.; Llanillo, M.; Antequera, F.; Hernández-Hernández, A., 2014:
PTPN13 regulates cellular signalling and β-catenin function during megakaryocytic differentiation

Freiss, G.; Chalbos, D., 2011:
PTPN13/PTPL1: an important regulator of tumor aggressiveness

Wilson, K.E.; Li, Y-Wei.; Yang, N.; Shen, H.; Orillion, A.R.; Zhang, J., 2014:
PTPN14 forms a complex with Kibra and LATS1 proteins and negatively regulates the YAP oncogenic function

Wang, W.; Huang, J.; Wang, X.; Yuan, J.; Li, X.; Feng, L.; Park, J-Il.; Chen, J., 2012:
PTPN14 is required for the density-dependent control of YAP1

Morgan, A.R.; Han, D.Y.; Huebner, C.; Lam, W.J.; Fraser, A.G.; Ferguson, L.R., 2010:
PTPN2 but not PTPN22 is associated with Crohn's disease in a New Zealand population

Glas, Jürgen.; Wagner, J.; Seiderer, J.; Olszak, T.; Wetzke, M.; Beigel, F.; Tillack, C.; Stallhofer, J.; Friedrich, M.; Steib, C.; Göke, B.; Ochsenkühn, T.; Karbalai, N.; Diegelmann, J.; Czamara, D.; Brand, S., 2012:
PTPN2 gene variants are associated with susceptibility to both Crohn's disease and ulcerative colitis supporting a common genetic disease background

Yu, W.; Hegarty, J.P.; Berg, A.; Kelly, A.A.; Wang, Y.; Poritz, L.S.; Franke, A.; Schreiber, S.; Koltun, W.A.; Lin, Z., 2012:
PTPN2 is associated with Crohn's disease and its expression is regulated by NKX2-3

Wiede, F.; Ziegler, A.; Zehn, D.; Tiganis, T., 2015:
PTPN2 restrains CD8⁺ T cell responses after antigen cross-presentation for the maintenance of peripheral tolerance in mice

Wu, Z.; Chen, H.; Sun, F.; Xu, J.; Zheng, W.; Li, P.; Chen, S.; Shen, M.; Zhang, W.; Li, M.; You, X.; Wu, Q.; Zhang, F.; Li, Y., 2014:
PTPN2 rs1893217 single-nucleotide polymorphism is associated with risk of Behçet's disease in a Chinese Han population

Moore, F.; Colli, M.L.; Cnop, M.; Esteve, M.Igoillo.; Cardozo, A.K.; Cunha, D.A.; Bugliani, M.; Marchetti, P.; Eizirik, Décio.L., 2009:
PTPN2, a candidate gene for type 1 diabetes, modulates interferon-gamma-induced pancreatic beta-cell apoptosis

Santin, I.; Moore, F.; Colli, M.L.; Gurzov, E.N.; Marselli, L.; Marchetti, P.; Eizirik, D.L., 2012:
PTPN2, a candidate gene for type 1 diabetes, modulates pancreatic β-cell apoptosis via regulation of the BH3-only protein Bim

Ge, J.; Li, H.; Gu, D.; Du, W.; Xue, F.; Sui, T.; Xu, J.; Yang, R., 2014:
PTPN22 -1123G > C polymorphism is associated with susceptibility to primary immune thrombocytopenia in Chinese population

Napolioni, V.; Natali, A.; Saccucci, P.; Lucarini, N., 2011:
PTPN22 1858C>T (R620W) functional polymorphism and human longevity

Ostanek, L.; Ostanek-Pańka, M.; Bobrowska-Snarska, D.; Bińczak-Kuleta, A.; Fischer, K.; Kaczmarczyk, M.; Ciechanowicz, A.; Brzosko, M., 2015:
PTPN22 1858C>T gene polymorphism in patients with SLE: association with serological and clinical results

Totaro, M.Ciro.; Tolusso, B.; Napolioni, V.; Faustini, F.; Canestri, S.; Mannocci, A.; Gremese, E.; Bosello, S.Laura.; Alivernini, S.; Ferraccioli, G., 2012:
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis

Majorczyk, E.; Pawlik, A.; Kuśnierczyk, P., 2011:
PTPN22 1858C>T polymorphism is strongly associated with rheumatoid arthritis but not with a response to methotrexate therapy

Tang, G-ping.; Hu, L.; Zhang, Q-hua., 2014:
PTPN22 1858C/T polymorphism is associated with rheumatoid arthritis susceptibility in Caucasian population: a meta-analysis

Kordonouri, O.; Hartmann, R.; Badenhoop, K.; Kahles, H.; Ilonen, J., 2011:
PTPN22 1858T allele is associated with younger age at onset of type 1 diabetes and is not related to subsequent thyroid autoimmunity

Bravo, M.Jose.; Colmenero, J.Dios.; Queipo-Ortuño, M.Isabel.; Morata, P.; Orozco, G.; Martin, J.; Alonso, A.; Caballero, A., 2009:
PTPN22 C1858T polymorphism and human brucellosis

Montes-Cano, M.A.; García-Lozano, J.R.; Aguilar-Reina, J.; Romero-Gómez, M.; Barroso, N.; Nuñez-Roldán, A.; Martín, J.; González-Escribano, M.F., 2009:
PTPN22 C1858T polymorphism and the outcome of hepatitis C virus infection

Gomes, F.M.C.S.; Bianco, B.; Teles, J.S.; Christofolini, D.M.; de Souza, A.M.B.; Guedes, A.D.; Barbosa, C.P., 2010:
PTPN22 C1858T polymorphism in women with endometriosis

Salliot, C.; Dawidowicz, K.; Lukas, Cédric.; Guedj, M.; Paccard, C.; Benessiano, J.; Dougados, M.; Nicaise, P.; Meyer, O.; Dieudé, P., 2011:
PTPN22 R620W genotype-phenotype correlation analysis and gene-environment interaction study in early rheumatoid arthritis: results from the ESPOIR cohort

Martorana, D.; Maritati, F.; Malerba, G.; Bonatti, F.; Alberici, F.; Oliva, E.; Sebastio, P.; Manenti, L.; Brugnano, R.; Catanoso, M.G.; Fraticelli, P.; Guida, G.; Gregorini, G.; Possenti, S.; Moroni, G.; Leoni, A.; Pavone, L.; Pesci, A.; Sinico, R.A.; D.T.ma, L.; D'Amico, M.; Tumiati, B.; D'Ippolito, R.; Buzio, C.; Neri, T.M.; Vaglio, A., 2012:
PTPN22 R620W polymorphism in the ANCA-associated vasculitides

Lefvert, A.Kari.; Zhao, Y.; Ramanujam, R.; Yu, S.; Pirskanen, R.; Hammarström, L., 2008:
PTPN22 R620W promotes production of anti-AChR autoantibodies and IL-2 in myasthenia gravis

Zhang, Z-H.; Chen, F.; Zhang, X-L.; Jin, Y.; Bai, J.; Fu, S-B., 2008:
PTPN22 allele polymorphisms in 15 Chinese populations

Namjou, B.; Kim-Howard, X.; Sun, C.; Adler, A.; Chung, S.A.; Kaufman, K.M.; Kelly, J.A.; Glenn, S.B.; Guthridge, J.M.; Scofield, R.H.; Kimberly, R.P.; Brown, E.E.; Alarcón, G.S.; Edberg, J.C.; Kim, J-Hoon.; Choi, J.; Ramsey-Goldman, R.; Petri, M.A.; Reveille, J.D.; Vilá, L.M.; Boackle, S.A.; Freedman, B.I.; Tsao, B.P.; Langefeld, C.D.; Vyse, T.J.; Jacob, C.O.; Pons-Estel, B.; Niewold, T.B.; Moser Sivils, K.L.; Merrill, J.T.; Anaya, J-Manuel.; Gilkeson, G.S.; Gaffney, P.M.; Bae, S-Cheol.; Alarc, 2014:
PTPN22 association in systemic lupus erythematosus (SLE) with respect to individual ancestry and clinical sub-phenotypes

Maine, C.J.; Marquardt, K.; Cheung, J.; Sherman, L.A., 2014:
PTPN22 controls the germinal center by influencing the numbers and activity of T follicular helper cells

Zikherman, J.; Hermiston, M.; Steiner, D.; Hasegawa, K.; Chan, A.; Weiss, A., 2009:
PTPN22 deficiency cooperates with the CD45 E613R allele to break tolerance on a non-autoimmune background

Sahin, N.; Bicakcigil, M.; Atagunduz, P.; Direskeneli, H.; Saruhan-Direskeneli, G., 2007:
PTPN22 gene polymorphism in Behçet's disease

El-Zawahry, B.Mohamed.; Azzam, O.Ahmed.; Zaki, N.Sameh.; Abdel-Raheem, H.Mohamed.; Bassiouny, D.Ahmed.; Khorshied, M.Mamdooh., 2013:
PTPN22 gene polymorphism in Egyptian alopecia areata patients and its impact on response to diphencyprone immunotherapy

Pradhan, V.; Borse, V.; Ghosh, K., 2010:
PTPN22 gene polymorphisms in autoimmune diseases with special reference to systemic lupus erythematosus disease susceptibility

Douroudis, K.; Shcherbakova, A.; Everaus, H.; Aints, A., 2011:
PTPN22 gene regulates natural killer cell proliferation during in vitro expansion

Ivashkiv, L.B., 2013:
PTPN22 in autoimmunity: different cell and different way

Chang, H-Hsin.; Miaw, S-Chuen.; Tseng, W.; Sun, Y-Wei.; Liu, C-Chun.; Tsao, H-Wei.; Ho, I-Cheng., 2013:
PTPN22 modulates macrophage polarization and susceptibility to dextran sulfate sodium-induced colitis

Bianco, B.; Verreschi, I.T.N.; Oliveira, K.C.; Guedes, A.D.; Galera, B.B.; Galera, M.F.; Barbosa, C.P.; Lipay, M.V.N., 2010:
PTPN22 polymorphism is related to autoimmune disease risk in patients with Turner syndrome

Brzoza, Z.; Grzeszczak, W.; Rogala, B.; Trautsolt, W.; Moczulski, D., 2012:
PTPN22 polymorphism presumably plays a role in the genetic background of chronic spontaneous autoreactive urticaria

Roque, J.Barros.; O'Leary, C.A.; Kyaw-Tanner, M.; Duffy, D.L.; Gharahkhani, P.; Vogelnest, L.; Mason, K.; Shipstone, M., 2012:
PTPN22 polymorphisms may indicate a role for this gene in atopic dermatitis in West Highland white terriers

Bhanusali, D.G.; Sachdev, A.; Olson, M.A.; Gerlach, J.A.; Sinha, A.A., 2014:
PTPN22 profile indicates a novel risk group in Alopecia areata

Zheng, P.; Kissler, S., 2013:
PTPN22 silencing in the NOD model indicates the type 1 diabetes-associated allele is not a loss-of-function variant

Fichna, M.; Zurawek, M.; Januszkiewicz-Lewandowska, D.; Fichna, P.; Nowak, J., 2011:
PTPN22, PDCD1 and CYP27B1 polymorphisms and susceptibility to type 1 diabetes in Polish patients

Chang, H-Hsin.; Tai, T-Shyuan.; Lu, B.; Iannaccone, C.; Cernadas, M.; Weinblatt, M.; Shadick, N.; Miaw, S-Chuen.; Ho, I-Cheng., 2012:
PTPN22.6, a dominant negative isoform of PTPN22 and potential biomarker of rheumatoid arthritis

Płoski, Rł.; Dziunycz, P.; Kostrzewa, G.; Roszkowski, P.I.; Barcz, E.; Zabek, J.; Milewski, Łukasz.; Kamiński, Pł.; Malejczyk, J., 2009:
PTPN22/LYP 1858C>T gene polymorphism and susceptibility to endometriosis in a Polish population

Cardinale, V.; Alvaro, D., 2014:
PTPN3 mutations and HBV may exert synergistic effects in the origin of the intrahepatic cholangiocarcinoma

Sooman, L.; Ekman, S.; Tsakonas, G.; Jaiswal, A.; Navani, S.; Edqvist, P-Henrik.; Pontén, F.; Bergström, S.; Johansson, M.; Wu, X.; Blomquist, E.; Bergqvist, M.; Gullbo, J.; Lennartsson, J., 2014 :
PTPN6 expression is epigenetically regulated and influences survival and response to chemotherapy in high-grade gliomas

Ausavarat, S.; Tongkobpetch, S.; Praphanphoj, V.; Mahatumarat, C.; Rojvachiranonda, N.; Snabboon, T.; Markello, T.C.; Gahl, W.A.; Suphapeetiporn, K.; Shotelersuk, V., 2011:
PTPRF is disrupted in a patient with syndromic amastia

Xiao, J.; Lee, S-Tae.; Xiao, Y.; Ma, X.; Houseman, E.Andres.; Hsu, L-I.; Roy, R.; Wrensch, M.; de Smith, A.J.; Chokkalingam, A.; Buffler, P.; Wiencke, J.K.; Wiemels, J.L., 2014:
PTPRG inhibition by DNA methylation and cooperation with RAS gene activation in childhood acute lymphoblastic leukemia

Toland, A.E.; Rozek, L.S.; Presswala, S.; Rennert, G.; Gruber, S.B., 2008:
PTPRJ haplotypes and colorectal cancer risk

Hou, J.; Xia, Y.; Jiang, R.; Chen, D.; Xu, J.; Deng, L.; Huang, X.; Wang, X.; Sun, B., 2014:
PTPRO plays a dual role in hepatic ischemia reperfusion injury through feedback activation of NF-κB

Huang, Y-Teng.; Li, F-Fei.; Ke, C.; Li, Z.; Li, Z-Tai.; Zou, X-Fang.; Zheng, X-Xuan.; Chen, Y-Ping.; Zhang, H., 2014:
PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy

Motiwala, T.; Majumder, S.; Ghoshal, K.; Kutay, H.; Datta, J.; Roy, S.; Lucas, D.M.; Jacob, S.T., 2008:
PTPROt inactivates the oncogenic fusion protein BCR/ABL and suppresses transformation of K562 cells

Hendriks, W.J.A.J.; Dilaver, Gönül.; Noordman, Y.E.; Kremer, B.; Fransen, J.A.M., 2009:
PTPRR protein tyrosine phosphatase isoforms and locomotion of vesicles and mice

Schmitt, I.; Bitoun, E.; Manto, M., 2009:
PTPRR, cerebellum, and motor coordination

Feng, X.; Scott, A.; Wang, Y.; Wang, L.; Zhao, Y.; Doerner, S.; Satake, M.; Croniger, C.M.; Wang, Z., 2015:
PTPRT regulates high-fat diet-induced obesity and insulin resistance

Lim, S-Hee.; Moon, J.; Lee, M.; Lee, J-Ran., 2013:
PTPRT regulates the interaction of Syntaxin-binding protein 1 with Syntaxin 1 through dephosphorylation of specific tyrosine residue

Makinoshima, H.; Ishii, G.; Kojima, M.; Fujii, S.; Higuchi, Y.; Kuwata, T.; Ochiai, A., 2013:
PTPRZ1 regulates calmodulin phosphorylation and tumor progression in small-cell lung carcinoma

Samayawardhena, L.A.; Pallen, C.J., 2010:
PTPalpha activates Lyn and Fyn and suppresses Hck to negatively regulate FcepsilonRI-dependent mast cell activation and allergic responses

Eissler, T.; Hodges, C.P.; Meier, H., 2012:
PTPan--overcoming memory limitations in oligonucleotide string matching for primer/probe design

Wang, B-Cheng., 2008:
PTPases: "Eph" ective arbitrators of attraction

De Franceschi, L.; Biondani, A.; Carta, F.; Turrini, F.; Laudanna, C.; Deana, R.; Brunati, A.Maria.; Turretta, L.; Iolascon, A.; Perrotta, S.; Elson, A.; Bulato, C.; Brugnara, C., 2008:
PTPepsilon has a critical role in signaling transduction pathways and phosphoprotein network topology in red cells

Burgoyne, A.M.; Palomo, J.M.; Phillips-Mason, P.J.; Burden-Gulley, S.M.; Major, D.L.; Zaremba, A.; Robinson, S.; Sloan, A.E.; Vogelbaum, M.A.; Miller, R.H.; Brady-Kalnay, S.M., 2010:
PTPmu suppresses glioma cell migration and dispersal

Pulido, R.; Stoker, A.W.; Hendriks, W.J.A.J., 2014:
PTPs emerge as PIPs: protein tyrosine phosphatases with lipid-phosphatase activities in human disease

Shen, Y.; Tenney, A.P.; Busch, S.A.; Horn, K.P.; Cuascut, F.X.; Liu, K.; He, Z.; Silver, J.; Flanagan, J.G., 2009:
PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration

Wang, J.; Yu, L.; Zheng, X., 2013:
PTPα-mediated Src activation by EGF in human breast cancer cells

Bartlett, L.; Ho, Y-H., 2009:
PTQ anal implants for the treatment of faecal incontinence

Cappellin, L.; Loreto, F.; Aprea, E.; Romano, A.; del Pulgar, Jé.Sánchez.; Gasperi, F.; Biasioli, F., 2014:
PTR-MS in Italy: a multipurpose sensor with applications in environmental, agri-food and health science

Liu, D.; Feilberg, A.; Nielsen, A.Michael.; Adamsen, A.Peter.S., 2013:
PTR-MS measurement of partition coefficients of reduced volatile sulfur compounds in liquids from biotrickling filters

Schuhfried, E.; Biasioli, F.; Aprea, E.; Cappellin, L.; Soukoulis, C.; Ferrigno, A.; Märk, T.D.; Gasperi, F., 2011:
PTR-MS measurements and analysis of models for the calculation of Henry's law constants of monosulfides and disulfides

Masi, E.; Romani, A.; Pandolfi, C.; Heimler, D.; Mancuso, S., 2016:
PTR-TOF-MS analysis of volatile compounds in olive fruits

Fabris, A.; Biasioli, F.; Granitto, P.M.; Aprea, E.; Cappellin, L.; Schuhfried, E.; Soukoulis, C.; Märk, T.D.; Gasperi, F.; Endrizzi, I., 2010:
PTR-TOF-MS and data-mining methods for rapid characterisation of agro-industrial samples: influence of milk storage conditions on the volatile compounds profile of Trentingrana cheese

Yener, S.; Romano, A.; Cappellin, L.; Märk, T.D.; Sánchez Del Pulgar, Jé.; Gasperi, F.; Navarini, L.; Biasioli, F., 2014:
PTR-ToF-MS characterisation of roasted coffees (C. arabica) from different geographic origins

Nare, B.; Garraway, L.A.; Vickers, T.J.; Beverley, S.M., 2009:
PTR1-dependent synthesis of tetrahydrobiopterin contributes to oxidant susceptibility in the trypanosomatid protozoan parasite Leishmania major

Aung, C.Sanda.; Hill, M.M.; Bastiani, M.; Parton, R.G.; Parat, M-Odile., 2011:
PTRF-cavin-1 expression decreases the migration of PC3 prostate cancer cells: role of matrix metalloprotease 9

Nassar, Z.D.; Moon, H.; Duong, T.; Neo, L.; Hill, M.M.; Francois, M.; Parton, R.G.; Parat, M-Odile., 2014:
PTRF/Cavin-1 decreases prostate cancer angiogenesis and lymphangiogenesis

Gámez-Pozo, A.; Sánchez-Navarro, I.; Calvo, E.; Agulló-Ortuño, Mía.Teresa.; López-Vacas, Río.; Díaz, E.; Camafeita, E.; Nistal, M.; Madero, R.; Espinosa, E.; López, J.Antonio.; Fresno Vara, J.Ángel., 2012:
PTRF/cavin-1 and MIF proteins are identified as non-small cell lung cancer biomarkers by label-free proteomics

Yi, J-Sung.; Mun, D-Gi.; Lee, H.; Park, J-sub.; Lee, J-Woo.; Lee, J-Seon.; Kim, S-Jin.; Cho, B-Rae.; Lee, S-Won.; Ko, Y-Gyu., 2013:
PTRF/cavin-1 is essential for multidrug resistance in cancer cells

Richardson, C.E.; Spilker, K.A.; Cueva, J.G.; Perrino, J.; Goodman, M.B.; Shen, K., 2014:
PTRN-1, a microtubule minus end-binding CAMSAP homolog, promotes microtubule function in Caenorhabditis elegans neurons

Corrado, G.; Tebaldi, T.; Bertamini, G.; Costa, F.; Quattrone, A.; Viero, G.; Passerini, A., 2015:
PTRcombiner: mining combinatorial regulation of gene expression from post-transcriptional interaction maps

Wang, J.; Zhang, Z.; Wang, Y.; Li, L.; Chai, R.; Mao, X.; Jiang, H.; Qiu, H.; Du, X.; Lin, F.; Sun, G., 2013:
PTS1 peroxisomal import pathway plays shared and distinct roles to PTS2 pathway in development and pathogenicity of Magnaporthe oryzae

Augustine, J.Kallikat.; Akabote, V.; Hegde, S.Ganapati.; Alagarsamy, P., 2009:
PTSA-ZnCl2: an efficient catalyst for the synthesis of 1,2,4-oxadiazoles from amidoximes and organic nitriles

Liu, P.; Pan, Y-Ming.; Xu, Y-Li.; Wang, H-Shan., 2012:
PTSA-catalyzed Mannich-type-cyclization-oxidation tandem reactions: one-pot synthesis of 1,3,5-substituted pyrazoles from aldehydes, hydrazines and alkynes

Andersen, T.Elmose.; Elklit, A.; Brink, O., 2013:
PTSD Symptoms Mediate the Effect of Attachment on Pain and Somatisation after Whiplash Injury

Duke, M.R.; Moore, R.S.; Ames, G.M., 2011:
PTSD Treatment-Seeking Among Rural Latino Combat Veterans: A Review of the Literature

Zauderer, C.R., 2014:
PTSD after childbirth: early detection and treatment

Sundin, J.; Fear, N.T.; Iversen, A.; Rona, R.J.; Wessely, S., 2010:
PTSD after deployment to Iraq: conflicting rates, conflicting claims

Ryb, G.E.; Dischinger, P.C.; Read, K.M.; Kufera, J.A., 2011:
PTSD after severe vehicular crashes

Peller, A.J.; Najavits, L.M.; Nelson, S.E.; LaBrie, R.A.; Shaffer, H.J., 2010:
PTSD among a treatment sample of repeat DUI offenders

Creamer, M.; Wade, D.; Fletcher, S.; Forbes, D., 2011:
PTSD among military personnel

Sabella, D., 2013:
PTSD among our returning veterans

Rusiecki, J.A.; Byrne, C.; Galdzicki, Z.; Srikantan, V.; Chen, L.; Poulin, M.; Yan, L.; Baccarelli, A., 2013:
PTSD and DNA Methylation in Select Immune Function Gene Promoter Regions: A Repeated Measures Case-Control Study of U.S. Military Service Members

Beckerman, N.L.; Auerbach, C., 2012:
PTSD and HIV in women: the role of gender in this dual diagnosis

Oldham, J., 2008:
PTSD and Suicide

Tanev, K.S.; Pentel, K.Z.; Kredlow, M.A.; Charney, M.E., 2014:
PTSD and TBI co-morbidity: scope, clinical presentation and treatment options

Liedl, A.; Knaevelsrud, C., 2008:
PTSD and chronic pain: development, maintenance and comorbidity--a review

Wisdom, N.M.; Pastorek, N.J.; Miller, B.I.; Booth, J.E.; Romesser, J.M.; Linck, J.F.; Sim, A.H., 2014:
PTSD and cognitive functioning: importance of including performance validity testing

Taber, K.H.; Hurley, R.A., 2009:
PTSD and combat-related injuries: functional neuroanatomy

Ralevski, E.; Olivera-Figueroa, L.A.; Petrakis, I., 2014:
PTSD and comorbid AUD: a review of pharmacological and alternative treatment options

Macdonald, A.; Danielson, C.Kmett.; Resnick, H.S.; Saunders, B.E.; Kilpatrick, D.G., 2011:
PTSD and comorbid disorders in a representative sample of adolescents: The risk associated with multiple exposures to potentially traumatic events

Krupnick, J.L., 2011 :
PTSD and depression among Palestinians: reactions to a study

Bailey, J.N.; Goenjian, A.K.; Noble, E.P.; Walling, D.P.; Ritchie, T.; Goenjian, H.A., 2010:
PTSD and dopaminergic genes, DRD2 and DAT, in multigenerational families exposed to the Spitak earthquake

Skelton, K.; Ressler, K.J.; Norrholm, S.D.; Jovanovic, T.; Bradley-Davino, B., 2012:
PTSD and gene variants: new pathways and new thinking

Mevissen, L.; de Jongh, A., 2010:
PTSD and its treatment in people with intellectual disabilities: a review of the literature

Hinton, D.E.; Hinton, A.L.; Eng, K-Thay.; Choung, S., 2013:
PTSD and key somatic complaints and cultural syndromes among rural Cambodians: the results of a needs assessment survey

Miller, A.B.; Schaefer, K.E.; Renshaw, K.D.; Blais, R.K., 2014:
PTSD and marital satisfaction in military service members: examining the simultaneous roles of childhood sexual abuse and combat exposure

Mitchell, K.S.; Aiello, A.E.; Galea, S.; Uddin, M.; Wildman, D.; Koenen, K.C., 2014:
PTSD and obesity in the Detroit neighborhood health study

Olza Fernández, I., 2013:
PTSD and obstetric violence

Cissell-Browne, D., 2011:
PTSD and our vets

Porter, K.E.; Pope, E.Brooke.; Mayer, R.; Rauch, S.A.M., 2014:
PTSD and pain: exploring the impact of posttraumatic cognitions in veterans seeking treatment for PTSD

Onoye, J.M.; Goebert, D.; Morland, L.; Matsu, C.; Wright, T., 2010:
PTSD and postpartum mental health in a sample of Caucasian, Asian, and Pacific Islander women

Ardino, V.; Milani, L.; Di Blasio, P., 2013:
PTSD and re-offending risk: the mediating role of worry and a negative perception of other people's support

Lee, D.J.; Liverant, G.I.; Lowmaster, S.E.; Gradus, J.L.; Sloan, D.M., 2015:
PTSD and reasons for living: associations with depressive symptoms and alcohol use

Glück, T.M.; Tran, U.S.; Lueger-Schuster, B., 2012:
PTSD and trauma in Austria's elderly: influence of wartime experiences, postwar zone of occupation, and life time traumatization on today's mental health status-an interdisciplinary approach

Ursano, R.J.; Zhang, L.; Li, H.; Johnson, L.; Carlton, J.; Fullerton, C.S.; Benedek, D.M., 2009:
PTSD and traumatic stress from gene to community and bench to bedside

Park, C.L.; Mills, M.Alice.; Edmondson, D., 2012:
PTSD as Meaning Violation: Testing a Cognitive Worldview Perspective

Berger, O.; McNiel, D.E.; Binder, Rée.L., 2013:
PTSD as a criminal defense: a review of case law

Cusack, K.J.; Herring, A.H.; Steadman, H.J., 2014:
PTSD as a mediator between lifetime sexual abuse and substance use among jail diversion participants

Yeager, D.E.; Magruder, K.M., 2015:
PTSD checklist scoring rules for elderly Veterans Affairs outpatients

Calabrese, J.R.; Prescott, M.; Tamburrino, M.; Liberzon, I.; Slembarski, R.; Goldmann, E.; Shirley, E.; Fine, T.; Goto, T.; Wilson, K.; Ganocy, S.; Chan, P.; Serrano, M.Beth.; Sizemore, J.; Galea, S., 2011:
PTSD comorbidity and suicidal ideation associated with PTSD within the Ohio Army National Guard

Perez, S.; Johnson, D.M., 2008:
PTSD compromises battered women's future safety

Cornelius, J.R.; Kirisci, L.; Reynolds, M.; Clark, D.B.; Hayes, J.; Tarter, R., 2011:
PTSD contributes to teen and young adult cannabis use disorders

Pridmore, S.; Khan, M.A., 2012:
PTSD criterion in proverbs

McCarron, K.K.; Reinhard, M.J.; Bloeser, K.J.; Mahan, C.M.; Kang, H.K., 2015:
PTSD diagnoses among Iraq and Afghanistan veterans: comparison of administrative data to chart review

Shelby, R.A.; Golden-Kreutz, D.M.; Andersen, B.L., 2008:
PTSD diagnoses, subsyndromal symptoms, and comorbidities contribute to impairments for breast cancer survivors

Asmundson, G.J.G.; Taylor, S., 2009:
PTSD diagnostic criteria: understanding etiology and treatment

Holowka, D.W.; Marx, B.P.; Gates, M.A.; Litman, H.J.; Ranganathan, G.; Rosen, R.C.; Keane, T.M., 2015:
PTSD diagnostic validity in Veterans Affairs electronic records of Iraq and Afghanistan veterans

Gamito, P.; Oliveira, J.; Rosa, P.; Morais, D.; Duarte, N.; Oliveira, S.; Saraiva, T., 2010:
PTSD elderly war veterans: a clinical controlled pilot study

Ammerman, R.T.; Putnam, F.W.; Chard, K.M.; Stevens, J.; Van Ginkel, J.B., 2012:
PTSD in Depressed Mothers in Home Visitation

Norris, F.H.; Vanlandingham, M.J.; Vu, L., 2012:
PTSD in Vietnamese Americans following Hurricane Katrina: prevalence, patterns, and predictors

Ren, Z.J.; Deng, H.; Hsu, L.K.George., 2011:
PTSD in a one year old girl after the Wenchuan earthquake in Sichuan, China

Wangelin, B.C.; Tuerk, P.W., 2016:
PTSD in active combat soldiers: to treat or not to treat

Scheeringa, M.S.; Zeanah, C.H.; Cohen, J.A., 2012:
PTSD in children and adolescents: toward an empirically based algorithma

O'Connor, M., 2011:
PTSD in older bereaved people

Streb, M.; Häller, P.; Michael, T., 2015:
PTSD in paramedics: resilience and sense of coherence

Van Loey, N.E.E.; van Son, M.J.M.; van der Heijden, P.G.M.; Ellis, I.M., 2008:
PTSD in persons with burns: an explorative study examining relationships with attributed responsibility, negative and positive emotional states

Undavalli, C.; Das, P.; Dutt, T.; Bhoi, S.; Kashyap, R., 2014:
PTSD in post-road traffic accident patients requiring hospitalization in Indian subcontinent: A review on magnitude of the problem and management guidelines

Sonis, J., 2014:
PTSD in primary care--an update on evidence-based management

Jacobowitz, W., 2015:
PTSD in psychiatric nurses and other mental health providers: a review of the literature

Friedman, M.J., 2014:
PTSD in the DSM-5: reply to Brewin (2013), Kilpatrick (2013), and Maercker and Perkonigg (2013)

Fisher, M.P., 2015:
PTSD in the U.S. military, and the politics of prevalence

Goodwin, L.; Rona, R.J., 2014:
PTSD in the armed forces: what have we learned from the recent cohort studies of Iraq/Afghanistan?

Nayback, A.Marie., 2009:
PTSD in the combat veteran: using Roy's Adaptation Model to examine the combat veteran as a human adaptive system

Lapp, L.Kimberly.; Agbokou, C.; Ferreri, F., 2014:
PTSD in the elderly: the interaction between trauma and aging

Yehuda, R.; Vermetten, E.; McFarlane, A.C.; Lehrner, A., 2014:
PTSD in the military: special considerations for understanding prevalence, pathophysiology and treatment following deployment

Theroux, R., 2010:
PTSD in the postpartum period: a cause or an effect?

Chopra, M.P.; Zhang, H.; Pless Kaiser, A.; Moye, J.A.; Llorente, M.D.; Oslin, D.W.; Spiro, A., 2014:
PTSD is a chronic, fluctuating disorder affecting the mental quality of life in older adults

Boscarino, J.A., 2012:
PTSD is a risk factor for cardiovascular disease: time for increased screening and clinical intervention

Gill, J.M.; Saligan, L.; Woods, S.; Page, G., 2009 :
PTSD is associated with an excess of inflammatory immune activities

Hall, K.S.; Beckham, J.C.; Bosworth, H.B.; Sloane, R.; Pieper, C.F.; Morey, M.C., 2015:
PTSD is negatively associated with physical performance and physical function in older overweight military Veterans

Zoellner, L.A.; Rothbaum, B.O.; Feeny, N.C., 2012:
PTSD not an anxiety disorder? DSM committee proposal turns back the hands of time

Boscarino, J.A.; Adams, R.E., 2009:
PTSD onset and course following the World Trade Center disaster: findings and implications for future research

Brown, E.A.; Kenardy, J.A.; Dow, B.L., 2015:
PTSD perpetuates pain in children with traumatic brain injury

Zaffina, S.; Camisa, V.; Monducci, E.; Vinci, M.Rosaria.; Vicari, S.; Bergamaschi, A., 2014:
PTSD prevalence and associated risk factors after a fire disaster that broke out in a paediatric hospital: a cross-sectional study

Hafstad, G.Sofie.; Dyb, G.; Jensen, T.K.; Steinberg, A.M.; Pynoos, R.S., 2015:
PTSD prevalence and symptom structure of DSM-5 criteria in adolescents and young adults surviving the 2011 shooting in Norway

Mitka, M., 2008:
PTSD prevalence still high for persons living near World Trade Center attacks

Smith, T.C.; Wingard, D.L.; Ryan, M.A.K.; Kritz-Silverstein, D.; Slymen, D.J.; Sallis, J.F.; Seggerman, S.L.; Boyd, G.D.; Creaven, G.; Davies, J.; Endara, S.; Farnell, L.; Granado, N.; Gumbs, G.; Kelton, M.; LeardMann, C.; Leleu, T.; McGrew, J.; Reed, R.; Snell, K.; Spiegel, S.; Welch, K.; White, M.; Whitmer, J.; Wong, C.; Zimmermann, L.; Stoia, M.; Amoroso, P.J.; Boyko, E.J.; Gackstetter, G.D.; Gray, G.C.; Hooper, T.I.; Riddle, J.R.; Smith, B.; Wells, T.S., 2009:
PTSD prevalence, associated exposures, and functional health outcomes in a large, population-based military cohort

Tapia, Géraldine.; Clarys, D.; El Hage, W.; Belzung, C.; Isingrini, M., 2007:
PTSD psychiatric patients exhibit a deficit in remembering

Miller, J.K.; Wiener, J.M., 2014:
PTSD recovery, spatial processing, and the val66met polymorphism

Maguen, S.; Stalnaker, M.; McCaslin, S.; Litz, B.T., 2010:
PTSD subclusters and functional impairment in Kosovo peacekeepers

Davis, R.Meghan.; Davis, H., 2007:
PTSD symptom changes in refugees

Runyon, M.K.; Deblinger, E.; Steer, R.A., 2014:
PTSD symptom cluster profiles of youth who have experienced sexual or physical abuse

Zuromski, K.L.; Davis, M.T.; Witte, T.K.; Weathers, F.; Blevins, C., 2015:
PTSD symptom clusters are differentially associated with components of the acquired capability for suicide

Sullivan, T.P.; Holt, L.J., 2008:
PTSD symptom clusters are differentially related to substance use among community women exposed to intimate partner violence

Polusny, M.A.; Ries, B.J.; Schultz, J.R.; Calhoun, P.; Clemensen, L.; Johnsen, I.R., 2008:
PTSD symptom clusters associated with physical health and health care utilization in rural primary care patients exposed to natural disaster

Jakupcak, M.; Tull, M.T.; McDermott, M.J.; Kaysen, D.; Hunt, S.; Simpson, T., 2011:
PTSD symptom clusters in relationship to alcohol misuse among Iraq and Afghanistan war veterans seeking post-deployment VA health care

Ruggero, C.J.; Kotov, R.; Callahan, J.L.; Kilmer, J.N.; Luft, B.J.; Bromet, E.J., 2015:
PTSD symptom dimensions and their relationship to functioning in World Trade Center responders

Vasterling, J.J.; Proctor, S.P.; Friedman, M.J.; Hoge, C.W.; Heeren, T.; King, L.A.; King, D.W., 2010:
PTSD symptom increases in Iraq-deployed soldiers: comparison with nondeployed soldiers and associations with baseline symptoms, deployment experiences, and postdeployment stress

Greer, G.R.; Grob, C.S.; Halberstadt, A.L., 2014:
PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program

Hruska, B.; Irish, L.A.; Pacella, M.L.; Sledjeski, E.M.; Delahanty, D.L., 2014:
PTSD symptom severity and psychiatric comorbidity in recent motor vehicle accident victims: a latent class analysis

Littleton, H.; Ullman, S.E., 2014:
PTSD symptomatology and hazardous drinking as risk factors for sexual assault revictimization: examination in European American and African American women

Young-Wolff, K.C.; Fromont, S.C.; Delucchi, K.; Hall, S.E.; Hall, S.M.; Prochaska, J.J., 2015:
PTSD symptomatology and readiness to quit smoking among women with serious mental illness

Hartley, T.A.; Violanti, J.M.; Sarkisian, K.; Andrew, M.E.; Burchfiel, C.M., 2014:
PTSD symptoms among police officers: associations with frequency, recency, and types of traumatic events

Hathaway, L.M.; Boals, A.; Banks, J.B., 2010:
PTSD symptoms and dominant emotional response to a traumatic event:an examination of DSM-IV Criterion A2

Sullivan, C.P.; Elbogen, E.B., 2015:
PTSD symptoms and family versus stranger violence in Iraq and Afghanistan veterans

Irwin, K.C.; Konnert, C.; Wong, M.; O'Neill, T.A., 2014:
PTSD symptoms and pain in Canadian military veterans: the mediating roles of anxiety, depression, and alcohol use

Larsen, S.E.; Fitzgerald, L.F., 2011:
PTSD symptoms and sexual harassment: the role of attributions and perceived control

Hensley, L.; Varela, R.Enrique., 2008:
PTSD symptoms and somatic complaints following Hurricane Katrina: the roles of trait anxiety and anxiety sensitivity

Arnaboldi, P.; Lucchiari, C.; Santoro, L.; Sangalli, C.; Luini, A.; Pravettoni, G., 2014:
PTSD symptoms as a consequence of breast cancer diagnosis: clinical implications

Berry, K.; Ford, S.; Jellicoe-Jones, L.; Haddock, G., 2013:
PTSD symptoms associated with the experiences of psychosis and hospitalisation: a review of the literature

Bokszczanin, A., 2007:
PTSD symptoms in children and adolescents 28 months after a flood: age and gender differences

Boals, A.; Schuettler, D., 2008:
PTSD symptoms in response to traumatic and non-traumatic events: the role of respondent perception and A2 criterion

Levendosky, A.A.; Bogat, G.Anne.; Martinez-Torteya, C., 2013:
PTSD symptoms in young children exposed to intimate partner violence

Hamama-Raz, Y.; Solomon, Z.; Cohen, A.; Laufer, A., 2009:
PTSD symptoms, forgiveness, and revenge among Israeli Palestinian and Jewish adolescents

McDevitt-Murphy, M.E.; Williams, J.L.; Bracken, K.L.; Fields, J.A.; Monahan, C.J.; Murphy, J.G., 2010:
PTSD symptoms, hazardous drinking, and health functioning among U.S.OEF and OIF veterans presenting to primary care

Brailey, K.; Vasterling, J.J.; Proctor, S.P.; Constans, J.I.; Friedman, M.J., 2007:
PTSD symptoms, life events, and unit cohesion in U.S. soldiers: baseline findings from the neurocognition deployment health study

Besser, A.; Neria, Y., 2009:
PTSD symptoms, satisfaction with life, and prejudicial attitudes toward the adversary among Israeli civilians exposed to ongoing missile attacks

Simpson, T.L.; Kaysen, D.; Bowen, S.; MacPherson, L.M.; Chawla, N.; Blume, A.; Marlatt, G.A.; Larimer, M., 2007:
PTSD symptoms, substance use, and vipassana meditation among incarcerated individuals

Wiederhold, B.K., 2010:
PTSD threatens global economies

Hoge, C.W.; Grossman, S.H.; Auchterlonie, J.L.; Riviere, L.A.; Milliken, C.S.; Wilk, J.E., 2015:
PTSD treatment for soldiers after combat deployment: low utilization of mental health care and reasons for dropout

Graves, R.Elaine.; Freedy, J.R.; Aigbogun, N.U.; Lawson, W.B.; Mellman, T.A.; Alim, T.N., 2011:
PTSD treatment of African American adults in primary care: the gap between current practice and evidence-based treatment guidelines

Washington, D.L.; Yano, E.M., 2014:
PTSD women Veterans' prevalence of PTSD care

Reid, L.M.; McMillan, T.M.; Harrison, A.G., 2012:
PTSD, attention bias, and heart rate after severe brain injury

Croy, I.; Schellong, J.; Joraschky, P.; Hummel, T., 2010 :
PTSD, but not childhood maltreatment, modifies responses to unpleasant odors

Afari, N.; Harder, L.H.; Madra, N.J.; Heppner, P.S.; Moeller-Bertram, T.; King, C.; Baker, D.G., 2010:
PTSD, combat injury, and headache in Veterans Returning from Iraq/Afghanistan

Pinna, K.L.M.; Johnson, D.M.; Delahanty, D.L., 2014:
PTSD, comorbid depression, and the cortisol waking response in victims of intimate partner violence: preliminary evidence

Cougle, J.R.; Resnick, H.; Kilpatrick, D.G., 2010:
PTSD, depression, and their comorbidity in relation to suicidality: cross-sectional and prospective analyses of a national probability sample of women

Zerach, G.; Solomon, Z.; Cohen, A.; Ein-Dor, T., 2015:
PTSD, resilience and posttraumatic growth among ex-prisoners of war and combat veterans

Cooper, J.; Metcalf, O.; Phelps, A., 2015:
PTSD--an update for general practitioners

Hansen, M.; Andersen, T.Elmose.; Armour, C.; Elklit, A.; Palic, S.; Mackrill, T., 2011:
PTSD-8: A Short PTSD Inventory

Gao, X.; Luo, X., 2011:
PTSD-positive screening and factors influencing the mental state in victims evacuated/ not evacuated from Wenchuan earthquake area within 1 month

Schaumberg, K.; Vinci, C.; Raiker, J.S.; Mota, N.; Jackson, M.; Whalen, D.; Schumacher, J.A.; Coffey, S.F., 2015:
PTSD-related alcohol expectancies and impulsivity interact to predict alcohol use severity in a substance dependent sample with PTSD

Alexander, S.; Kuntz, S., 2012:
PTSD-related sleep disturbances: is there evidence-based treatment?

Kirkbride, J.F., 2016:
PTSD: An Elusive Definition

Weiss, D.S., 2012:
PTSD: constructs, diagnoses, disorders, syndromes, symptoms, and structure

Corvalan, J.C.; Klein, D., 2011:
PTSD: diagnosis, evolution, and treatment of combat-related psychological/psychiatric injury

Meyer, J.E., 2010:
PTSD: how to recognize the many faces of this hidden disorder

Cantor, C., 2010:
PTSD: in defence of stoicism

Moore, B.A., 2013:
PTSD: past, present, and future

Tick, E., 2013:
PTSD: the sacred wound

Rhoads, J.; Pearman, T.; Rick, S., 2008:
PTSD: therapeutic interventions post-Katrina

Savel, T.G.; Lee, B.A.; Ledbetter, G.; Brown, S.; Lavalley, D.; Taylor, J.; Thompson, P., 2013:
PTT Advisor: A CDC-supported initiative to develop a mobile clinical laboratory decision support application for the iOS platform

Brilhault, J.; Noël, V., 2012:
PTT functional recovery in early stage II PTTD after tendon balancing and calcaneal lengthening osteotomy

Gil, E.; Bailón, R.; Vergara, Jé.María.; Laguna, P., 2010:
PTT variability for discrimination of sleep apnea related decreases in the amplitude fluctuations of PPG signal in children

Minematsu, T.; Egashira, N.; Kajiya, H.; Takei, M.; Takekoshi, S.; Itoh, Y.; Tsukamoto, H.; Itoh, J.; Sanno, N.; Teramoto, A.; Osamura, R.Yoshiyuki., 2007:
PTTG is a secretory protein in human pituitary adenomas and in mouse pituitary tumor cell lines

Yan, S.; Zhou, C.; Lou, X.; Xiao, Z.; Zhu, H.; Wang, Q.; Wang, Y.; Lu, N.; He, S.; Zhan, Q.; Liu, S.; Xu, N., 2009:
PTTG overexpression promotes lymph node metastasis in human esophageal squamous cell carcinoma

Tong, Y.; Zhao, W.; Zhou, C.; Wawrowsky, K.; Melmed, S., 2012:
PTTG1 attenuates drug-induced cellular senescence

Anonymous, 2013:
PTTG1 expression and it's rapidly evolving role in the progression and development of systemic malignancies

Huang, S.; Liao, Q.; Li, L.; Xin, D., 2014:
PTTG1 inhibits SMAD3 in prostate cancer cells to promote their proliferation

Yoon, C-Hwan.; Kim, M-Jung.; Lee, H.; Kim, R-Kwon.; Lim, E-Jung.; Yoo, K-Chun.; Lee, G-Haeng.; Cui, Y-Hong.; Oh, Y.Seok.; Gye, M.Chan.; Lee, Y.Yiul.; Park, I-Chul.; An, S.; Hwang, S-Gu.; Park, M-Jin.; Suh, Y.; Lee, S-Jae., 2012:
PTTG1 oncogene promotes tumor malignancy via epithelial to mesenchymal transition and expansion of cancer stem cell population

Demeure, M.J.; Coan, K.E.; Grant, C.S.; Komorowski, R.A.; Stephan, E.; Sinari, S.; Mount, D.; Bussey, K.J., 2014:
PTTG1 overexpression in adrenocortical cancer is associated with poor survival and represents a potential therapeutic target

Li, H.; Yin, C.; Zhang, B.; Sun, Y.; Shi, L.; Liu, N.; Liang, S.; Lu, S.; Liu, Y.; Zhang, J.; Li, F.; Li, W.; Liu, F.; Sun, L.; Qi, Y., 2013:
PTTG1 promotes migration and invasion of human non-small cell lung cancer cells and is modulated by miR-186

Moreno-Mateos, M.A.; Espina, Águeda.G.; Torres, Bén.; Gámez del Estal, Mía.M.; Romero-Franco, A.; Ríos, R.M.; Pintor-Toro, Jé.A., 2012:
PTTG1/securin modulates microtubule nucleation and cell migration

Panguluri, S.Kumar.; Yeakel, C.; Kakar, S.S., 2008:
PTTG: an important target gene for ovarian cancer therapy

Attitalla, I.Hamad., 2012:
PTU induction provide quick screening of hypo and hyperlipidemia

Chaalal, A.; Poirier, R.; Blum, D.; Gillet, B.; Le Blanc, P.; Basquin, M.; Buée, L.; Laroche, S.; Enderlin, Vérie., 2015:
PTU-induced hypothyroidism in rats leads to several early neuropathological signs of Alzheimer's disease in the hippocampus and spatial memory impairments

Bhanja, S.; Chainy, G.B.N., 2010:
PTU-induced hypothyroidism modulates antioxidant defence status in the developing cerebellum

Oehler, C.; Lang, S.; Dimmerling, P.; Bolesch, C.; Kloeck, S.; Tini, A.; Glanzmann, C.; Najafi, Y.; Studer, G.; Zwahlen, D.R., 2016:
PTV margin definition in hypofractionated IGRT of localized prostate cancer using cone beam CT and orthogonal image pairs with fiducial markers

Zhang, M.; Moiseenko, V.; Liu, M., 2007:
PTV margin for dose escalated radiation therapy of prostate cancer with daily on-line realignment using internal fiducial markers: Monte Carlo approach and dose population histogram (DPH) analysis

Tanderup, K.; Pötter, R.; Lindegaard, J.Christian.; Berger, D.; Wambersie, Aé.; Kirisits, C., 2011:
PTV margins should not be used to compensate for uncertainties in 3D image guided intracavitary brachytherapy

Nestle, U.; Kotzerke, J., 2010:
PTV--PET traced volume?

Liu, W.; Frank, S.J.; Li, X.; Li, Y.; Zhu, R.X.; Mohan, R., 2013:
PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization

Zhou, W.; Li, H.; Feng, X-Ling.; Wang, L.; Zhu, B.; Li, H.; Yao, K-Tai.; Ren, C-Ping., 2007:
PTX1 in nasopharyngeal carcinoma by RNAi technology

He, X.; Han, B.; Bai, X.; Zhang, Y.; Cypel, M.; Mura, M.; Keshavjee, S.; Liu, M., 2010:
PTX3 as a potential biomarker of acute lung injury: supporting evidence from animal experimentation

Bozza, S.; Campo, S.; Arseni, B.; Inforzato, A.; Ragnar, L.; Bottazzi, B.; Mantovani, A.; Moretti, S.; Oikonomous, V.; De Santis, R.; Carvalho, A.; Salvatori, G.; Romani, L., 2014:
PTX3 binds MD-2 and promotes TRIF-dependent immune protection in aspergillosis

Guo, P.; Zhang, S-Zhen.; He, H.; Zhu, Y-Ting.; Tseng, S.C.G., 2012:
PTX3 controls activation of matrix metalloproteinase 1 and apoptosis in conjunctivochalasis fibroblasts

de Boer, M.G.J.; Halkes, C.J.M.; van de Vosse, E., 2014:
PTX3 deficiency and aspergillosis

Vehreschild, J.Janne.; Vehreschild, M.J.G.T.; Cornely, O.A., 2014:
PTX3 deficiency and aspergillosis

Nebuloni, M.; Pasqualini, F.; Zerbi, P.; Lauri, E.; Mantovani, A.; Vago, L.; Garlanda, C., 2011:
PTX3 expression in the heart tissues of patients with myocardial infarction and infectious myocarditis

de Kruif, M.D.; Limper, M.; Sierhuis, K.; Wagenaar, J.F.P.; Spek, C.Arnold.; Garlanda, C.; Cotena, A.; Mantovani, A.; ten Cate, H.; Reitsma, P.H.; van Gorp, E.C.M., 2010:
PTX3 predicts severe disease in febrile patients at the emergency department

Lee, E-Jin.; Song, D-Hyun.; Kim, Y-Ju.; Choi, B.; Chung, Y-Ho.; Kim, S-Min.; Koh, J-Min.; Yoon, S-Yong.; Song, Y.; Kang, S-Wook.; Chang, E-Ju., 2014:
PTX3 stimulates osteoclastogenesis by increasing osteoblast RANKL production

Dong, Z.; An, F.; Wu, T.; Zhang, C.; Zhang, M.; Zhang, Y.; An, G.; An, F., 2011:
PTX3, a key component of innate immunity, is induced by SAA via FPRL1-mediated signaling in HAECs

Pucci, S.; Fisco, T.; Zonetti, M.J.; Bonanno, E.; Mazzarelli, P.; Mauriello, A., 2015:
PTX3: a modulator of human coronary plaque vulnerability acting by macrophages type 2

Lin, J-Huei.; Haug, P.J., 2008:
PTXT Finder - an application for finding appropriate EHR data elements for data analysis using cross referencing information sources

Martinache, G.; Zerbib, M.; Descazeaud, A.; Debré, B.; Peyromaure, M., 2008:
PTa bladder tumours: prognostic factors of recurrence and progression

Saladin, A.; Fiorucci, Sébastien.; Poulain, P.; Prévost, C.; Zacharias, M., 2009:
PTools: an opensource molecular docking library

Gregor, I.; Steinbrück, L.; McHardy, A.C., 2013:
PTree: pattern-based, stochastic search for maximum parsimony phylogenies

Röllin, S.; Sahli, H.; Holzer, R.; Astner, M.; Burger, M., 2009:
PU and NP analysis of soil and sediment samples with ICP-MS

Qu, Z.; Wang, S.; Teng, R.; Yi, X., 2014:
PU-H71 effectively induces degradation of IκB kinase β in the presence of TNF-α

Burda, P.; Curik, N.; Kokavec, J.; Basova, P.; Mikulenkova, D.; Skoultchi, A.I.; Zavadil, J.; Stopka, T., 2010:
PU.1 activation relieves GATA-1-mediated repression of Cebpa and Cbfb during leukemia differentiation

Jin, F.; Li, Y.; Ren, B.; Natarajan, R., 2011:
PU.1 and C/EBP(alpha) synergistically program distinct response to NF-kappaB activation through establishing monocyte specific enhancers

Feng, R.; Desbordes, S.C.; Xie, H.; Tillo, E.Sanchez.; Pixley, F.; Stanley, E.Richard.; Graf, T., 2008:
PU.1 and C/EBPalpha/beta convert fibroblasts into macrophage-like cells

Termén, S.; Tollin, M.; Rodriguez, E.; Sveinsdóttir, Sún.H.; Jóhannesson, B.; Cederlund, A.; Sjövall, J.; Agerberth, B.; Gudmundsson, G.H., 2008:
PU.1 and bacterial metabolites regulate the human gene CAMP encoding antimicrobial peptide LL-37 in colon epithelial cells

Gupta, P.; Gurudutta, G.U.; Saluja, D.; Tripathi, R.P., 2010:
PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis

Yoon, H.; Boss, J.M., 2010:
PU.1 binds to a distal regulatory element that is necessary for B cell-specific expression of CIITA

Wei, F.; Zaprazna, K.; Wang, J.; Atchison, M.L., 2009:
PU.1 can recruit BCL6 to DNA to repress gene expression in germinal center B cells

Xu, J-Hua.; Wang, T.; Wang, X-Guo.; Wu, X-Peng.; Zhao, Z-Zhou.; Zhu, C-Gang.; Qiu, H-Ling.; Xue, L.; Shao, H-Jie.; Guo, M-Xiong.; Li, W-Xin., 2010:
PU.1 can regulate the ZNF300 promoter in APL-derived promyelocytes HL-60

Choe, K.S.; Ujhelly, O.; Wontakal, S.N.; Skoultchi, A.I., 2010:
PU.1 directly regulates cdk6 gene expression, linking the cell proliferation and differentiation programs in erythroid cells

Gu, Z-Min.; Liu, C-Xu.; Wu, S-Fang.; Zhao, M.; Xu, H-Zhang.; Liu, W.; Zhou, H-Chen.; Chen, G-Qiang.; Wu, Y-Li., 2011:
PU.1 directly regulates retinoic acid-induced expression of RIG-G in leukemia cells

Albajar, M.; Gutierrez, P.; Richard, C.; Rosa-Garrido, M.; Gómez-Casares, M.Teresa.; Steegmann, J.L.; León, J.; Delgado, M.Dolores., 2008:
PU.1 expression is restored upon treatment of chronic myeloid leukemia patients

Foxler, D.E.; James, V.; Shelton, S.J.; Vallim, T.Q.de.A.; Shaw, P.E.; Sharp, T.V., 2011:
PU.1 is a major transcriptional activator of the tumour suppressor gene LIMD1

Okuno, Y.; Yuki, H., 2013:
PU.1 is a tumor suppressor for B cell malignancies

Zhu, X-Jun.; Yang, Z-Fa.; Chen, Y.; Wang, J.; Rosmarin, A.G., 2013:
PU.1 is essential for CD11c expression in CD8(+)/CD8(-) lymphoid and monocyte-derived dendritic cells during GM-CSF or FLT3L-induced differentiation

Takemoto, C.M.; Brandal, S.; Jegga, A.G.; Lee, Y-Nam.; Shahlaee, A.; Ying, Y.; Dekoter, R.; McDevitt, M.A., 2010:
PU.1 positively regulates GATA-1 expression in mast cells

Ziliotto, R.; Gruca, M.R.; Podder, S.; Noel, G.; Ogle, C.K.; Hess, D.A.; DeKoter, R.P., 2014:
PU.1 promotes cell cycle exit in the murine myeloid lineage associated with downregulation of E2F1

Ji, S.; Li, W.; Bao, L.; Han, P.; Yang, W.; Ma, L.; Meng, F.; Cao, B., 2014:
PU.1 promotes miR-191 to inhibit adipogenesis in 3T3-L1 preadipocytes

Chang, H-Chen.; Han, L.; Jabeen, R.; Carotta, S.; Nutt, S.L.; Kaplan, M.H., 2009:
PU.1 regulates TCR expression by modulating GATA-3 activity

Desai, S.; Bolick, S.C.E.; Maurin, M.; Wright, K.L., 2009:
PU.1 regulates positive regulatory domain I-binding factor 1/Blimp-1 transcription in lymphoma cells

Merad, M., 2010:
PU.1 takes control of the dendritic cell lineage

de la Rica, L.; Rodríguez-Ubreva, J.; García, M.; Islam, A.B.M.M.K.; Urquiza, Jé.M.; Hernando, H.; Christensen, J.; Helin, K.; Gómez-Vaquero, C.; Ballestar, E., 2015:
PU.1 target genes undergo Tet2-coupled demethylation and DNMT3b-mediated methylation in monocyte-to-osteoclast differentiation

Zhao, M.; Duan, X-Fang.; Wen, D-Hua.; Chen, G-Qiang., 2009:
PU.1, a novel caspase-3 substrate, partially contributes to chemotherapeutic agents-induced apoptosis in leukemic cells

Bheda, A.; Yue, W.; Gullapalli, A.; Shackelford, J.; Pagano, J.S., 2011:
PU.1-dependent regulation of UCH L1 expression in B-lymphoma cells

Sun, Y.; Sun, J.; Tomomi, T.; Nieves, E.; Mathewson, N.; Tamaki, H.; Evers, R.; Reddy, P., 2013:
PU.1-dependent transcriptional regulation of miR-142 contributes to its hematopoietic cell-specific expression and modulation of IL-6

Xu, X-Wei.; Ding, B-Wen.; Zhu, C-Rong.; Ji, W.; Li, J-Shou., 2014:
PU.1-silenced dendritic cells prolong allograft survival in rats receiving intestinal transplantation

Xue, Y.; Liu, X.; Sun, J., 2010:
PU/PTFE-stimulated monocyte-derived soluble factors induced inflammatory activation in endothelial cells

Du, C.; Shi, J.; Shi, J.; Zhang, L.; Cao, S., 2014:
PUA/PSS multilayer coated CaCO3 microparticles as smart drug delivery vehicles

Kulyyassov, A.; Shoaib, M.; Pichugin, A.; Kannouche, P.; Ramanculov, E.; Lipinski, M.; Ogryzko, V., 2011:
PUB-MS: a mass spectrometry-based method to monitor protein-protein proximity in vivo

Li, W.; Dai, L.; Wang, G-Liang., 2013:
PUB13, a U-box/ARM E3 ligase, regulates plant defense, cell death, and flowering time

Anonymous, 1947:
PUBLIC Dental Service Association sickness and accident insurance scheme for dental technicians

Anonymous, 1948:
PUBLIC Dental service in Sweden

Ellison, E.J.; Brock, F.W., 1935:
PUBLIC EASY MARK NO. 1: On Certain Collection(?) Agencies

Enslow, L.H.; Cohn, M.M.; Galan, P.G.; Ferguson, G.H.; Gorman, A.E.; Green, C.E.; Miller, A.P.; Pool, C.L.; Reynolds, L.B.; Steel, E.W.; Sullivan, E.C.; Tatlock, M.W.; Waterman, E.L., 1933:
PUBLIC HEALTH ENGINEERING: Public Health Engineering Manual

Anonymous, 1912:
PUBLIC HEALTH NOTES: Public Health in England and Wales in 1910

Khan, A.M.; Mydra, H.; Nevarez, A., 2017:
Clinical Practice Updates in the Management Of Immune Thrombocytopenia

Moree, E.A., 1916:
PUBLIC HEALTH PUBLICITY: THE ART OF FOCUSING PUBLIC OPINION: IV. Newspaper Publicity

Moree, E.A., 1916:
PUBLIC HEALTH PUBLICITY: THE ART OF STIMULATING AND FOCUSING PUBLIC OPINION: I The Scope of Publicity

Moree, E.A., 1916:
PUBLIC HEALTH PUBLICITY: THE ART OF STIMULATING AND FOCUSING PUBLIC OPINION: III. Making a Meeting Effective

Moree, E.A., 1916:
PUBLIC HEALTH PUBLICITY: THE ART OF STIMULATING AND FOCUSSING PUBLIC OPINION: II. Organizing for Health Publicity

Moree, E.A., 1916:
PUBLIC HEALTH PUBLICITY: V. Newspaper Advertising

Merrill, M.H., 1958:
PUBLIC HEALTH REPORT: Increase in Arthropod-Borne Encephalitis a Possibility

Hagmann, M., 2007:
PUBLIC HEALTH: Deaths Among Heroin Users Present a Puzzle

Anonymous, 2014:
PUBLIC Health dentistry; four year success report

Anonymous, 2010:
PUBLIC charities and leprosy in ancient Byzantium

Anonymous, 2011:
PUBLIC health centenary

Anonymous, 1946:
PUBLIC health during six years of war

Anonymous, 2012:
PUBLIC health nursing in Sweden

Anonymous, 1946:
PUBLIC health service drinking water standards. 1946

Anonymous, 2011:
PUBLIC medical care

Anonymous, 2016:
PUBLIC veterinary services in Great Britain and Ireland

Anonymous, 2014:
PUBLICATIONS from the Marine Biological Laboratory, 1941-1945

Fresiello, L.; Gu, Y.John.; Ferrari, G.; Di Molfetta, A.; Rakhorst, G., 2011:
PUCA pump and IABP comparison: analysis of hemodynamic and energetic effects using a digital computer model of the circulation

Bertoni, G., 2009:
PUCHI and floral meristem identity

Das, B.; Cook, D.J.; Schmitter-Edgecombe, M.; Seelye, A.M., 2012:
PUCK: An Automated Prompting System for Smart Environments: Towards achieving automated prompting; Challenges involved

Norel, R.; Petrey, D.; Honig, B., 2010:
PUDGE: a flexible, interactive server for protein structure prediction

Adam, J., 1896:
PUERPERAL FEVER TREATED by ANTISTREPTOCOCCIC SERUM, followed immediately by ENTERIC FEVER

Goodall, J.R., 1930:
PUERPERAL INFECTIONS: An Extramural Lecture

Wilson, E.A.; Christie, T., 1925:
PUERPERAL INSANITY: Notes of Cases Treated by Injections of Ovarian Extract (Whole Gland), from the Dundee Mental Hospital, Westgreen

Anonymous, 1946:
PUERPERAL bacteriaemia and septicaemia

Anonymous, 2014:
PUERTO RICO marches on

Anonymous, 1947:
PUERTO RICO, summary of vital statistics, 1945

Zhang, L-fei.; Yang, W-long.; Dong, L.; Shi, S-xin.; Zhou, L.; Zhang, X-lan.; Li, L-ling.; Niu, S.; Huang, Y-ru., 2015:
PUF passive air sampling of polycyclic aromatic hydrocarbons in atmosphere of the Yangtze River Delta, China: spatio-temporal distribution and potential sources

Quenault, T.; Lithgow, T.; Traven, A., 2011:
PUF proteins: repression, activation and mRNA localization

Pushpa, K.; Kumar, G.Anil.; Subramaniam, K., 2013:
PUF-8 and TCER-1 are essential for normal levels of multiple mRNAs in the C. elegans germline

Vaid, S.; Ariz, M.; Chaturbedi, A.; Kumar, G.Anil.; Subramaniam, K., 2013:
PUF-8 negatively regulates RAS/MAPK signalling to promote differentiation of C. elegans germ cells

Mainpal, R.; Priti, A.; Subramaniam, K., 2012:
PUF-8 suppresses the somatic transcription factor PAL-1 expression in C. elegans germline stem cells

Racher, H.; Hansen, D., 2013:
PUF-8, a Pumilio homolog, inhibits the proliferative fate in the Caenorhabditis elegans germline

Lee, D.; Ohn, T.; Chiang, Y-Chin.; Quigley, G.; Yao, G.; Liu, Y.; Denis, C.L., 2010:
PUF3 acceleration of deadenylation in vivo can operate independently of CCR4 activity, possibly involving effects on the PAB1-mRNP structure

Abete, P.; Testa, G.; Galizia, G.; Della-Morte, D.; Cacciatore, F.; Rengo, F., 2010:
PUFA for human health: diet or supplementation?

Carrié, I.; Abellan Van Kan, G.; Rolland, Y.; Gillette-Guyonnet, S.; Vellas, B., 2010:
PUFA for prevention and treatment of dementia?

Venna, V.Reddy.; Deplanque, D.; Allet, Cécile.; Belarbi, K.; Hamdane, M.; Bordet, Régis., 2008:
PUFA induce antidepressant-like effects in parallel to structural and molecular changes in the hippocampus

Abbatecola, A.M.; Evans, W.; Paolisso, G., 2010:
PUFA supplements and type 2 diabetes in the elderly

Monse, B.; Heinrich-Weltzien, R.; Benzian, H.; Holmgren, C.; van Palenstein Helderman, W., 2010:
PUFA--an index of clinical consequences of untreated dental caries

Schmutzler, S.; Bachmann, L.; Fuhrmann, H.; Schumann, J., 2011:
PUFA-dependent alteration of oxidative parameters of a canine mastocytoma cell line

Cascio, M.Grazia., 2014:
PUFA-derived endocannabinoids: an overview

Kello, M.; Mikes, Jír.; Jendzelovský, R.; Koval, Ján.; Fedorocko, P., 2010:
PUFAs enhance oxidative stress and apoptosis in tumour cells exposed to hypericin-mediated PDT

Das, U.N., 2013:
PUFAs in sickle cell disease

Yu, G.; Li, H.; Ha, S.; Shih, I-Ming.; Clarke, R.; Hoffman, E.P.; Madhavan, S.; Xuan, J.; Wang, Y., 2011:
PUGSVM: a caBIG™ analytical tool for multiclass gene selection and predictive classification

Eifler, M.; Uecker, R.; Weisbach, H.; Bogdanow, B.; Richter, E.; König, L.; Vetter, B.; Lenac-Rovis, T.; Jonjic, S.; Neitzel, H.; Hagemeier, C.; Wiebusch, Lüder., 2016:
PUL21a-Cyclin A2 interaction is required to protect human cytomegalovirus-infected cells from the deleterious consequences of mitotic entry

Anonymous, 1946:
PULLORUM disease; historical sketch

Bogen, E., 1930:
PULMONARY HEMORRHAGE: AN INVESTIGATION OF THE EXCITING FACTORS IN TUBERCULOUS HEMOPTYSIS: Clinical Prize Paper of the Fifty-Ninth Annual Session of the California Medical Association

Anonymous, 1945:
PULMONARY anoebiasis

Anonymous, 2010:
PULMONARY complications of thrombophlebitis

Anonymous, 1948:
PULMONARY infarction; a new physical sign

Kahne, S.J., 1969:
PULSE in the City of the Future

Aguirre, K.M.; Balser, T.C.; Jack, T.; Marley, K.E.; Miller, K.G.; Osgood, M.P.; Pape-Lindstrom, P.A.; Romano, S.L., 2015:
PULSE vision & change rubrics

Zhang, Y.; Yan, W.; Jung, Y.Sam.; Chen, X., 2013:
PUMA Cooperates with p21 to Regulate Mammary Epithelial Morphogenesis and Epithelial-To-Mesenchymal Transition

Yu, J., 2010:
PUMA Kills Stem Cells to Stall Cancer?

Chipuk, J.E.; Green, D.R., 2009:
PUMA cooperates with direct activator proteins to promote mitochondrial outer membrane permeabilization and apoptosis

Dudgeon, C.; Wang, P.; Sun, X.; Peng, R.; Sun, Q.; Yu, J.; Zhang, L., 2011:
PUMA induction by FoxO3a mediates the anticancer activities of the broad-range kinase inhibitor UCN-01

Zhang, C.; Zhang, J.; Zhang, A.; Wang, Y.; Han, L.; You, Y.; Pu, P.; Kang, C., 2011:
PUMA is a novel target of miR-221/222 in human epithelial cancers

Li, Y.; Liu, X.; Rong, F., 2011:
PUMA mediates the apoptotic signal of hypoxia/reoxygenation in cardiomyocytes through mitochondrial pathway

Zhang, Y.; Xing, D.; Liu, L., 2009:
PUMA promotes Bax translocation by both directly interacting with Bax and by competitive binding to Bcl-X L during UV-induced apoptosis

Kondratovskii, P.M.; Dubikov, A.I.; Doroshevskaya, A.Yu.; Eliseikina, M.G., 2015:
PUMA protein in p53 regulatory molecule pattern determines the prognosis for patients with lymphoproliferative diseases

Myers, M.; Morgan, F.Hamish.; Liew, S.H.; Zerafa, N.; Gamage, T.Upeksha.; Sarraj, M.; Cook, M.; Kapic, I.; Sutherland, A.; Scott, C.L.; Strasser, A.; Findlay, J.K.; Kerr, J.B.; Hutt, K.J., 2015:
PUMA regulates germ cell loss and primordial follicle endowment in mice

Qiu, W.; Carson-Walter, E.B.; Kuan, S.Fan.; Zhang, L.; Yu, J., 2009:
PUMA suppresses intestinal tumorigenesis in mice

Hikisz, Pł.; Kiliańska, Z.M., 2013:
PUMA, a critical mediator of cell death--one decade on from its discovery

Qiu, W.; Wang, X.; Leibowitz, B.; Yang, W.; Zhang, L.; Yu, J., 2011:
PUMA-mediated apoptosis drives chemical hepatocarcinogenesis in mice

Qiu, W.; Wu, B.; Wang, X.; Buchanan, M.E.; Regueiro, M.D.; Hartman, D.J.; Schoen, R.E.; Yu, J.; Zhang, L., 2011:
PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice

Labi, V.; Villunger, A., 2011:
PUMA-mediated tumor suppression: A tale of two stories

Hoffman, G.E.; Logsdon, B.A.; Mezey, J.G., 2014:
PUMA: a unified framework for penalized multiple regression analysis of GWAS data

Qiu, G-xing., 2007:
PUMC classification and fusion level selection for adolescent idiopathic scoliosis

Shigunov, Pícia.; Sotelo-Silveira, J.; Kuligovski, C.; de Aguiar, A.Melo.; Rebelatto, C.K.; Moutinho, Jé.A.; Brofman, P.S.; Krieger, M.A.; Goldenberg, S.; Munroe, D.; Correa, A.; Dallagiovanna, B., 2012:
PUMILIO-2 is involved in the positive regulation of cellular proliferation in human adipose-derived stem cells

Tunc, B.; Ghanbari, Y.; Smith, A.R.; Pandey, J.; Browne, A.; Schultz, R.T.; Verma, R., 2015:
PUNCH: Population Characterization of Heterogeneity

Giorgini, S.; Barbisan, F.; Morichetti, D.; Mazzucchelli, R.; Marzioni, D., 2009:
PUNLMP or not PUNLMP? This is the problem

Dalla Palma, P., 2012 :
PUNLMPs are sunflowers and not snowglobes

Anonymous, 1948:
PURCHASE tax on medicines

Anonymous, 1936:
PURE FOOD AND DRUGS: Activities of the Bureau of Food and Drugs of the California State Board of Health: Report for the Month of January, 1936

Veltman, L.; Larison, K., 2014:
PURE conversations: enhancing communication and teamwork

Kanamori, T.; Fujino, Y.; Ueda, T., 2014:
PURE ribosome display and its application in antibody technology

Ueda, T., 2011:
PURE system: a reconstituted cell-free protein synthesis system

Shimizu, Y.; Ueda, T., 2010:
PURE technology

Ueda, T., 2007:
PURE technology for protein production

Yoneya, T.; Mamitsuka, H., 2008:
PURE: a PubMed article recommendation system based on content-based filtering

Rangachary, L.; Rajagopalan, R.Pallavur.; Singh, T.Munna.; Krishnan, M.Haravey., 2012:
PURIFICATION and characterization of ddt-dehydrohalogenase from Pseudomonas putida T5

Anonymous, 1942:
PURKYNE-A Pioneer in Ophthalmoscopy

Ewigman, B.; Susman, J., 2008:
PURLS--translating research into reality

Deane, K.; Jones, K.; Stevermer, J.J., 2010:
PURLS: A-fib and rate control: don't go too low

Barnhouse, K.; Zolotor, A.J.; Stulberg, D., 2010:
PURLS: How best to help kids lose weight

Rowland, K.; Schumann, S-Anne., 2010:
PURLs. Palliative care: earlier is better

Wellington, L.; Prasad, S., 2012:
PURLs. Should breastfeeding babies be given pacifiers?

Pereira, S.; Nguyen, L.; Stevermer, J.J., 2014:
PURLs: A simple way to reduce catheter-associated UTIs

Lounsbery, J.; Prasad, S.; Rowland, K., 2010:
PURLs: Add a fibrate to a statin?

Morris, L.; Stevermer, J.J., 2013:
PURLs: An alternative to warfarin for patients with PE

Sharma, U.A., 2010:
PURLs: Another option for patients with liver disease

Kirley, K.; Sharma, U.; Rowland, K., 2012:
PURLs: BP meds: this simple change improves outcomes

Stephens, L.A.; Stevermer, J.J., 2012:
PURLs: Counseling is a must with this smoking cessation aid

Rogers, N.; Stevermer, J.J., 2011:
PURLs: Ear wax removal: help patients help themselves

Thomas, G.B.; Asher, G.N.; Mounsey, A., 2014:
PURLs: Finally, a way to relieve cancer-related fatigue

Jones, K.; Ewigman, B., 2011:
PURLs: Help for recurrent bacterial vaginosis

Page, C.; Mounsey, A.; Rowland, K., 2014:
PURLs: Is self-swabbing for STIs a good idea?

Urban, K.; Kirley, K.; Stevermer, J.J., 2014:
PURLs: It's time to use an age-based approach to D-dimer

Slatkoff, S.; Gamboa, S.; Zolotor, A.J.; Mounsey, A.L.; Jones, K., 2011:
PURLs: PSA testing: when it's useful, when it's not

Slattengren, A.H.; Christensen, T.; Prasad, S.; Jones, K., 2014:
PURLs: Prolotherapy: a nontraditional approach to knee osteoarthritis

Swenson, A.K.; Brown, D.; Stevermer, J.J., 2012:
PURLs: Pulse oximetry for newborns: should it be routine?

Boisselle, C.; Rowland, K., 2012:
PURLs: Rethinking antibiotics for sinusitis: again

Nissly, T.; Prasad, S., 2014:
PURLs: Should you consider antibiotics for exacerbations of mild COPD?

Slattengren, A.H.; Prasad, S.; Kaiseruddin, M.Altaf., 2014:
PURLs: Should you screen for postpartum depression?

Oyola, S.; Jones, K.; Rao, G., 2013:
PURLs: Suspect carpal tunnel? Try this

Kirley, K.; Nguyen, L., 2014:
PURLs: Think twice about nebulizers for asthma attacks

Kirley, K.; Rowland, K., 2011:
PURLs: Time to try this warfarin alternative?

Wells, J.C.; Stevermer, J.J., 2013:
PURLs: Trauma care--don't delay with TXA

Mounsey, A.; Roque, J.M.; Egan, M., 2014:
PURLs: Why you shouldn't start beta-blockers before surgery

Rao, G.; Rowland, K., 2011:
PURLs: Zinc for the common cold--not if, but when

Kaiseruddin, A.; Oyola, S.; Rao, G., 2013:
PURLs: a safer way to prevent VTE recurrence

Ashkin, E.; Mounsey, A., 2013:
PURLs: a spoonful of honey helps a coughing child sleep

Stevermer, J.J.; Rogers, N.V., 2011:
PURLs: arthritis pain? These supplements provide little relief

Brown, D.; Rowland, K., 2012:
PURLs: combatting lice in a single treatment

Levy, R.; Prasad, S.; Rowland, K., 2011:
PURLs: consider this option for heavy menstrual bleeding

Bergeson, K.; Rogers, N.; Prasad, S., 2013:
PURLs: corticosteroids for a sore throat?

Slattengren, A.H.; Prasad, S.; Oyola, S., 2016:
PURLs: is this pregnancy viable?

Jones, K.; Egan, M.; Stevermer, J.J., 2011:
PURLs: offer this contraceptive to breastfeeding new moms

Brown, D.; Rowland, K., 2013:
PURLs: optimal timing for peripheral IV replacement?

Levy, R.; Prasad, S., 2013:
PURLs: patient overusing antianxiety meds? Say so (in a letter)